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ABSTRACT 
 
The principal aim of the research described in this thesis was to develop a technique 
of non-invasively measuring the oxygen saturation within the retinal vasculature of human 
subjects (retinal oximetry). The evaluation of a hyperspectral fundus camera used to acquire 
retinal images in different wavelengths of visible light, and the image analysis techniques 
used to perform retinal oximetry are described.   
Validation of the oximetry techniques was performed using an artificial eye 
containing human blood of known oxygen saturation: the calculated oxygen saturation was 
compared to the gold standard measurement. The mean differences between the calculated 
and measured oxygen saturations were small.  
Hyperspectral imaging/oximetry of normal subjects was performed to characterize the 
oximetric features of the retinal vasculature. The mean oxygen saturation (± SD) of the 
temporal retinal arterioles and venules were 110.8% (± 11.8%) and 27.7% (± 3.2%) 
respectively.  
The application of the retinal oximetry technique was explored in patients with retinal 
arterial and venous occlusion to determine whether oximetric changes in the retinal 
vasculature could be detected. Variation in measured oxygen saturation of the retinal 
arterioles and venules respectively were apparent, and corresponded with angiographic 
features of retinal capillary loss. 
The techniques were applied to patients with asymmetrical primary open angle 
glaucoma to determine whether oximetric changes could be detected. The mean oxygen 
saturation of the temporal retinal venules were significantly higher [44.8% (± 24.2%)] in the 
more advanced glaucomatous eyes compared to normal subjects. Hyperoxia of the retinal 
venules suggests reduced oxygen consumption as a consequence of inner retinal dysfunction 
in glaucoma. However, because of the small sample size, further research on a larger 
population of subjects is required to support this finding. 
Hyperspectral imaging could be used to detect oximetric abnormalities in the retinal 
vasculature in patients with retinovascular occlusion and glaucoma. 
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Chapter 1: Introduction. 
 
1.1. The Human Eye. 
 
1.1.1.  An Applied Gross Anatomy of the Human Eye and the Visual System. 
 
The eye is a highly specialized sensory organ located in the anterior portion of the 
orbit which makes up the visual system. The main function of the eye is to enable vision. 
This is achieved by processing reflected or emitted light from objects in the environment. 
Light entering the eye travels through the ocular media which consists of the cornea, anterior 
chamber, crystalline lens and vitreous. The result is the projection of an inverted image on to 
the retina. Upon reaching the retina, the light photons undergo first-order processing by the 
photoreceptors (located in the outer retina) into neural signals. Second-order processing of 
the neuronal signals occurs throughout the inner layers of the retina. The neuronal 
information is transmitted to the ganglion cells (located in the inner most layer of the retina) 
which is subsequently relayed to the brain via the optic nerve, optic chiasm, optic tracts and 
lateral geniculate bodies. Further processing of the visual information is performed in the 
visual cortex, occipitotemporal, temporal, occipitoparietal, and parietal lobes of the brain. 
(Figure 1.1) 
 
1.1.2. The Structure of the Eye. 
 
The human adult eye (Figure 1.2) is approximately spherical in shape with an average 
anteroposterior diameter of 24 mm (range 21-26 mm) (Snell and Lemp, 1998). The eye is 
comprised of three coats (tunics), the corneoscleral coat, the uvea (and uveal tract) and the 
neural layer (retina). 
The cornea is a thin and transparent structure which, due to the difference in the 
refractive index of between the air and tear film of the eye, constitutes two thirds of the total 
refractive power of the human eye (~40 D) (Sivak, 1988). The sclera is a white, avascular 
fibrous coat consisting of irregularly-arranged collagen fibrils. Its principle function is to 
protect the intraocular contents of the eye.  
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The uvea and uveal tract are pigmented layers consisting of the iris, ciliary body and 
choroid. The iris is a thin, circular structure located anterior to the lens which contains several 
layers of pigment cells which determine the colour of the iris and blocks light from passing 
through the iris to the retina. 
The ciliary body is a circumferential ring of tissue comprising of the ciliary muscle 
and ciliary processes which extends from the sclera spur anteriorly to the ora serrata 
posteriorly. It has three principal functions: accommodation, aqueous humour production and 
production of the lens zonules and extracellular components of the vitreous. 
 
Figure 1.1: The human visual pathway. 
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Figure 1.2: The structure of the human eye. 
 
 
 
1.1.2.1. The Choroid. 
 
 The choroid, located between the retina and sclera, is comprised of a rich network of 
blood vessels, cells and connective tissues. Histologically, the choroid is comprised of five 
layers: Bruch's membrane (inner most layer), choroiocapillaris, the two vascular layers 
(Haller's and Sattler's), and the suprachoroid (Figure 1.3A and B) (Hogan et al., 1971). The 
thickness of the choroid is variable, approximately 426 µm at the subfovea (Brown et al., 
2009), and is thought to be dependent on intraocular pressure (IOP)(Nickla et al., 1998; 
Nickla et al., 2002), refractive state of the eye (Hung et al., 2000; Troilo et al., 2000), blood 
flow (Fitzgerald et al., 2002) and diurnal variations (Brown et al., 2009). 
The choriocapillaris is a thin (10 μm at the fovea) layer apposed to Bruch’s membrane 
consisting of a network of wide-bore fenestrated capillaries about 20 - 40 µm wide (Bill et 
al., 1983). The capillaries originate from the arterioles in Sattler’s layer and form a hexagonal 
arrangement of capillaries. The post-capillary venous channels drain the periphery of the 
hexagonal lobules (Figure 1.4). The flow of red blood cells is about 79% that of the velocity 
of red blood cells in the retinal capillaries (Wajer et al., 2000). 
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Figure 1.3: The choroid. A. A schematic illustration of the choroidal layers (Remington, 
1998). B. Histological section of the outer retina and choroid in the primate eye. RPE: retinal 
pigment epithelium; CC: choriocapillaris; SL: Sattler's layer; HL: Haller's layer (Forrester et 
al., 2002). 
 
 
 
Figure 1.4: The choriocapillaris and arterioles in Sattler’s layer (Forrester et al., 2002). 
 
 
 
 
The vascular layers of the choroid consists of the outer Haller's layer of large blood 
vessels and the inner Sattler's layer of intermediate sized vessels that feed and drain the 
capillary network. Blood is supplied primarily from the long and short posterior ciliary 
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arteries and venous drainage occurs via a complex of large vortex veins each draining a 
sector of the choroid to the superior and inferior ophthalmic veins in the orbit (Figure 1.5). 
The suprachoroid is a 30 µm thick avascular layer containing collagen, melanocytes and 
fibroblasts separating the choroid from the sclera. 
 
Figure 1.5: Arterial supply and venous drainage of the eye. (SPCA: short posterior ciliary 
artery; LPCA: long posterior ciliary artery) (Forrester et al., 2002). 
 
 
 
The main function of the choroid is to supply the outer two thirds of the retina with 
oxygen and nutrients. Other functions of the choroid include thermoregulation by heat 
dissipation through traversing blood vessels, drainage of aqueous humor (Alm and Nilsson, 
2009), modulation of IOP via blood flow regulation and light absorption.  
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1.1.2.2. The Lens. 
 
The lens consists of a thin, transparent and elastic biconvex capsule that encloses a 
collection of specialized cells (lens fibres). It is located posterior to the iris and anterior to the 
vitreous suspended by the zonular fibres attached laterally. The primary function of the lens 
is to enable a sharp image to be formed on the retina by changing its refractive properties 
(accommodation). This is achieved by the contractile state of the ciliary muscle. The 
refractive power of the adult human lens in its relaxed state is approximately 19D (Smith, 
2003) and varies with age (Jones et al., 2005; Borja et al., 2008). 
 
1.1.2.3. The Vitreous. 
 
The vitreous is a transparent, virtually acellular extracellular matrix located posterior 
to the lens, posterior lens zonules and ciliary body; and is surrounded posteriorly by the retina 
and pars planar. It consists of more than 98% water and its gel-like structure is attributed by 
the presence of fine, unbranched collagen fibrils interspersed by a network of hyaluronan. Its 
physiological functions are incompletely understood, however its main role is thought to be a 
means to provide nutrients and oxygen to the lens (Fatti, 1977).  
 
1.1.2.4. The Retina. 
 
The retina is the light sensitive innermost coat of the eye which converts light photons 
into neural impulses that are transmitted to the brain enabling vision. The en face aspect of 
the retina can be defined into several regions with different topographical characteristics 
(Figure 1.6).   
The posterior pole (area centralis) is a 5 – 6 mm circular area located between the 
superior and inferior temporal arterioles. It contains several layers of ganglion and bipolar 
cells (Spitznas, 1977). 
The fovea (macula lutea), located 3 mm lateral to the optic disc, is a 1.5 mm diameter 
circular area in the posterior pole. It consists of a thin bottom and a thickened margin which 
represents the lateral displacement of second and third order neurons in the inner nuclear 
layer (mostly the cell bodies of Müller glia cells). It consists exclusively of tightly packed 
cone photoreceptors (150,000 per mm2). A network of capillaries, located at the level of the 
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internal nuclear layer, encircle the fovea which consists of an avascular zone 250 – 600 μm 
wide. 
The foveola is a central circular area within the lowest point of the fovea. It is 350 μm 
in diameter and 150 μm thick. The cone photoreceptors are enclosed by the processes of the 
Müller cells which, in addition to the retinal pigment epithelium (RPE) via the underlying 
choriocapillaris, provides nutritional support to sustain the high metabolic demand of the 
cones (Schubert, 2008). 
The peripheral retina extends from the border of the posterior pole to the ora serrata 
anteriorly. It consists predominantly of rod photoreceptors (30,000 per mm2) and is 
comparatively thinner (110 - 140 μm thick) than the retina at the posterior pole primarily due 
to the presence of only one layer of ganglion cell bodies. 
The optic disc (optic nerve head) is a circular structure medial to the macula 
consisting of ganglion cell axons penetrating the underlying sclera (lamina cribrosa) as it 
enters the optic nerve. This structure is devoid of photoreceptors. The central retinal vessels, 
originating from the ophthalmic artery and vein, traverses through the centre of the optic disc 
and branches out to supply the retina (Figures 1.6 and 1.7). The short posterior ciliary arteries 
medial and lateral to the optic nerve, originating from the ophthalmic artery, form an arcuate 
anastamosis within the peripapillary sclera forming a complete circle in the majority of eyes 
(Olver et al., 1990; Onda et al., 1995) which is synonymous to the arterial circle described by 
Haller and Zinn (Zinn, 1755)(Figure 1.7). These vessels provide the blood supply to the 
axons in the prelaminar and laminar portions of the optic nerve.  
The optic disc is often used as a landmark to separate the retina into quadrants. The 
temporal and nasal halves are delineated by a vertical line and the superior and inferior halves 
are delineated by a horizontal line passing through the centre of the optic disc (Figure 1.6). 
The angioarchitecture of the large retinal blood vessels can be classified according to the 
quadrants through which they traverse. 
The retina is organized into two distinct layers: the inner neurosensory retina and an 
outer RPE (Figure 1.8). The neurosensory retina is a transparent layer composed 
predominantly of neural cells (photoreceptors, bipolar and ganglion cells). The activities of 
these cells are regulated by supporting cells, namely the horizontal, amacrine and Müller cells 
whose cell bodies and axonal processes traverse the inner and outer nuclear layers and inner 
and outer plexiform layers. Bipolar and horizontal cells synapse with the photoreceptors in 
the outer plexiform layer. Within the inner plexiform layer the bipolar and amacrine cells 
synapse with the dendrites of the ganglion cells. These connections represent the initial 
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circuitary of the visual pathway. Other cell types interspersed within the neurosensory retinal 
layer include vascular endothelium, pericytes, and microglia. 
 
Figure 1.6: En face view of the human retina. (CRA: central retinal artery; CRV: central 
retinal vein; STA: superotemporal arteriole; STV: superotemporal venule; ITA: 
inferotemporal arteriole; ITV: inferotemporal venule; INA: inferonasal arteriole; INV: 
inferonasal venule; SNA: superonasal arteriole; SNV: superonasal venule). 
 
 
 
Figure 1.7: The anterior optic nerve (Sadun 2008). 
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Figure 1.8: Layers of the retina and neural connections. A. Electron micrograph of the retina 
demonstrating the various layers (Forrester et al., 2002). B. Schematic illustration of the 
neuronal connections in the retina (Schubert, 2008). (GCL: ganglion cell layer; GC: ganglion 
cell; NFL: nerve fibre layer; V: retinal vessel; IPL: inner plexiform layer; INL: inner nuclear 
layer; OPL outer plexiform layer; ONL: outer nuclear layer; INS: inner segments; OS: outer 
segments; RPE: retinal pigment epithelium; CC: choriocapillaris). 
 
 
 
There are two main types of photoreceptors in the human eye: rods and cones. The 
human retina contains approximately 96 million rods and 4.6 million cones (Curcio et al., 
1990). They are specialized neuronal cells capable of phototransduction – a process by which 
the energy from a light photon is converted into the membrane potential of the photoreceptor. 
Both rods and cones possess an outer and inner segment. The outer segment functions to 
detect light photons and the inner segment houses the important organelles for cellular 
metabolism. However, these cells are functionally distinct; rods have low spatial resolution, 
are highly sensitive to light, and are primarily responsible for sensing brightness, contrast and 
motion. Cones are relatively insensitive to light but have high spatial resolution and are 
specialized for colour, depth and visual acuity. 
The retinal ganglion cells are a diverse group of specialized neurones that provide the 
link between the retina and the higher visual pathway, their axons exit the eye via the optic 
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nerve and synapse with the cell bodies of the lateral geniculate nucleus (LGN). There are 
several ganglion cell subtypes with a diverse range of functions. Although largely age-
dependent (Harman et al., 2000; Gao and Hollyfield, 1992; Harwerth et al., 2008), there are 
approximately 0.7 to 1.5 million ganglion cells in the human retina (Curcio and Allen, 1990). 
The RPE is the outer pigmented layer of the retina composed of a monolayer of 
hexagonal cells located between the photoreceptors and Bruch’s membrane. It extends from 
the optic disc to the ora serrata and has a number of important functions. Its role in supporting 
the photoreceptors, such as the synthesis of enzymes for visual pigment metabolism, 
membrane transport of metabolites, requires a high demand of energy which is reflected by 
the abundance of mitochondria located towards its basal zones. 
 
1.1.2.5. The Retinal and Choroidal Circulation. 
 
The human retina has a dual blood supply to meet the high metabolic demands of the 
neural tissues and RPE. The inner two-thirds of the retina are supplied from branches of the 
central retinal vessels and the outer one-third of the retina is supplied by the choroid creating 
a watershed zone at the outer plexiform layer. The central retinal artery, derived from the 
ophthalmic artery (first branch of the internal carotid artery)(Heyreh, 1962), arises from the 
centre of the optic nerve and is in close association with the central retinal vein. It decreases 
to approximately 110 µm as it crosses the optic disc margin and it typically branches into 
superior and inferior arterioles which further divide into temporal and nasal branches.  
The four major branches of the central retinal artery are usually devoid of elastic fibers and 
internal elastic membrane and represent functional end-arterioles which supply an area (or 
quadrant) of the retina with no overlap. These branches traverse across the retina within the 
nerve fibre layer bounded anteriorly by the inner limiting membrane.  
Within the retinal layers, capillaries are organized into one to three layers of laminar 
meshwork (Shimizu et al., 1978), typically at the level of the ganglion cell layer and inner 
nuclear layer, enabling nutritional support to all retinal cells. Retinal capillaries are 5-6 µm in 
diameter, are more abundant at the macula compared to the peripheral retina and are absent in 
the fovea and capillary-free zones adjacent to large arterioles and venules. The blood-retinal 
barrier is formed by the tight junctions of the capillary endothelial cells and RPE which 
functions to prevent the intracellular movement of water-soluble molecules into the retina. 
The retinal venules are located in the inner retina and follow the course of the 
arterioles draining into the central retinal vein. Often the arterioles cross the venules 
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anteriorly and at this location the two vessels share an adventitial coat. Near the optic disc the 
retinal veins are approximately 150 µm in diameter (Duker and Weiter, 1991). 
The posterior ciliary arteries originate from the ophthalmic artery and further divide 
into two long posterior ciliary arteries and several short posterior ciliary arteries. The short 
posterior ciliary arteries enter the choroid in the submacular and peripapillary region and 
supply the posterior choriocapillaris. The recurrent branches of the long ciliary arteries in 
addition to recurrent branches of the anterior ciliary arteries supply the anterior 
choriocapillaris. In approximately 30% of the population a cilioretinal artery is present 
(Justice and Lehmann, 1976) and arises directly from the posterior ciliary artery providing an 
anastamotic connection between the retinal and choroidal circulation.  
A network of large vortex veins located at the equator drains blood from the choroid 
into the superior and inferior orbital veins and into the cavernous sinus and pterygoid plexus 
respectively. The central retinal vein drains the retina and prelaminar portion of the optic 
nerve into the cavernous sinus. 
The blood-retinal barrier (BRB) consists of an inner BRB (comprised of the tight 
junction between endothelial cells of the retinal vessels) and an outer BRB (comprised of the 
RPE). It is a physiological interface that selectively separates the neural tissue in the retina 
from the blood in order to maintain an optimal microenvironment for retinal function. 
 Blood flow in the choroid is regulated by the autonomic nervous system via the 
presence of sympathetic nerve fibre endings (Guglielmone and Cantino, 1982). In contrast, 
no nerve fibres are present in the walls of the retinal vessels (Ehinger, 1966) indicating that 
blood flow is autoregulated by the vascular tone of the resistance vessels mediated by local 
vasoactive substances. The retinal circulation is characterized by a low blood flow rate (80 
mL/minute) and the choroid in contrast has a high level of flow (800 mL/minute) (Alm and 
Bill, 1973; Feke et al., 1989; Roh and Weiter, 2008 ). Approximately 85% of total ocular 
blood flow is supplied by the choroidal circulation and 4% of the total ocular blood flow is 
diverted to the retinal circulation (Alm and Bill, 1973). The differences between the retinal 
and choroidal haemodynamics reflect the topographical variations in metabolic activity 
throughout the layers of the retina. Over 90% of the oxygen delivered to the retina is 
consumed by the photoreceptors which are highly metabolically active. In the dark adapted 
eye, where photoreceptor metabolism is highest, over 90% of the oxygen supply is consumed 
to sustain the depolarized resting potential via active transport of ions across the cell 
membrane (Bill et al., 1983; Linsenmeier et al., 1981; Linsenmeier and Braun, 1992). 
Approximately 70% of oxygen and glucose consumption is supplied by the choroid (Alm, 
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1992). The high flow in the choroidal circulation is thought to generate and maintain a high 
concentration gradient of oxygen to overcome the RPE barrier that separates the choroid from 
the photoreceptors (Alm and Bill, 1973; Alm, 1992). As a consequence of this high flow, 
oxygen extraction is relatively low in comparison to the retinal circulation (arterio-venous 
difference of 3% versus 40% respectively) (Törnquist et al., 1979; Hickam et al., 1963). 
 
 
1.2. Oxygen Physiology. 
 
1.2.1. Oxygen Transport. 
 
Oxygen is utilized in most tissues as a primary substrate for generating energy which 
is important in maintaining tissue viability and function. In humans, oxygen in the alveoli of 
the lungs diffuses into the pulmonary blood which in turn is transported to the tissues. 
Ninety-seven percent of oxygen in blood is bound to haemoglobin contained in the red blood 
cells. Haemoglobin is a complex iron-containing metalloprotein whereby each molecule of 
haemoglobin is composed of four polypeptide protein chains tightly bound to a non-protein 
haeme group consisting of a flat organic ring (porphyrin ring) surrounding a single iron atom 
(Figure 1.9). The red colour of haemoglobin is due to the red fluorescence properties of the 
porphyrin molecules. The four iron atoms form a weak, and reversible, co-ordinate covalent 
bond with a molecule of oxygen.  
 The amount of oxygen bound to haemoglobin (per cent saturation of haemoglobin) 
progressively increases as the blood oxygen concentration (pressure of oxygen - PO2) 
increases. This relationship is known as the oxygen-haemoglobin dissociation curve and has a 
distinct sigmoid shape which describes the affinity of haemoglobin for oxygen. Several 
factors can displace the curve (Figure 1.10) and influence the oxygen affinity of 
haemoglobin. For example, an increase in blood carbon dioxide concentration and hydrogen 
ions reduces the affinity of haemoglobin molecules to oxygen and augments the release of 
oxygen from the blood into the tissues. 
Arterial blood upon reaching the peripheral tissues typically has a PO2 of 104 mm Hg. 
Continuous consumption of oxygen by the cells in the tissues results in the diffusion of 
oxygen down a concentration gradient into several compartments (oxygen cascade), before 
reaching the mitochondria (4 - 20 mm Hg) for energy production. Generally, oxygen partial 
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pressures of between 1 - 3 mm Hg is required to sustain cellular functions (Guyton and Hall, 
2006), therefore in the resting state there is an abundance of oxygen for the cells to function. 
 
Figure 1.9: The molecular structure of haemoglobin showing the α and β subunits of the 
haemoglobin protein (red and blue) and the iron containing haeme group (green). 
 
 
 
Figure 1.10: The oxygen-haemoglobin dissociation curve. 
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1.2.2. Cellular Metabolism of Oxygen. 
 
Cells utilize a series of interconnected metabolic reactions to generate energy from 
nutrients (cellular respiration). The universal energy currency in the cell is adenosine 
triphosphate (ATP), a nucleotide that is repeatedly converted from it precursor adenosine 
diphosphate (ADP). ATP is not stored, it is converted when required and immediately 
consumed. Several cellular reactions use glucose, amino acids and fatty acids via the 
glycolytic pathway in the cytoplasm, Kreb’s cycle and oxidative phosphorylation in the 
mitochondria of the cells to generate ATP (Figure 1.11). ATP contains high energy phosphate 
bonds which are readily released in an exothermic chemical reaction when ATP is 
hydrolyzed in endothermic cellular reactions (Ferguson et al. 2002). In the presence of 
oxygen, more molecules of ATP can be formed via oxidative phosphorylation in the 
mitochondria (aerobic respiration) compared to anaerobic respiration. ATP is used in 
maintaining cellular structure, synthesis and transportation of macromolecules and proteins 
and intracellular signalling.  
In the mitochondria, a small concentration of cellular oxygen is required to enable the 
enzymatic chemical processes to occur. At a cellular PO2 of greater than 1 mmHg the main 
limiting factor for energy production is the concentration of ADP in the cells (Guyton and 
Hall, 2006). When ADP concentration is increased the rate of oxygen consumption is 
increased. Energy consumption is therefore self-regulated by the energy requirement and 
expenditure of the cell. 
 
Figure 1.11: Schematic processes of cellular respiration.  
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1.3. Physiology of the Retina. 
 
1.3.1. Phototranduction and Intercellular Visual Processing 
 
The primary function of the retina is to capture light photons and convert it into neural 
stimuli. This process of phototransduction begins in the outer segments of the photoreceptors 
and is still incompletely understood. Photoreceptors maintain a constant intracellular 
concentration of sodium (Na+) and potassium (K+) via a high density of ATP dependent 
Na+/K+ pumps located on the cell membranes of the inner segments. These pumps actively 
expel Na+ ions out of the photoreceptor with an inward uptake of K+ ions. The dark adapted 
photoreceptors are maintained in a constant depolarized state (-40 mV) by a continuous 
passage of K+ ions through non-gated K+-selective channels and the inward diffusion of Na+ 
ions through cyclic guanosine monophosphate (cGMP) gated Na+ channels. The depolarized 
state of the photoreceptor opens voltage-gated calcium (Ca2+) channels which in turn 
increases the intracellular Ca2+ and stimulates the release of glutamate into the synaptic cleft 
between the photoreceptors and bipolar cells. Photopigment molecules (rhodopsin and 
iodopsin) located in the cell membranes of the photoreceptor outer segments undergo 
photoisomerization when exposed to a light photon. A series of molecular cascading 
reactions results in the hyperpolarization of the cells due to the closure of the Na+ channels, 
and subsequently the closure of the voltage-gated Ca2+ channels. As intracellular Ca2+ 
concentration decreases the release of glutamate is reduced. Consequently, the demand for 
energy and oxygen consumption is greater in darkness than in light (Okawa et al., 2008; 
Ames et al., 1992; Wangsa-Wirawan and Linsenmeier, 2003, Yu and Cringle, 2002). 
Bipolar and horizontal cells in the retina provide modulatory processing of the neural 
information which is relayed to the ganglion cells for higher-order processing. Amacrine cells 
and Müller cells are also thought to be involved in neuromodulation and further processing of 
the neural information (Masland, 1996). Retinal ganglion cells are spontaneously generating 
action potentials at the base rate which is further increased upon excitation by the retinal 
interneurons (Henne et al, 2000). 
 
1.3.2. Retinal Metabolism. 
 
The metabolic activity required to sustain dark currents, phototransduction and 
processing of the neural information is extremely high. These processes require energy of 
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which the majority is supplied in the form of ATP via oxidative phosphorylation in the 
mitochondria. The abundance of mitochondria in cells within the retina reflect the 
compartmentalized energy characteristic of its layers with the highest demand for energy in 
the unmyelinated ganglion cells, the outer plexiform layer, inner segments of the 
photoreceptors, and the RPE (Wang et al., 2003; Bristow et al., 2002; Andrews et al., 1999).  
 
 
1.4. Retinal Pathologies. 
 
1.4.1. Retinal Vascular Occlusion 
 
1.4.1.1. Definition and Classification 
 
Retinal venous obstructive disease is a condition in which obstruction to the retinal 
venous system occurs in central, hemi-central or branch retina vein. Conversely, retinal 
arterial obstructive disease occurs as a result of an obstruction to the central, cilio-retinal or 
branch retinal artery.  
 
1.4.1.2. Retinal Vein Occlusion 
 
Branch retinal vein occlusion (BRVO) is the most common form of retinal vein 
occlusion with a prevalence between 0.6% to 1.1% compared to the prevalence of central 
retinal vein occlusion (CRVO) between 0.1% and 0.4% (Klein et al., 2000; Mitchell et 
al.,1996). The incidence of BRVO and CRVO increases with age and is associated with other 
risk factors such as systemic hypertension, cardiovascular disease, increased body mass 
index, diabetes (CRVO only) and a history of glaucoma (The Eye Disease Case-Control 
Study Group, 1993).  
The underlying pathogenesis of most forms of BRVO has been proposed to occur as a 
result of compression at arteriovenous (A/V) crossing sites, endothelial damage due to 
turbulent blood flow (Christoffersen and Larsen, 1999) with subsequent thrombus formation 
within veins. Retinal veins share a common adventitial sheath at A/V crossings (Frangieh et 
al., 1982) which can be compressed between the retina and the retinal arteries particularly in 
the presence of arteriosclerosis (hardening of the arterial walls) (Duker and Brown, 1989; 
Zhao et al., 1993). Hyperviscosity of the blood as a result of high haematocrit and other 
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haematological disorders have also been associated with thrombus formation in BRVO 
(Remky et al., 1996; Kuhli-Hattenbach et al.,2010). 
 The pathogenesis of CRVO is less clear but it is generally accepted that it is 
multifactoral with both local and systemic factors playing crucial roles in the development of 
thrombus formation and permanent or temporary stagnation of venous blood flow. The main 
contributing factors are thought to be compression of the central retinal vein by the central 
retinal artery within the common adventitial sheath in the optic nerve at the level of or 
posterior to the lamina cribrosa (Green et al., 1981), haemodynamic abnormalities such as 
hypotension, haematological abnormalities and primary abnormalities of the wall of the 
central retinal vein (inflammation or degeneration) (Heyreh, 1994; Janssen et al., 2005; 
Williamson, 1977).  
Histopathological studies of branch (Frangieh et al., 1982) and central retinal vein 
occlusions (Green et al., 1981) have identified a common feature of atrophy of the inner 
retinal layers involving the nerve fibre layer, ganglion cell layer, and layers down to the inner 
aspect of the inner nuclear layer (Figure 1.12) with preservation of the outer retina (Wolter, 
1961). 
 
Figure 1.12: Histopathology of retinal vein occlusion. A. Atrophy of an inner retina distal to 
a branch retinal vein occlusion (periodic-acid Schiff, magnification x 450) (Frangieh et al., 
1982). B. Atrophy of the inner retina in a central retinal vein occlusion (periodic-acid Schiff, 
magnification x 525) (Green et al., 1981). Both histological sections show atrophic changes 
involving the ganglion cell layer, down to the inner aspect of the inner nuclear layer. 
 
 
A B
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Clinically, patients with CRVO typically present with sudden onset visual disturbance 
or loss. The fundoscopic features of CRVO include widespread deep and superficial retinal 
haemorrhages, dilated and tortuous venules, cotton-wool spots and retinal oedema. In 
contrast, patients with BRVO may be asymptomatic or present with visual blurring and a 
visual field defect corresponding to the area of the affected retina. The fundoscopic features 
of BRVO are similar to CRVO but are confined to the region of the retina drained by the 
occluded vein. Old, “burnt-out” retinal vein occlusion may exhibit venous collaterals and 
vascular sheathing. CRVO can be further categorized into two distinct groups, ischaemic and 
non-ischaemic. Ischaemic CRVO is associated with poor visual acuity (6/60 or worse), a 
relative afferent pupillary defect, presence of multiple intense and deep intra-retinal 
haemorrhages and multiple cotton-wool spots. Angiography, a test that enables the 
visualization of anatomic structures by the passage of a fluorescent dye, is the most 
commonly used technique for differentiating between ischaemic and non-ischaemic CRVO. 
The Central Retinal Vein Occlusion Study (CVOS) delineated ischaemic and non-ischaemic 
CRVOs using fluorescein angiography, designating an area of capillary nonperfusion greater 
than 10 disc diameters as ischemic and less than 10 disc diameters as nonischaemic (The 
Central Vein Occlusion Study, 1993). 
 The prognosis of BRVO is comparatively more favourable than CRVO with 50-60% 
of patients maintaining vision of 6/12 or better (Gutman et al., 1974; Michels and Gass, 1974; 
Qunilan et al., 1990). The main causes for poor final visual acuities are chronic macular 
oedema, macular ischaemia, retinal neovascularization and neovascular glaucoma (The 
Central Vein Occlusion Study, 1993; Gutman et al., 1974; Michels and Gass, 1974; Wetzig et 
al., 1979; Hayreh et al., 1983). The mainstay of current treatment for retinal vein occlusion is 
the application of argon laser photocoagulation in the presence of macular oedema (BRVO 
only) and ocular neovascularization (The Branch Retinal Vein Occlusion Study Group, 
1984). 
 
1.4.1.3. Retinal Artery Occlusion 
 
The estimated prevalence of central retinal artery occlusion (CRAO) is approximately 
0.85 in 100,000 (Rumelt et al., 1999). The prevalence of branch retinal artery occlusion 
(BRAO) is not known, but is thought to be less prevalent than CRAO. Retinal artery 
occlusion commonly affect patients over 60 years of age (Sharma et al., 1998), and is 
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associated with atherosclerosis, systemic hypertension, and diabetes (Brown and Magaragal, 
1982). 
Retinal artery occlusion occurs as a result of an obstruction to the retinal arterioles, 
most commonly from an embolic source. Inflammation of the retinal arterioles (vasculitis) is 
a less frequent condition that can result in occlusion of the retinal artery.  
In primates, experimental acute retinal artery occlusion is histologically associated 
with oedema of the inner neuronal cells within the first few hours of the insult (Figure 1.13) 
(Radius and Anderson, 1981). Experimental chronic arterial insufficiency results in the 
development of an acellular zone within the inner retina incorporating the nerve fibre layer, 
ganglion cell layer and inner plexiform layer with sparing of the outer plexiform and nuclear 
layers and photoreceptors (Hayreh et al., 2004; Zimmerman, 1965; Dahrling, 1965). The 
relationship between the duration of retinal ischaemia and the onset of irreversible retinal 
damage is unclear. Hayreh et al. (1980) demonstrated that primate retinas are able to tolerate 
up to 100 minutes of ischaemia. 
 
Figure 1.13: Light micrographs of a primate retina at intervals following experimental 
central retinal artery occlusion. A. Thirty minutes after occlusion: no abnormality seen in the 
retinal tissue. B. Four hours after occlusion: thickening and oedema of the inner-retinal 
layers. C. Twenty-four hours after occlusion: disorganization of the inner retina with atrophy 
of the ganglion cells and nerve fibre layer (Paraphenylene diamine; magnification x200) 
(Radius and Anderson, 1981). 
 
 
 
The classical presentation of a patient with a retinal artery occlusion is a sudden, 
painless, partial (BRAO) or profound (CRAO) visual loss. Visual field defect may be central 
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or sectoral. An afferent pupillary defect is usually present within seconds of a CRAO (Brown 
and Magaragal, 1982). The initial fundoscopic features may be unremarkable followed by a 
diffuse white appearance of the retina in the region supplied by the branch or central retinal 
artery. In CRAO, a cherry-red spot at the foveola is present due to incomplete hypoxia of the 
thin retina at the foveola which is supplied primarily by the choriocapillaris. The prognosis 
for BRAO is usually good when the fovea is unaffected, with approximately 80% of eyes 
achieving a final visual acuity of 6/12 or better (Brown et al., 1981). In contrast, the visual 
prognosis of CRAO is poor with 66% of eyes achieving a final visual acuity of 6/60 or worse 
(Brown and Magaragal, 1982). Currently there is no known effective treatment for CRAO 
(Fraser and Siriwardena et al., 2002). 
 
1.4.2. Glaucoma 
 
Glaucoma is a disease characterized by a combination of mid-peripheral visual field 
loss, structural changes to the retinal nerve fibre layer (thinning) and optic disc (excavation or 
cupping). Increased intra-ocular pressure (IOP) is considered a risk factor for the 
development of glaucoma. Glaucoma can be divided into two major subgroups: angle closure 
glaucoma (ACG), in which drainage of the aqueous humor through the trabecular meshwork 
is obstructed by apposition of the iris to the peripheral cornea; and open angle glaucoma 
(OAG), in which drainage of the aqueous humor through the trabecular meshwork is not 
obstructed by the iris, but IOP is increased because of increased intrinsic trabecular resistance 
to aqueous drainage. Both open-angle and closed-angle glaucoma can occur secondary to 
other ocular and systemic conditions. There is a further group of OAG patients, with 
characteristic optic nerve head and visual field changes, who nonetheless, have IOP 
measurements consistently within the normal range: this ‘normal tension glaucoma’(NTG) 
subgroup constitutes a variable proportion of the OAG patient population. 
Glaucoma is the second leading cause of blindness globally (Roodhooft, 2002) and in 
the UK (Bunce and Wormald, 2006). The prevalence of glaucoma in 2010 is estimated to be 
2.6% globally and this is expected to rise to 2.8% by 2020, because of the changing world 
demographic (Quigley and Broman, 2006). OAG is anticipated to continue to be the most 
common form of glaucoma in the developed world. This section will focus on an overview of 
primary open angle glaucoma (POAG).  
The underlying mechanisms of the leading to the pathogenesis of POAG are not fully 
understood. Many risk factors have been associated with POAG including race (Buhrmann et 
 49 
 
al, 2000; Tielsch et al., 1991), family history of POAG (Tielsch et al., 1994; McNaught et al., 
2000; Wolfs et al., 1998), age over 50 years (Tielsch et al., 1991), elevated IOP (AGIS 
Investigators, 2000; Heijl et al., 2002; Gordon et al., 2002) and myopia (Mitchell et al., 
1999).  
The two main pathological features that define POAG are a characteristic pattern of 
damage to the optic nerve head with an associated pattern of visual field loss. 
Macroscopically, the optic disc in POAG becomes progressively more excavated as a result 
of a axonal loss, loss of the axonal myelin sheath posterior to the lamina cribrosa and 
posterior bowing of the lamina cribrosa (Radius and Pederson, 1984). Structural changes in 
the trabecular meshwork (Alvarado et al., 1984; Clark et al., 1995) is thought to contribute 
towards reduced aqueous outflow, and an increase in the IOP in most patients.  
In glaucomatous human eyes and experimental animal models of glaucoma, it has 
been widely documented that degenerative retinal ganglion cells undergo apoptosis, 
(Kerrigan et al., 1997; Quigley et al., 1995; Garcia-Valenzuela et al., 1994; Garcia-
Valenzuela et al., 1995) a slow progressive non-necrotic process of programmed cell death 
that is characterized by DNA cleavage by endonucleases known as caspases, chromosome 
clumping, cytoskeletal degeneration, cell shrinkage and plasma membrane blebbing followed 
by the phagocytosis of the cell by neighbouring phagocytic cells (Kerrigan et al., 1997; 
Okisaka et al., 1997; Tezel and Yang, 2004; Tatton et al., 2003). The underlying mechanisms 
that induce retinal ganglion cell apoptosis, and leads to the progression of glaucomatous optic 
neuropathy is unclear, but is believed to be multifactoral. These mechanisms can be broadly 
categorized into three groups: mechanical, biochemical, and vascular. The mechanical 
hypothesis of glaucomatous optic neuropathy suggests that the blockade of axoplasmic flow 
as a result of increased IOP impedes the transport of trophic factors, such brain-derived 
neurotrophic factors essential for retinal ganglion cell (RGC) viability (Lampert et al., 1968; 
Anderson and Hendrickson, 1974; Minckler et al., 1976; Quigley et al., 2000; Johnson et al., 
2000; Pease et al., 2000). Additionally, compression and shearing of the ganglion cell axons 
could be caused by pressure induced structural distortions of the lamina cribrosa (Morgan et 
al., 1998). Numerous biochemical mechanisms have been implicated in the pathogenesis of 
glaucomatous optic neuropathy such as elevated glutamate as a result of excitotoxicity 
(Dreyer et al., 1996; Vorwerk et al., 1999; Levkovitch-Verbin et al., 2002; Wamsley et al., 
2005; Lipton, 2003), oxidative stress and free radical damage as a result of mitochondrial 
dysfunction (Tatton et al., 2001; Tezel et al., 2005; Abu-Amero et al., 2006; Gherghel et al., 
2005; Ferreira et al., 2004; Carelli et al., 2004), raised inflammatory cytokines (Yan et al., 
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2000; Pang et al., 2005) and altered autoimmune status within the retina (Joachim et al., 
2005; Kremmer et al., 2001; Wax et al., 1994; Tezel et al., 1999). The “vascular theory” of 
glaucoma implicates chronic hypoxia due to vascular dysfunction and reduced retinal blood 
flow (Hayreh, 1985; Osborne et al., 2001; Flammer, 1994; Chung et al., 1999; Tezel and 
Wax, 2004; Cioffi et al., 2004)(possibly due to compression of the capillaries [Findl et al., 
1997; Pillunat et al., 1997]) in the pathogenesis of glaucomatous optic neuropathy.  
A number of tests have been developed to complement the clinical evaluation of the 
patient in order to confirm the diagnosis of glaucoma, to monitor its progression/efficacy of 
treatment. Optic nerve head and retinal nerve fibre layer analysis is an integral part of the 
evaluation of glaucoma and is typically performed by stereo biomicroscopy. The 
characteristic changes of the optic disc in glaucoma are focal, or generalized, excavation of 
the neuroretinal rim which may be associated with optic disc haemorrhage(s), blood vessel 
baring and/ or bayoneting, slit-like defects in the retinal nerve fibre layer, and peripapillary 
atrophy.  
 
1.4.2.1. Visual Field Assessment 
 
Visual field testing is the mainstay of assessing the visual function of individuals with 
suspected glaucoma to establish a diagnosis, and for those with glaucoma it is used to 
determine the severity and monitor the progression of the disease. A normal visual field test 
indicates the presence of a high proportion of functioning retinal ganglion cells (Sample and 
Johnson, 2001). The essence of a visual field test is to present a light stimulus of a given 
intensity and size onto a background of standard luminance. The threshold light intensity 
eliciting a response to the stimulus indicated by the patent is measured at points throughout 
the field of vision. Currently, the standard achromatic automated perimetry (SAP) is the most 
commonly performed visual field test in glaucoma, and is considered to be the gold standard 
for assessing visual function in glaucoma (Delago et al., 2002). SAP is performed with one of 
four threshold tests. The 24-2 threshold measuring test pattern, a commonly used test for 
glaucoma, consists of 54 stimulus locations covering the central field (24 degrees temporally, 
superiorly and inferiorly; 30 degrees nasally) placed at 6 degree intervals vertically and 
horizontally. SAP test results, however, demonstrate long term fluctuation, particularly in 
regions with established visual field defects (Keltner et al., 2005; Artes et al., 2002), which 
means that glaucomatous progression is sometimes difficult to confirm. Fluctuation in SAP is 
multifactoral, and includes patient related factors such as performance, fatigue, learning 
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effects, changes in pupil size, incorrect refractive correction and true physiological 
variability. These drawbacks have led to improvements in the threshold test algorithms to 
improve its accuracy, repeatability and sensitivity. In particular, the application of the 
Swedish Interactive Threshold Algorithm (SITA), which is faster and demonstrates 
comparable reproducibility to the standard threshold test (Bengtsson and Heijl, 1998) has 
become a popular test of visual field and has been incorporated into the Humphrey Visual 
Field Analyzer.  
Despite numerous enhancements to SAP a major limitation is that least 25% - 35% of 
the ganglion cells may be lost before SAP can detect functional damage (Harwerth et al., 
2002) indicating that significant functional deficits are present before it could be detected. 
Recent advances in understanding selective ganglion cell loss in glaucoma has led to the 
development of other perimetry tests such as the short-wavelength automated perimetry 
(SWAP), frequency-doubling technology (FDT) perimetry, focussed on targeting individual 
ganglion cell sub-populations in the pursuit of earlier detection of glaucoma and reliable 
assessment of glaucomatous progression. These tests, however, have inherent limitations; 
SWAP, for example has been shown to have higher variability on repeated tests compared to 
SAP (Blumenthal et al., 2003; Wild et al., 1998). FDT perimetry has been reported to have 
high false-positive results in the presence of advanced cataracts and mild posterior sub 
capsular cataracts (Casson and James, 2006). Objective electrophysiological tests of visual 
function developed to detect glaucoma at an early stage have yet to be adopted for routine 
clinical use. 
 
1.4.2.2. Optic Nerve Head Imaging 
 
Imaging modalities such as stereoscopic optic disc photography, confocal scanning 
laser ophthalmoscopy (e.g. Heidelberg Retina Tomograph, HRT), optical coherence 
tomography (OCT) and scanning laser polarimetry (e.g. GDx VCC) have been developed to 
provide an objective and quantitative measurement of the optic nerve head and retinal nerve 
fibre layer. Each imaging modality have their merits and pitfalls. Stereoscopic optic disc 
photography has been commonly used to document the baseline appearance of the optic disc, 
and qualitatively identify progressive glaucomatous optic disc changes. It is however 
subjective, and there is reportedly significant interobserver variation (Azuara-Blanco et al., 
2003; Jampel et al., 2009). It is also highly dependent on the quality of the images, which is 
influenced on the clarity of the ocular media and extent of the pupil dilation. However, recent 
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developments in digital stereoscopic optic disc analysis are more objective, reproducible, and 
may allow sharing of the optic disc image for teaching purposes (Sheen et al., 2004; Morgan 
et al., 2005). The HRT III, has been shown to have quite high sensitivity in discriminating 
normal from glaucomatous optic nerve heads (Zelefsky et al., 2006). Furthermore, the 
Confocal Scanning Laser Ophthalmoscopy (CSLO) ancillary study to the Ocular 
Hypertension Treatment Study (OHTS) underpinned the evidence-base for using imaging 
technology by demonstrating that abnormal changes of the ONH measured by the HRT were 
detected prior to visual field testing abnormalities (Zangwill et al., 2005). However, the early 
versions of the HRT had significant interoperator variability due to the subjective manual 
input of a contour line placed at the optic disc margin by the operator (Miglior et al., 2002; 
Garway-Heath et al., 1999; Iester et al., 2001). OCT has been shown to be as effective at 
differentiating between normal and glaucomatous eyes, as other imaging modalities, such as 
the HRT III and GDx VCC (Kanamori et al., 2006; Greaney et al., 2002; Zangwill et al., 
2001; Medeiros et al., 2004). The value of OCT technology in monitoring the progression of 
glaucoma is presently uncertain due to a current lack of longitudinal studies with sufficient 
length of follow-up. Scanning laser polarimetry has been less commonly adopted in clinical 
practice and is susceptible to ocular media opacities and spurious non-RNFL (retinal nerve 
fibre layer) birefringence. 
 
1.4.2.3. Evidence for the Importance of IOP in the Pathogenesis of Glaucoma 
 
 Several studies have shown that lowering IOP slows or prevents the progression of 
glaucoma in those with advanced glaucoma (Collaborative Initial Normal-Tension Glaucoma 
Study [CINTGS 1998a, 1998b] and Advanced Glaucoma Intervention Study [AGIS 
Investigators, 2000 ]), those with early to moderate glaucoma (Collaborative Initial 
Glaucoma Treatment Study [CIGTS Study Group, 2001] and Early Manifest Glaucoma Trial 
[Heijl et al., 2002; Leskea et al., 2003]), and those with high risk of developing glaucoma 
(Kass et al., 2002). Randomized controlled trials have shown that lowering IOP by 18% from 
baseline is associated with approximately 40% reduction in rates of worsening glaucoma over 
5 years (Heijl et al., 2002; CINTGS 1998b; Leskea et al., 2003; CIGTS Study Group, 2001). 
Although these studies implicate IOP as an important factor in the pathogenesis of glaucoma, 
raised IOP is not an exclusive characteristic of glaucoma as some individuals have 
glaucomatous optic neuropathy with normal IOP and conversely some individuals have 
raised IOP without developing signs of glaucoma. The principal goal of current medical and 
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surgical treatment modalities for glaucoma is to preserve visual function by lowering of IOP. 
These include the use of topical medications, laser trabeculoplasty, filtration surgery or a 
combination of these.  
 
 
1.4.2.4. Measurement of Retinal Blood Flow and Evidence for a Role in 
Glaucoma Pathogenesis 
 
Clinical evidence indicating an ischaemic component in the pathophysiology of 
glaucoma include the association of vascular dysregulatory IOP independent factors in 
normal tension glaucoma such as migraine (Wang et al., 1997; Curseifen et al., 2000), 
Raynaud phenomenon (peripheral vascular disorders)(Gass et al., 1997; O’Brien and Butt, 
1999), nocturnal hypotension (Hayreh et al., 1994), sleep apnoea (Girkin et al., 2006) and 
reduced cerebral blood flow (Sugiyama et al., 2006). These entities represent vascular 
dysregulation. Additionally, there is growing evidence to suggest that blood pressure and 
ocular perfusion is an important factor in the pathogenesis of POAG (Costa et al., 2009). 
Recent discoveries of increased concentrations of endothelin, a potent vasoconstrictor, in the 
aqueous humor of glaucoma patients (Iwabe et al., 2010); and hypoxia-inducible factor 
1alpha (HIF-1alpha), a protein synthesized by cells in response to hypoxia, in the retina and 
optic nerve in post-mortem human glaucomatous eyes (Tezel and Wax, 2004) have added 
support to the role of chronic hypoxia or ischaemia contributing towards glaucomatous optic 
neuropathy (Hayreh, 1985; Osborne et al., 2001; Flammer, 1994; Chung et al., 1999). Retinal 
blood flow is dependent on the activity of the endothelial cells because they have no 
autonomic innervation. Endothelial cells release number of factors including endothelium 
derived vasoactive factors which regulates the tone of vascular smooth muscle. Vessel size is 
also regulated by neural and glial cells (neurovascular coupling)(Falsini et al., 2002).  
Several techniques have been used to measure ocular blood flow. Fluorescein 
angiography has been used to measure mean retinal circulation transit time (Bjärnhall et al., 
2007), arteriovenous transit time (Wolf et al., 1989) and to qualitatively assess the perfusion 
of the intraretinal and optic disc microvascular capillary beds (Spaeth, 1975; Schwartz, 
1994). However, the relationship between transit times and regional retinal blood flow is not 
robust (Tomic et al., 2001). Blue field entopic technique measures leucocytic flow in the 
retinal perifoveal vessels. This method is subjective, relies heavily on the co-operation of the 
patient and it is unclear whether leucocytic flow is proportional to retinal blood flow 
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(Fuchsjäger-Mayrl et al., 2002). Laser Doppler velocimetry (LDV) determines the velocity of 
blood cells in larger retinal blood vessels using the optical Doppler shift of a coherent laser 
beam (Feke et al., 2006). Measurements of vessel diameter are required at selected 
measurement sites to determine volumetric blood flow. LDV is not able to measure blood 
flow in the optic nerve head. Laser speckle flowgraphy (LSFG)(Briers and Fercher, 1982; 
Tamaki et al., 1995; Tamaki et al., 1997) and laser Doppler flowmetry (LDF)(Riva and 
Falsini, 2008) provides an estimate of blood flow in the microcirculation of the retinal tissue 
illuminated by a coherent laser. These techniques require a clear media and for the subject to 
maintain perfect fixation. Further limitations of LSFG and LDF include its inability to 
measure flow in large retinal vessels, the ambiguity as to which capillary beds within the 
retina are being measured and whether they are pertinent to the pathogenesis of glaucoma 
(Caproli and Coleman, 2010). Colour Doppler imaging (CDI) measures erythrocyte velocity 
in the large ophthalmic vessels (such as the ophthalmic artery) and has been evaluated in 
glaucoma (Galassi et al., 1992). The relevance of ophthalmic artery velocity measurements is 
questionable since the ophthalmic artery perfuses other structures around the eye and has 
been shown to be unaffected when IOP is 45 mm Hg (Harris et al., 1996). Additionally, 
erythrocyte velocity may underestimate blood flow particularly in vasodilated vessels 
(Goebel et al., 1995). Furthermore, CDI measurements are highly variable and is dependent 
on the position of the probe (Caproli and Coleman, 2010). Despite new innovative technical 
advances in assessing ocular haemodynamics, there is no current gold standard for measuring 
ocular blood flow and ocular blood flow measurements are not currently considered suitable 
for the diagnosis and management of patients with glaucoma.   
 
 
1.5. Retinal Oxygen. 
 
1.5.1. Measurement of Retinal Oxygen.  
 
The accurate quantification of retinal oxygen concentration in retinal tissues and blood 
vessels is currently not well established. A number of different approaches have been 
reported in the literature. In general, the techniques used to study retinal oxygen can be 
divided into invasive and non-invasive methods. 
 55 
 
Invasive techniques include the use of oxygen sensitive microelectrodes (Briol et al., 
2007; Stefánsson et al., 1992), phosphorescence quenching (Lo et al., 1996; Shonat et al., 
1992; Zukerman, 1993) and functional magnetic resonance imaging (fMRI)(Duong et al., 
2002). The invasiveness of these techniques has mostly limited its use to animal studies.  
The mainstay of non-invasive retinal oximetry techniques involves the use of 
spectrophotometric systems, enabled by established knowledge of the optical properties of 
the haemoglobin derivatives, offers one of the most promising methods of safely deducing 
the oxygen saturation (OS) in the retinal tissues and vasculature. Many different 
spectrophotometric systems and analysis methodologies have been developed and tested. A 
brief overview will be discussed in later sections.  
 
 
1.5.2. Principles of Photometric Oximetry. 
 
1.5.2.1. Dual-Wavelength Oximetry. 
 
Oximetry is defined as the measurement of the OS in either blood or in tissues. Prior 
to the measurement of blood OS, clinical hypoxaemia was traditionally detected by the 
presence of central or peripheral cyanosis by observing the colouration of the mucous 
membranes and the peripheral tissues. The colouration is related to the relative amounts of 
oxygenated and deoxygenated haemoglobin. However, it was shown that this clinical sign 
was a poor indicator of central hypoxaemia (Comroe et al., 1947) and more accurate 
measures of blood OS was required to clinically monitor patients.  
 The development of the photoelectric cell enabled the measurement of light 
absorption which contributed to the development of spectrophotometers. As a result, the 
spectrophotometric study of the extinction coefficients (a measurement of how much light is 
absorbed by a substance at a given wavelength) of reduced haemoglobin (Hb) and 
oxyhaemoglobin (HbO2) was made possible; these measurements are central to the technique 
of oximetry.  
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 The first documentation of the spectra of undiluted haemolysed and whole blood were 
made by Drabkin and Austin (1935) who was later able to demonstrate the applicability of 
the Lambert-Beer law in determining the OS of blood (Drabkin and Schmidt, 1945). 
The Lambert-Beer law (Figure 1.14) in transmission blood oximetry assumes that for 
any given wavelength of light its absorption is dependent on the extinction coefficient of the 
blood solution (ε), its concentration or haematocrit (c) and the distance (d) the light has to 
travel through the solution (path length): 
 
   =     × 10
  (  ×  × )         (Eq. 1.1) 
 
where, IT is the amount of light transmitted through a solution and IO is the amount of 
incident light.  
Figure 1.14: The Lambert-Beer Law.  
 
 
 
 
 57 
 
The optical density (OD) of a solution is a measure of its transmittance, and is defined 
by:  
 
   =  −      (
  
  
) =    ×   ×          (Eq. 1.2) 
 
where, IT is the intensity of transmitted light (after passing through the solution), IO is 
the intensity of incident light, ε is the extinction coefficeint of a solution, c is the 
concentration of the absorbing element in the solution, and d is the distance through the 
solution light has to travel (path length). Therefore the OD of a solution of blood is a function 
of its extinction coefficient, concentration and the path length the light has to travel. 
The main absorbing component of human blood is haemoglobin, therefore its 
extinction coefficient is considered to be equal to that of haemoglobin. The extinction 
coefficients of Hb and HbO2 have been extensively researched using various methodologies 
and spectrophotometric techniques. One of the most commonly used data on the extinction 
coefficients of Hb and HbO2 is that published by van Assendelft (Figure 1.15)(van 
Assendelft, 1970). The haemoglobincyanide methods that were used to derive the extinction 
coefficients of the haemoglobin derivatives are today still recognized as the international 
standard for haemoglobinometry. 
Figure 1.15: The molar extinction coefficients of deoxyhaemoglobin (Hb) and 
oxyhaemoglobin (HbO2) derivatives as a function of wavelength. 
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Kramer and Elam were able to demonstrate the linear relationship between the OS of 
blood and it absorption of red and infrared wavelengths of light (see Appendix 1 for the 
mathematical proof)(Kramer et al., 1951). This finding was pivotal in the development of 
clinical oximeters. Matthes and Gross (1939a, 1939b) were the first to demonstrate the use of 
an isosbestic wavelength (extinction of Hb and HbO2 are equal) and an oxygen sensitive 
wavelength in the red and infrared regions respectively to compensate for variables such as 
the haematocrit, path length and light intensity. This technique of measuring the blood OS 
using an isosbestic and an oxygen sensitive wavelength is the basis of clinical dual-
wavelength oximetry used today.  
The integration of optical plethsmography (analysis of the pulsatile component of the 
arterial cycle) with oximetry enabled the development of pulse oximeters which are capable 
of measuring the arterial oxygen saturation by isolating the arterial signal from the venous, 
bone and tissue components (Aoyagi et al., 1974). The calibration of pulse oximeters are 
performed to this date using data acquired from normal subjects during induced hypoxia. 
That is, as soon as a constant state of hypoxia is achieved, the values of the red-infrared 
optical density ratios (ODR) are obtained in conjunction with the arterial blood gas 
measurements. Unfortunately, these calibration tests were carried out at arterial blood gas 
saturations of greater than 70%, the lowest tolerable state of systemic oxygenation in humans. 
At oxygen saturations below 70% the calibration has been estimated by linear interpolation 
and therefore the accuracy below this level is questionable. Sarnquist and Todd (1980) 
reported that pulse oximeters were overestimating the true oxygen saturation with an average 
reading of 70% when the true OS  was 50%. This overestimation is thought to be caused by 
the scattering of red/infrared light in the blood vessels (Shimada et al., 1984). 
 The cuvette oximeter (CO-oximeter) represents the current gold standard method for 
photometric oximetry and is used to calibrate pulse oximeters. It is also an essential 
component in blood gas analyzers commonly used in the intensive care setting. This device 
uses multiple wavelengths to measure the OS of blood and concentrations of other 
haemoglobin derivatives in addition to Hb and HbO2. Importantly, CO-oximeters achieve a 
high degree of accuracy because the blood is analyzed ex vivo under strictly controlled 
conditions. In addition, most CO-oximeters haemolyse the blood sample prior to oximetric 
measurements to remove the confounding effects of light scattering. 
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1.5.2.2. Light Scattering and its Implications on Photometric Oximetry. 
 
Kramer and Elam (1951) were the first to demonstrate that although the Lambert-Beer 
law is true for solutions of haemoglobin it fails to accurately describe the transmission of 
light in whole blood and that OS had a non-linear relationship with haematocrit and optical 
path length. The main contributing factor to this phenomenon is thought to be the scattering 
effects of blood. As a consequence a number of in vitro studies, involving the nature of light 
propagation through whole blood, have attempted to describe the scattering effects of whole 
blood. The scattering of light in whole blood is thought to be caused by the red blood cells 
(RBC) and the refractive changes at the RBC-plasma interface (Zdrojkowski and Pisharoty, 
1970; Johnson, 1970; Longini and Zdrojkowski, 1968) which has been shown to be 
dependent on wavelength, haematocrit and the path length (Johnson, 1970; Loewinger et al., 
1964; Anderson and Sekelj, 1967).  
Three theories have found general acceptance in its application to describe the 
scattering effects of whole blood. The photon diffusion theory describes the transport 
characteristics of wave intensities and has similarities to the diffusion of molecules in liquids. 
Its purpose has been used describe the propagation of photons (from collimated light) through 
highly scattering, dense  media with a short mean free path which can be approximated by 
“random walk” of photons. Zdrojkowski and Pisharoty (1970) applied the theory to derive an 
optical density equation of whole blood. The Kubelka-Munk theory (Kubelka and Munk, 
1931) describes the absorption and scattering properties of a homogenous slab of pigmented 
material providing a reflectance model. It makes no assumptions (phenomenological) on the 
characteristics of light absorption and scattering. The “two-flux” component of the theory 
only considers the diffuse radiation reflected from the material and assumes that the radiation 
scatters in two opposite directions through the medium. The Kubelka-Munk theory was 
applied by Janssen (1972) to assess the absorption and scattering characteristics of whole 
blood. A number of studies (Loewinger et al., 1964; Anderson and Sekelj, 1967) have 
adopted and supported Twersky's theory of multiple scattering (Twersky 1962, 1970a, 
1970b), which describes the nature of light transmission in biological suspensions containing 
large, low-refracting and absorbing particles (red blood cells) using separate absorbing and 
scattering terms. In its simplest form the scattering phenomenon can be incorporated into the 
Lambert-Beer equation. 
 60 
 
 The in vivo application of an oximetry model to account for the wavelength dependent 
scattering component was reported by Pittman and Duling (1975a) who adopted Twersky’s 
multiple scattering theory and demonstrated that a three-wavelength technique could be used 
to calculate the scattering component of blood in addition to the oxygen saturation. These 
techniques were applied to OS measurements on small blood vessels in hamster retractor 
muscles with a reported accuracy of 4.8% oxygen saturation (Pittman and Duling, 1975b). 
One of the main challenges for in vivo oximetry has been to implement the theories 
and findings that account for light scattering to obtain accurate measurements of human 
blood oxygen saturation. This is particularly relevant in retinal oximetry. 
 
1.5.3. Principles of Spectral Imaging 
 
Spectral imaging is a relatively new technique which combines the capabilities of 
spectroscopy and imaging. Spectroscopy is an established method of analyzing materials by 
means of acquiring and identifying the spectral signatures of its constituents using various 
combinations or sequences of wavelengths. The structure of atoms and molecules is directly 
related to its spectrum. Various wavelengths in the electromagnetic spectrum can be used 
which is absorbed by molecules, resulting in atomic vibrations and rotations specific to the 
inter-atomic bonds. A continuous series of specific wavelengths is able to provide 
characteristic spectrum or spectral signature which defines of the structure of a given 
molecule. Spectral signatures can be obtained by acquiring and analyzing a series of 
wavelengths reflected or transmitted through matter to enable the identification of its 
constituent substance(s). Figure 1.16A illustrates the collection of a spectral signature from a 
single point of an object (the fundus is used in this example) using visible light. A series of 
multiple wavelengths are used which defines its spectral resolution and range; this determines 
its ability to identify specific molecules. However, the main limitation of this technique is the 
lack of spatial information which has restricted the use of spectroscopy to a specific subset of 
scientific disciplines.  
Imaging is a method of obtaining spatial and temporal information from a scene. 
Currently, conventional digital imaging techniques involve the use of a digital camera (such 
as a charged-coupled device) to record data. The information from a scene is represented in 
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the form of a two dimensional array of intensity values. In grayscale (monochromatic) 
images, the intensity of each pixel represents a single wavelength (Figure 1.16B) and 
therefore extraction of spectral information is not possible.   
Spectral imaging addresses the shortcomings of spectroscopy and imaging by 
combining the two methodologies to generate a number of grayscale images at various 
wavelengths thereby providing both spectral and spatial information. It can be broadly 
categorized into two distinct modalities: multispectral and hyperspectral imaging which can 
be performed invasively and non-invasively. Multispectral imaging uses a number of non-
contiguous wavelengths at large bandwidths apart (Figure 1.16C). In contrast, hyperspectral 
imaging uses a large number of contiguous wavelengths at narrow bandwidths (high spectral 
resolution, Figure 1.16D). A multispectral or hyperspectral imaging system is capable of 
producing a reflectance or transmission spectrum of each pixel within the image enabling the 
identification of substances by means of identifying its respective spectral signature.  
Both multispectral and hyperspectral imaging systems are comprised of a number of 
empirical components as depicted in Figures 1.16C and 1.16D. Light from a source can be 
dispersed into the required wavelengths before or after it reaches the scene. The reflected or 
transmitted light from the scene is collected into a detector, such as charged-coupled device. 
The subsequent series of images are subsequently processed and analyzed to detect 
substances contained within the scene based on the spectral signature of each pixel.  
The performance of a spectral imaging system is principally dependent on a 
combination of its spectral and spatial resolution. Hyperspectral imaging provides a more 
detailed pixel spectrum which enables more information to be obtained for accurate 
classification and quantification compared to a multispectral pixel spectrum. A higher spatial 
resolution influences the accuracy of the spectral analysis by reducing the spectral distortion 
incurred by other substances contained within each pixel. Modern hyperspectral imaging 
systems usually record a stack of time-sequential images onto a two dimensional detector 
array, at a sequence of wavelengths forming a hyperspectral data cube. The spectral 
dispersion technique can be attained through a variety of filtering methods which have 
specific advantages and disadvantages. Discrete filters uses a succession of narrow band 
filters inserted in the optical path of the imaging system. Tunable filters, comprising a family 
of acusto-optical tunable filters (AOTFs), liquid crystal tunable filters and interferometer 
filters, have no moving parts and are able to be electronically tuned to any particular 
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wavelength. Conventional discrete filter wheels are slow, contain bulky mechanical parts, 
limited in colour palette, and less reliable than their electronic tunable filter counterparts. 
Spectral imaging systems incorporating tunable filters enables the rapid access of specific 
wavelengths at random. However, tunable filters have a limited spectral range, are sensitive 
to temperature and polarization and can attenuate the transmission of light. AOTFs have an 
additional effect of shifting the image during wavelength scanning.  
Hyperspectral imaging requires sensitive detectors and powerful computers to enable 
fast processing of the images that comprise the data cube. The advancement of computer 
hardware and improved detectors has expanded its use from the remote sensing disciplines to 
laboratory and clinical research.  
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Figure 1.16: Principles of spectral imaging. The fundus is used as an example in the 
illustrations. A. In spectroscopy, the spectrum at every wavelength is recorded at a single 
point in the scene. B. In conventional grayscale imaging, the scene is projected onto detector 
which records the light intensity of each pixel on the 2 dimensional array. C. In multispectral 
imaging, the scene is either illuminated by several non-contiguous wavelengths or the 
reflected light is filtered into several non-contiguous wavelengths by a wavelength selector. 
The detector records the intensity of each pixel at the respective wavelengths. D. In 
hyperspectral imaging, the scene is either illuminated by numerous contiguous wavelengths 
or the reflected light is filtered into numerous contiguous wavelengths by a wavelength 
selector which enables the detector to record a spectrum for each pixel in the entire image 
plane. 
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1.5.4. Principles of Optical Retinal Oximetry. 
 
 The optical window of the eye encompasses a broad range of wavelengths between 
400 to 1400 nm (Boettner and Wolter, 1962) enabling these wavelengths to pass through the 
refractive components of the eye with minimal attenuation and reach the retina. In its 
simplest form, retinal oximetry requires an imaging system which captures images of the 
retina at multiple wavelengths of light. The wavelengths used in retinal oximetry (and other 
imaging modalities such as retinal OCT) is therefore limited by the optical window of the 
eye.  The OD of the retinal vessels at the chosen wavelengths can be estimated using various 
approaches. The most common technique is to calculate the negative logarithmic ratio of the 
light intensity at the centre of the retinal vessel to the light intensity adjacent to the target 
retinal vessel: 
         =  −      (
  
  
)         (Eq. 1.3) 
where IV and IR are the intensity of light reflected from the retinal vessel and adjacent 
retina respectively. The OD of the retinal vessels at the chosen wavelengths can subsequently 
be used to calculate the oxygen saturation, e.g. ODR of two wavelengths. 
 
1.5.5. Retinal and Choroidal Oximetry using Spectrophotometric Techniques. 
 
The various retinal oximeter designs that have been reported have evolved with the 
availability of newer technologies from standard photography, to digital photography, to the 
use of imaging spectroscopy and multispectral confocal slit-lamp ophthalmoscopes. 
Numerous dual and multiple wavelength combinations sensitive to changes in oxygen 
saturation have also been utilized. Subsequently, a variety of retinal oximetry analysis 
techniques have been described. A brief overview of influential spectrophotometric retinal 
oximetry studies will be described in this section with a focus on the instrument design, 
oximetry model and experimental/clinical findings. 
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1.5.5.1. Laing: The Choroidal Eye Oximeter and Photographic Eye Oximeter. 
 
 Laing and Cohen (1975) developed a “Photographic Eye Oximeter” comprising of a 
modified Zeiss fundus camera with a dichroic beam splitter and narrow-band interference 
filters that divided the reflected light from the fundus into two wavelengths centred at 470 nm 
(oxygen sensitive) and 515 nm (isosbestic). The retinal images at these two wavelengths were 
simultaneously recorded on photographic film which were scanned with a modified 
microdensitometer and the film’s transmission at selected parts of large retinal arteries were 
measured. In vivo animal experiments were performed on eight rabbits whose systemic OS 
was reduced to varying levels of oxygenation determined by clinical oximetry measurements 
of femoral artery blood samples. Retinal photographs were captured at various oxygen 
saturations and the ODR of the selected retinal arteries at the two wavelengths were plotted 
against the measured systemic OS. An experimental calibration curve was created by least 
mean square fitting. The accuracy of this technique was reported to be better than 1% oxygen 
saturation. 
Cohen and Laing (1976) subsequently modified their two wavelength Lambert-Beer 
oximetry model adopting functions developed by Twersky (1962, 1970a, 1970b) to account 
for the effect of vessel diameter and haematocrit on light scattering in blood. The double pass 
transmission of light passing through the blood column, reflecting from the retina and passing 
through the blood column a second time was also incorporated into the algorithm. The 
theoretical retinal oximetry model was thought to be able to correct for variations in 
haematocrit and vessel diameter with minimal changes in the OS. When applied to 
experimental calibration data (Laing and Cohen, 1975) the theoretical oximetry model was 
comparable at high oxygen saturations; however at low oxygen saturations the theoretical 
calibration line underestimated the actual oxygen saturations by up to 20%. Results of OS 
measurements in humans using the “Photographic Eye Oximeter” were never reported. 
 
1.5.5.2. Hickam: The Photographic Oximetry Technique. 
 
Hickam et al. (1963) described a photographic method to estimate the OS of the 
retinal veins in humans. Fundus photographs were obtained using two cameras containing 
different combinations of filters. A Bausch and Lomb fundus camera was modified with two 
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broadband filters, with wavelengths centred at 640 nm (oxygen sensitive) and 800 nm 
(isosbestic), enabling the capture of red-infrared retinal photographs. A second Zeiss fundus 
camera was adapted to obtain a combination of red-green (centred at 505 nm [isosbestic 
wavelength] and 640 nm) retinal photographs using a Zeiss microscope beamsplitter. The 
projection of the photographic negative onto a screen with a small perforation enabled 
density measurements to be made, using a photocell connected to a photometer, on the retinal 
vessels and optic disc adjacent to the vessel. The logarithmic sensitivity of photographic film 
enabled calculations of the vessel optical density which was performed for all the 
wavelengths. The ODR of two to three retinal veins at the optic disc in each eye of human 
subjects were calculated from red-infrared and red-green wavelength combinations. 
The estimation of the OS in the retinal veins was made using data from in vivo human 
calibration experiments. This involved measuring the ODR of retinal arteries in human 
subjects whose arterial OS were altered by changing the inspired oxygen content with the use 
of various gas mixtures of oxygen and nitrogen. The OS of arterial blood was determined by 
analysis of brachial artery blood samples at the time of imaging and was monitored during 
the imaging using an ear oximeter. Several arteries were measured in each subject to derive a 
mean arterial ODR in each subject at various degrees of systemic oxygenation. Linear 
regression analysis was performed to generate a linear calibration curve describing the 
relationship between oxygen saturation of the arteries and red-infrared and red-green optical 
ODRs. The regression lines were used to calculate the retinal venous OS from the measured 
red-infrared and red-green ODRs.  The mean (± SD) retinal venous OS was reported to be 
59% (± 11%) in normal human subjects (n = 55).  
In vitro validation experiments were performed by obtaining red-infrared images of 
heparinised venous blood samples from 4 normal subjects. The oxygenation of the venous 
blood was altered by exposing the venous blood to air and mixing it with venous blood not 
exposed to air. The OS of the sample was determined using a photometric method (Hickam 
and Frayser, 1949). Twenty venous blood samples with varying oxygen saturations were 
inserted into glass capillaries (internal diameters of 250 μm and 500 μm), placed in front of a 
white background and imaged through a +50D lens. A linear relationship between ODRs and 
the measured OS of the blood samples was confirmed. The standard deviations of the ODRs 
from the measured OS were relatively small: 6% and 9% OS in 500µm and 250µm glass 
capillaries respectively. The oximetry technique was limited by the influence of vessel 
diameter on the regression slopes which affected the accuracy of the OS estimation. A 
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decrease in the path length of light resulted in a larger change in the red-infrared ratio for a 
given change in OS. This was thought to result from a disproportionate change in the 
haemoglobin extinction coefficients at specific wavelengths for a given change in path 
length. 
In vivo validation of the oximetry technique was performed by measuring the retinal 
venous OS in humans whilst breathing various mixtures of carbon dioxide and oxygen induce 
systemic hypoxia and hyperoxia (Frayser and Hickam, 1964). Oximetric changes in the 
retinal veins were detected and correlated with the concentration of inspired oxygen. 
However, no correction for vessel diameter (influenced by the concentration of carbon 
dioxide) was made in the calculation of the OS.   
 
1.5.5.3. Delori: The Three-Wavelength Photoelectric Retinal Vessel Oximeter. 
 
Delori (1988) described a three wavelength method to determine the OS in retinal 
vessels using a photoelectric oximeter. The “Retinal Vessel Oximeter” comprised of a fundus 
camera integrated with three interference filters (mounted on a filter wheel), a 
photomultiplier and a photocathode. This enabled reflected light from a small area of the 
fundus (1500μm in diameter) to be filtered into wavelengths centred at 558, 569 and 586 nm. 
A slit, 530 μm in length, scanned a selected part of the retinal vessel generating thirty-two 
vessel profiles at each wavelength during a period of 1.6 seconds which were subsequently 
aligned. The estimation of the light transmission through the vessel, using the average vessel 
and background fundus reflectance, enabled the calculation the optical density of the vessel at 
each wavelength. 
The retinal vessel oximetry algorithm, incorporating the vessel transmission 
measurements and published haemoglobin extinction coefficients (van Assendelft, 1970), 
was based on the methods described by Pittman and Duling (1975a). Three simultaneous 
equations for each wavelength were solved to create a three wavelength oximetry algorithm. 
The effects of haemoglobin concentration, vessel diameter, light scattering by the red blood 
cells and fundus pigmentation were integrated into the algorithm. 
In vitro validation experiments were performed using blood obtained from two human 
subjects and circulated through glass capillaries (internal diameters of 50 μm, 100 μm and 
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150 μm) immersed in a water-filled artificial eye model eye containing various reflecting 
backgrounds. The OS of the washed blood was altered using either a mixture of oxygen and 
nitrogen gas or by mixing it with sodium dithionite (complete desaturation of blood). 
Measurements of the OS using the imaging system were compared to the measured OS by a 
CO-oximeter. Multiple regression analysis indicated an accurate correlation between the 
calculated and measured OS. The three wavelength oximetry model was reported to be most 
accurate in the range of 50 - 100%; in the range between 0 - 50% there was a tendency 
towards overestimating the measured OS. Blood flow rates between 1 – 90 μlitre/min did not 
significantly affect the calculated blood oxygen saturation.  
 In vivo studies of 22 normal human subjects involved the oximetry measurements in 
85 retinal arteries and 102 retinal veins. The mean (± SD) calculated OS was 98% (± 8%) and 
45% (± 7%) respectively. Variability in the oximetry measurements were thought to be due to 
several factors: eye movements, fundus pigmentation, effect of the central retinal vessel 
reflex, vicinity of neighbouring structures such as the optic disc, and pulsatile changes of the 
vessel diameter during the cardiac cycle.  
The three-wavelength oximetry technique was applied in a clinical study of seven 
patients with unilateral optic disc atrophy with nerve fibre layer defects (Sebag et al., 1989). 
The OS of several temporal and nasal retinal veins were compared to corresponding retinal 
veins in the unaffected fellow eye. Retinal arterial OS was not measured but was assumed to 
be constant at 97%. The mean arterio-venous difference in OS was significantly higher in the 
affected eye (indicating lower venous OS) compared to the fellow eye. This finding, in 
conjunction with laser Doppler velocimetry findings of reduced blood flow, indicated a 
reduction in the supply of oxygen in affected eyes. 
 
1.5.5.4. Schweitzer: The Imaging Ophthalmospectrometer. 
 
Schweitzer et al. (1992) developed an imaging ophthalmospectrometer, which 
consisted of a modified fundus camera with an attached spectrograph. The instrument 
illuminated the retina with a small (40 μm x 1.5 mm) slit of light and scattering by the ocular 
media was reduced by the confocal arrangement. A grating component within the 
spectrograph spectrally dispersed the reflected light from the fundus. An intensified charged-
coupled device was used to capture the reflectance spectrum (spectral range from 450 to 700 
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nm; spectral resolution of 2 nm) from the spectrograph in 10 ms which was then used to 
perform quantitative oximetric measurements of the retinal blood vessels (Schweitzer et al., 
1999). The complex oximetry model used was based on detailed research on the properties of 
fundal reflectance and the multiple light pathways in the eye (Hammer et al., 2001). 
In vitro experiments, using whole blood contained in quartz cuvettes of varying 
thicknesses, studied the influence of various simulated physiological conditions on the 
behaviour of the light paths in the retina (Schweitzer et al., 1999). At wavelengths between 
450 nm and 700 nm the light transmission through blood was reported to decrease with 
increasing cuvette thicknesses and haematocrit.   The reflectance spectrum of flowing blood 
was found to increase in proportion to an increase in blood velocity of up to 6mm/s. The 
characteristics of internal reflectance of light were also described. At wavelengths between 
500 nm to 600 nm (absorption-dominated wavelengths) the internal reflectance was found to 
be independent on cuvette thickness. At wavelengths between 600 nm to 700 nm (scattering-
dominated wavelengths) the internal reflectance increased with increased cuvette thickness.  
An oximetry algorithm was developed using wavelengths between 510 nm and 586 
nm where the internal reflectance was assumed to be constant and the light transmission is 
solely dependent on the vessel size and the haematocrit. The transmission and internal 
reflectance spectra of fully oxygenated and deoxygenated whole blood that were determined 
under experimental conditions were incorporated into the oximetry algorithm in place of 
published extinction coefficients of Hb and HbO2 (Schweitzer et al., 1999). Several other 
parameters were taken into account including the vessel size, haematocrit, reflectance of the 
fundus background and specular reflection of light. Seventy-six equations, obtained from 
each wavelength, were iteratively solved to calculate a number of unknown parameters which 
included the OS (Thamm et al., 1998). 
In vivo measurements of retinal vessel oxygen saturation were performed using the 
oximetry algorithm in 30 eyes of healthy subjects (Schweitzer et al., 1999). The mean (± SD) 
OS of 126 retinal arteries and 139 retinal veins were 92.2% (± 4.1%) and 57.9% (± 9.9%) 
respectively. The OS measured at points along the vessel away from the optic disc showed 
that the arterial oxygen saturation was constant up to a distance of 3 disc diameters. However, 
the retinal venous OS was found to be significantly lower at 1 disc diameter from the optic 
disc compared to the OS measurements performed at 2 disc diameters.  
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 Clinical studies using the oximetry technique was applied to compare patients with 
dry (n = 32 eyes) and wet (n = 14 eyes) age-related macular degeneration to a control group 
comprising of the offspring of the ARMD patients (n = 30 eyes) and normal subjects (n = 21 
eyes)(Schweitzer et al. 2000, 2001). The mean OS of the central retinal arteries were not 
significantly different between the compared groups whereas mean central retinal venous OS 
was significantly higher in the patients with age-related macular degeneration compared to 
the controls.  
 
1.5.5.5. Michelson: Retinal Oximetry using the Imaging Ophthalmospectrometer 
in Glaucoma. 
 
Michelson and Scibor (2006) used the imaging ophthalmospectrometer to compare 
the oxygen saturation of selected retinal vessels between patients with primary open-angle 
glaucoma (POAG) and a control group of normal subjects. Fifty-eight normal subjects, 49 
patients with “normal tension POAG” and 45 patients with “high tension POAG” were 
recruited. OS measurements were made at the supero-temporal retinal arteries and veins 1-3 
mm from the disc margin. A simplified oximetry model was used to calculate the OS which 
compensated for light scattering by the blood cells and retinal tissues, and light absorption by 
melanin in the retinal pigment epithelium and choroid (Hammer et al., 2002). The reflectance 
spectra of the analyzed retinal vessel was transformed linearly such that the reflectance 
values at the isosbestic wavelengths (522nm, 569nm and 586nm), were mapped onto the 
isosbestic reflectance values of the reference spectra (determined experimentally). This was 
assumed to correct for the influence of light scattering and absorption by melanin on the 
measured vessel reflectance. A fourth measuring wavelength (560nm), whose reflectance 
value was assumed to be linearly related to the OS, was used to calculate OS of the retinal 
vessel. 
The mean (± SD) retinal arteriolar and venular OS in the control group of normal 
subjects were 92.3% (± 3.4%) and 55.7% (± 6.8%) respectively. Repeatability of the retinal 
arteriolar OS measurements was demonstrated, however, the retinal venular OS were found 
to be more varied. The mean (± SD) retinal arteriolar OS in eyes with “normal tension 
POAG” [89.7% (± 5.4%)] was significantly lower than the control group, no difference was 
not found between the “high tension POAG” group [91.4% (± 4.0%)] and the control group. 
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The mean (± SD) retinal venular OS in the “normal tension POAG” [56% (± 8.3%)] and 
“high tension POAG” [58.3% (± 10.5%)] groups were not significantly different to the 
control group. Further analysis of the oximetry data showed that there was a significant 
correlation between the OS in the retinal arterioles and the neuroretinal rim area measured by 
HRT, such that a lower OS was associated with smaller rim areas. No significant relationship 
between the venular OS and neuroretinal rim area was found. 
 
1.5.5.6. Denninghoff: The Scanning Laser Eye Oximeter and Intravitreal Retinal 
Oximeter. 
 
 Denninghoff et al. developed an “Eye Oximeter” consisting of four diode lasers 
emitting wavelengths centred at 629, 678, 821 and 899 nm (Drewes et al., 1999). The 
wavelength selection was influenced by complex theoretical calculations and analysis of the 
optimal wavelength combinations for retinal vessel oximetry (Smith, 1999). Specular 
reflection in the vessel wall, thought to contribute to errors in the oximetry calculation, was 
reduced using a horizontal polarizer positioned in front of the detector (Denninghoff and 
Smith, 2000). Calibration of the modified Eye Oximeter involved a series of model eye 
experiments using whole human blood from one human subject which was then modified to 
create blood samples of varying haemoglobin concentrations (Drewes et al., 1999). The OS 
of the blood samples were altered by mixing with various combinations of nitrogen and 
oxygen gas concentrations providing a range of saturations from 6% -87% which was 
verified using a CO-oximeter. The blood samples were injected into micropipettes of varying 
internal diameters (110 – 268 μm) and placed in front of a 100% reflective Spectralon 
background within a model eye filled with index matched fluid. The extinction values of the 
various combinations of blood samples in the model eye were determined at the four 
wavelengths (629, 678, 821 and 899 nm). An oximetry model based on the Lambert-Beer law 
was derived which accounted for the wavelength dependence of red blood cell scattering, 
haematocrit and the path length of transmitted light. The accuracy of the oximetry model was 
determined by comparing the mean calculated OS to the measured OS of the blood samples. 
The reported error was small at measured oxygen saturations of 83% (± 4% error) but 
increased with lower oxygen saturations to a maximum at measured oxygen saturations of 
0% (± 52%). Retinal vessel measurements using the modified Eye Oximeter was only 
performed on one human subject. The mean oxygen saturation of the retinal veins and 
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arteries on the optic disc were 65% and 101 - 102% respectively. The mean oxygen saturation 
in the retinal veins and arteries away from the optic disc were 63% and 98% respectively. 
Variations in the fundal background reflectivity were acknowledged by the authors to 
contribute to calculation errors. 
 Salyer et al. (2006) explored the potential of intravitreal illumination on retinal 
oximetry. An intravitreal light source attached to a scanning monochromator was used to 
obliquely illuminate the retina. The advantage of this technique was to remove the 
confounding effects of specular vessel reflection and double-pass light paths on the oximetry 
calculation – although paracentral reflexes were evident in some vessels. Two anaesthetized 
pigs were subjected to graded hypoxia (from 100% to 50%) and multispectral images of a 
small section of the fundus containing a selected retinal artery and vein were captured using a 
digital camera. The OS in the aorta and inferior vena cava were measured using a CO-
oximeter at the time of retinal vessel measurements. The monochromator enabled intravitreal 
illumination of the fundus section with wavelengths of light ranging from 420 nm to 700 nm 
in 10 nm steps. Sequential multispectral fundal images were captured in synchrony with the 
cardiac cycle which minimized the effect of changing vessel diameter and potential 
alterations in the vessel OS at different points in the cardiac cycle. The registered images 
were used to measure the normalized single-pass transmittance spectra of the vessels studied. 
The OS was calculated by applying the Leavenburg-Marquard technique to fit the measured 
vessel transmission to a theoretical transmission model which incorporated the Lambert-Beer 
law and the published extinction coefficients of Hb and HbO2 (van Assendelft, 1970). This 
oximetry technique accounted for the scattering effects of the red blood cells and ocular 
media. 
In vivo experiments, using the multispectral intravitreal system, were performed on 
anaesthetized pigs and the transmittance spectral profiles of the retinal vessels were measured 
and characterized at a various systemic oxygen saturation levels. The transmission spectral 
profiles of the retinal arteries were shown to change at different oxygen saturations. Two 
main characteristics were noted: firstly, as the oxygen saturation decreases the local 
maximum of the transmission spectral profile in the 460 - 520 nm range moved from 510 nm 
to 480 nm and secondly the two minima at 542 nm and 577 nm converge to a broad minimum 
at 555 nm. The latter characteristic suggested the transition of the spectral profile of 
oxyhaemoglobin to reduced haemoglobin.   
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 The calculated retinal arterial oxygen saturations were shown to have a strong 
correlation with the measured arterial oxygen saturations. However, the retinal venous OS did 
not correlate with the mixed venous (inferior vena cava) OS. This was thought to have been 
caused by the creation of an oxygen diffusion gradient from the retinal veins into the vitreous 
cavity during the vitrectomy as the balanced salt solution is instilled, resulting in an 
underestimation of retinal venous oxygenation. Vascular autoregulation as a result of the 
increased oxygen diffusion could also have contributed to errors in calculating the retinal 
venous OS. 
 
1.5.5.7. Beach: Digital Multispectral and Hyperspectral Imaging of the Retina. 
 
Beach et al. (1999) developed a two wavelength retinal imaging system which 
consisted of a fundus camera and an optical beam splitter enabling the simultaneous 
generation of two retinal images which were subsequently filtered using two interference 
filters, centred at 569 nm (isosbestic) and 600 nm (oxygen sensitive), and recorded with a 
digital camera. A vessel detection algorithm enabled the calculation of the optical densities, 
at each wavelength, along the retinal blood vessel. Oxygen saturations along the retinal 
vessels were calculated from the optical density ratio (ODR = OD600 / OD569) which has a 
linear relationship with the measured OS (Pittman and Duling 1975a, 1975b). Confirmation 
of the linear relationship between the ODR and OS was demonstrated using the retinal 
oximeter in one healthy human subject during graded hypoxia. A strong negative correlation 
between the measured pulse oximetry OS and the measured ODR in the retinal arteries was 
demonstrated.  
Clinical studies were performed to measure the ODRs in 12 diabetic human subjects 
without clinical evidence of diabetic retinopathy during normoglycaemia and hyperglycaemia 
(Tiedeman et al., 1998). The ODRs of the retinal arteries did not change; however, the ODRs 
of the retinal veins were shown to increase during acute hyperglycaemia indicating a decrease 
in venular OS. It was thought that this was due to increased consumption of oxygen.  
The influence of fundal pigmentation on the oximetry calculations was explored in 7 
healthy human subjects exposed to graded hypoxia using various mixtures of oxygen and 
nitrogen (Beach et al., 1999). An ear oximeter was used to measure the systemic OS. The 
accuracy of three methods of calculating the optical densities and ODR of the retinal arteries 
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were compared. It was concluded that the introduction of a correcting factor which estimated 
the amount of fundal pigmentation was the most accurate method. However, these methods 
were acknowledged to be sensitive to vessel size, particularly in the range of 80 – 200 μm. 
Using the modified ODR the mean (± SD) retinal venous OS in 5 human subjects during 
normoxia and hyperoxia (100% inspired oxygen) were 19.2% (± 2.9%) and 55% (± 3.38%) 
respectively.  
Beach et al. subsequently developed a hyperspectral imaging system which consisted 
of a fundus camera  with an attached prism-grating-prism spectrograph coupled to a digital 
camera (Khoobehi et al., 2004). The system was used in a study involving two anaesthetized 
monkeys. A sequence of line scans across a small area of the optic disc were recorded by 
moving the imaging system and the data was processed to generate a three dimensional 
“hyperspectral data cube”, consisting of a sequence of images each representing a single 
wavelength from 410 nm to 950 nm with a spectral resolution of 2.5 nm. The hyperspectral 
signatures of the optic disc under normoxic and hyperoxic conditions (100% oxygen 
saturation) were compared in one monkey. In the second monkey hyperspectral signatures of 
the optic disc were generated at normal intraocular pressures and high intraocular pressures 
(induced through an infusion of saline in the anterior chamber) and compared. The 
reflectance spectral profile (between 450 nm and 600 nm) of the retinal vessels and temporal 
and nasal sections of the optic nerve head were analyzed. Under hyperoxic conditions 
increases in blood oxygen was found in the retinal arteries, retinal veins and optic nerve head 
tissue. Under high intraocular pressures the analysis indicated a reduction in oxygenated 
blood in the retinal vessels and optic nerve head tissues. Semi-quantitative OS maps, derived 
from complex analysis of the spectral profiles, illustrated the significant increased 
oxygenation of the retinal vessels and optic nerve head tissues during hyperoxia and 
decreased oxygenation during increased intraocular pressure. Subsequent  modifications to 
the oximetry algorithm, applied to further experiments involving 5 anaesthetized monkeys at 
normal and high intraocular pressures, indicated that capillary blood OS in the optic nerve 
head at normal intraocular pressures were intermediate to that of the retinal arteries and 
retinal veins (Beach et al., 2006). At high intraocular pressures there was a reduction in the 
OS of the retinal vessels and optic nerve head tissues.  
This hyperspectral imaging system was acknowledged to be susceptible to motion 
artefacts which limit its use to anaesthetized animal experiments and results from human 
studies have not been reported.  
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1.5.5.8. Stefánsson: Dual-Wavelength Digital Retinal Oximetry. 
 
The two-wavelength oximetry technique described by Beach et al. (1999) was 
adopted by Stefánsson and co-workers (Hardarson et al., 2006) who developed a retinal 
oximeter that produced simultaneous retinal images at four wavelengths. This was performed 
using a beam splitter which linked a fundus camera to a digital camera and enabled the 
separation of the original retinal image into four retinal images each representing 
wavelengths centred at 542, 558, 586 and 605 nm. Image processing algorithms aligned the 
images and a vessel detection algorithm enabled ODR calculations, along the retinal the 
blood vessels to be performed using only the 586 nm and 605 nm wavelengths. Optical 
density ratios from first degree retinal arterioles and venules of 18 normal eyes were 
measured and used to generate a quantitative oximetry model. Calibration of the model was 
performed by averaging the data from previously published OS calculations of the retinal 
arteries (Schweitzer et al., 2001; de Kock et al., 1993; Delori, 1988) and veins (Hickam et al., 
1963; Schweitzer et al., 2001; Beach et al., 1999; Delori, 1988). Several clinical studies in 
humans have been reported using this oximetry system.  
Retinal vessel oxygen saturations were performed on 16 normal eyes whilst breathing 
room air followed by systemic hyperoxia (100% oxygen saturation)(Beach et al., 1999). The 
mean (± SD) retinal arteriolar oxygen saturation significantly increased from 96% (± 9%) to 
101% (± 8%) and the retinal venules significantly increased from 55% (± 14%) to 78% (± 
15%). Further experiments comparing retinal vessel OS in human subjects in light and dark 
conditions (n = 13 dark to light; n = 19 light to dark) showed that the OS of the retinal 
arterioles and venules were significantly higher in the dark adapted eye (Hardarson et al., 
2009). This was thought to be due to increased outer retinal demand for oxygen. 
 Siesky et al. (2008) performed a randomized study comparing the effects of 
brinzolamide and dorzolamide on retinal oxygen saturation in 13 patients with POAG. The 
ODR of the retinal veins were significantly lower whilst on either brinzolamide or 
dorzolamide than that recorded at a baseline value (on timolol) indicating an increase in 
venous oxygenation. A subsequent randomized study of 13 patients with OAG or ocular 
hypertension demonstrated that the addition of dorzolamide to the patients already on timolol 
had no significant effect on the OS in the retinal arterioles, venules and arteriovenous 
differences (Traustason et al., 2009). However, a significant reduction in the retinal arteriolar 
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and venular OS was found when the treatment of the glaucoma subjects were changed from a 
dorzolamide-timolol combination to timolol monotherapy. More recently, Siesky et al. (2010) 
studied the effect of dorzolamide and timolol on the OS of the retinal vessels in 11 normal 
subjects and 11 POAG patients over an 8 month period. The OS of the retinal vessels did not 
change in both the normal and glaucoma groups with the addition of timolol and dorzolamide 
to timolol. However, increased blood flow in the superficial retina was found upon the 
addition of timolol to dorzolamide. The findings were thought to indicate an increased 
delivery of oxygen to the retina with the addition of dorzolamide to timolol.  
This dual-wavelength retinal oximeter was also used to determine the effects of 
glaucoma filtration surgery (n = 19) on the OS in the retinal arterioles and venules 
(Hardarson et al., 2009). No significant differences were found in the OS of the retinal 
arterioles and venules before and after surgery. 
 
1.5.5.9. Hammer: Dual-Wavelength “Oxygen Module”. 
 
 Hammer et al. (2009) reported the use of a dual wavelength retinal oximeter 
comprised of a fundus camera with an attached filter with transmission wavelengths centred 
at 548 nm and 610 nm. Retinal images were recorded onto a colour digital camera and an 
oximetry model, using the ODRs at the two wavelengths, was used. Compensation for the 
effects of vessel diameter and  fundus pigmentation were incorporated into the oximetry 
model by using methods previously described by Beach et al.(1999). and calibrating the ODR 
to normoxic and hyperoxic (100% OS) measurements in 20 normal subjects. The OS 
measurements along retinal arterioles and venules were demonstrated to be highly 
reproducible in 10 normal subjects. The mean (± SD) arteriolar and venular OS under 
normoxic conditions were 98% (± 10.1%) and 65% (± 11.7%) respectively. Inhalation of 
100% oxygen increased the mean arteriolar and venular OS by 2% and 7% respectively.  
 The oximetry system was applied to study the OS in diabetic patients (Hammer et al., 
2009). Forty-one diabetic patients with a range of retinopathy severity from mild non-
proliferative to proliferative diabetic retinopathy (DR) were compared to 12 age-matched 
controls. No significant difference in the arteriolar OS was reported between the controls and 
subjects with diabetic retinopathy of all severities. Venular OS increased with the severity of 
diabetic retinopathy with a mean (± SD) OS of 69% (± 7%) in subjects with mild non-
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proliferative DR and 75 (± 8%) in subjects with proliferative DR. This finding was thought to 
be due to arterio-venous shunting of blood. 
Gehlert et al. (2010) applied the retinal oximetry system to a cohort of 11 patients 
with retinal artery occlusion and reported a significant increase in arterial OS over a time 
from a mean (± SD) baseline OS of 73% (± 16%) to 87% (± 11%) five days after medical 
treatment. 
 
1.5.5.10. Yoneya: Fourier Transform Spectral Retinal Imager. 
 
Yoneya et al. (2002) developed a Fourier transform spectral imaging system which 
consisted of a interferometer coupled to a fundus camera and a digital camera enabling the 
collection of spectral data from two dimensional retinal images. Eleven subjects with recent 
onset CRVO were examined and compared to 4 normal fellow eyes. Reflectance data, at 
wavelengths between 480 nm and 600 nm, from each pixel in the retinal image were analyzed 
using an oximetry model based on the Lambert-Beer law which used the published extinction 
coefficients of haemoglobin (van Assendelft, 1970). Additional parameters accounted for the 
wavelength dependent scattering of light in the eye. Quantitative OS maps of the retinal 
tissues and vasculature was demonstrated. The OS of the retinal arteries and veins in the 
fellow eyes were calculated between 90 - 98% and 60% - 70% respectively. Oxygen 
saturations of less than 40% were detected in the retinal tissues that corresponded to areas of 
capillary non-perfusion and leakage seen in the fluorescein angiograms. In addition, it was 
shown that both hemispheres of the retina appeared hypoxic in hemi-CRVO.  
Further clinical studies using this imaging system compared oximetric retinal features 
between normal eyes (n = 20) and eyes with OAG (n = 15 low tension glaucoma and n = 41 
high tension glaucoma)(Ito et al., 2008). The mean (± SD) OS of the juxta-papillary retinal 
tissues in eyes with normal tension glaucoma [78% (± 8%)] and high tension glaucoma 
[(82% (± 10%)] were significantly lower than in normal eyes [88% (± 8%)]. There were no 
significant differences in the OS of the retinal arteries and veins between the groups. In the 
high tension glaucoma group, worsening of the visual field (mean deviation) was associated 
with a reduction in the inferotemporal and superotemporal retinal OS.  
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 More recently, Tsuchiashi et al. studied oximetric changes in the retinal tissues in the 
macular region of 22 patients with age-related macular degeneration (Tsuchihashi et al., 
2009). The main findings were a reduction in tissue OS 1 week following verteporfin 
photodynamic therapy in 11 patients which recovered to pre-treatment levels at 1 month. The 
study also found significantly higher tissue OS in patients with neovascular age-related 
macular degeneration compared to aged-matched normal subjects. 
This retinal imaging system is, however, limited by its spatial resolution in which 
each pixel in the image represents an area of 40 μm2. Therefore oximetric quantification of 
small retinal vessels could not be performed. Additionally, it was acknowledged that the 
influence of the choroidal circulation on the retinal tissue oxygen calculations is unclear. 
 
1.5.5.11. Other Retinal Oximetry Systems. 
 
A number of other retinal oximetry systems have been previously reported which are 
either in the experimental or early clinical stage of their development. The various designs 
have included dual wavelength (de Kock et al., 1993; Crittin et al., 2002; Nelson et al., 2005), 
multiwavelength (Ramella-Roman and Matthews, 2007; Muqit et al., 2010) and hyperspectral 
(Johnson et al., 2007; Arimoto et al., 2007) imaging systems. Numerous different methods of 
calculating the OS of the retinal vessel have also been described. Further investigations are 
required on these systems to establish their performance as a retinal oximeter. The use of a 
modified optical coherence tomography (Kagemann et al., 2007) and modified 
multiwavelength scanning laser ophthalmoscope (Ashman et al., 2001) has also been reported 
but the results demonstrated that these systems were not suited for retinal oximetry.  
 
1.6. Summary. 
 
Photometric oximetry is an established and important tool used is clinical medicine today. 
Its development has stemmed from years of detailed research which has enhanced our 
understanding of the optical properties of the functional haemoglobin derivatives. The 
theories and methods used to calculate the oxygen saturation of human blood have been 
exploited in retinal oximetry. The underlying premise for retinal oximetry is to determine the 
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characteristic distribution of oxygen within the retina in health and disease. Since the retina 
has a high metabolic demand for energy, and subsequently that of oxygen, to meet its 
functional role; the detection of abnormal oxygen supply and demand has the potential to 
provide a useful indicator of the functional status of the retina. Various retinal oximetry 
methodologies have been adopted which reflect the uncertainties and challenges of 
establishing a gold standard retinal oximetric technique. Nevertheless, previous retinal 
oximetry studies have provided a useful insight into the potential usefulness of retinal 
oximetry in providing an enhanced understanding of the normal physiology of the retina and 
pathophysiological mechanisms of common sight threatening ocular diseases such as 
glaucoma. In addition, oximetry of the retina could potentially inform on the effects of 
established treatment modalities on retinal function and influence the development of future 
treatments of sight threatening retinal diseases. 
 
 
1.7. Aims of the Research. 
 
The research that will be reported in the thesis will describe the development of 
techniques used to measure the OS in the retinal vessels using a hyperspectral imaging 
system.  
The aims of the research are: 
 to evaluate the wide-field hyperspectral retinal imaging system  
 to develop a robust and accurate method of measuring the OS in the retinal 
vasculature using image analysis techniques 
 to apply the oximetry techniques to human retinal images acquired by the 
hyperspectral retinal imaging system  
 to determine the ability of our oximetry technique to detect abnormal OS in 
the retinal vasculature in retinal diseases.  
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Chapter 2: The Hyperspectral Fundus Camera. 
 
2.1. Introduction. 
 
2.1.1. Clinical Applications of Multispectral and Hyperspectral Imaging. 
The widespread application of multispectral and hyperspectral imaging systems has 
encompassed a number of bio-medical fields such as cytogenetics (Nuffer et al., 2006; Timlin 
et al., 2005; Huebschman et al., 2002; Schultz et al., 2001), pathology (Goodacre et al., 1998) 
and oncology (Martin et al., 2006; Sorg et al., 2005). In particular, clinical oximetric research 
using spectral imaging has grown in popularity. This has originated from the appreciation of 
dissimilar spectral properties of oxygenated and deoxygenated haemoglobin which can be 
used to calculate the oxygen saturation (OS). The feasibility of oximetry using hyperspectral 
imaging has been tested in a variety of clinical sub-specialties such as assessing 
haemorrhagic shock (Cancio et al., 2006), tissue perfusion (Zuzak et al., 2001 and 2002) and 
microvascular disease in diabetes (Greenman et al., 2005) and sickle cell anaemia (Zuzak et 
al., 2003).  
 
2.1.2. Retinal Vessel Oximetry using Spectral Imaging. 
Since the first retinal vessel oximetry experiments reported in the late 1950s various 
approaches have been undertaken to non-invasively measure the OS of blood in the retinal 
vessels (described in Chapter 1). The calibration methods of these oximetry systems have 
ranged from in vitro model eye experiments to in vivo hypoxia and hyperoxia experiments on 
animals and humans. Numerous oximetry techniques have been developed and reported but 
as yet there is no agreed gold standard method of calculating the OS in the retinal blood 
vessels. However, it is apparent that there are two main requirements: firstly an imaging 
system capable of accurately extracting spectral data from the retinal blood vessels; and 
secondly, a robust and accurate method of calculating the OS that accounts for the 
confounding influence of the complex light interactions within the retinal vessels, retinal 
tissues and ocular media. These requirements represent the main challenge to the 
development of a mainstream clinical retinal oximeter. 
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The aims of this chapter are:  
 to describe the principle components of the hyperspectral fundus camera that was 
constructed by Heriot Watt University and used for the experimental and clinical 
oximetry research described in this thesis.  
 The ability this hyperspectral fundus camera to emit wavelengths of light within 
the visible spectrum is integral to its function as hyperspectral imaging system. 
Therefore, experiments performed to establish the performance of the 
hyperspectral in relation to its ability to generate light of various wavelengths are 
also described and the findings reported in this chapter. 
 
 
2.2. The Hyperspectral Fundus Camera 
 
2.2.1. Fundus Camera 
 
The hyperspectral imaging system consists of a commercial mydriatic fundus camera 
(Canon CF-60Z, Tokyo, Japan) which was modified to integrate a liquid crystal tuneable 
filter (LCTF) into the optical path of the camera enabling the  illumination of the retina using 
a number of user selected wavelengths of visible light (Figure 2.1). 
The basic optical system of the fundus camera consists of an annular illumination 
which projects light through the dilated pupil (Figure 2.2 left).  The reflected light from the 
retina exits the pupil through the centre of annular illumination and continues through the 
optical components of the fundus camera forming a retinal image at the image plane. The 
observation and focusing system of the fundus camera transfers the retinal image onto the 
detector plane (Figure 2.2 right).  
Two sources of illumination were incorporated into the design of the hyperspectral 
fundus camera. A tungsten bulb provided a continuous light source for viewing the retina and 
a xenon flash tube was used to illuminate the retina to enable the capture of a retinal image. 
The spectral transmission of the hyperspectal imaging system without the LCTF is shown in 
Figure 2.3. 
The safety of the hyperspectral imaging system was independently assessed and 
approved for use in humans by the chair of medical physics from Aberdeen University as a 
requisite for attaining local ethical approval. 
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Figure 2.1: Photograph of the hyperspectral fundus camera in operation and its main 
components. (LCTF: liquid crystal tunable filter; CCD: charge-coupled device). 
 
 
 
Figure 2.2: The main optical paths of the fundus camera. (Left) A schematic of the annular 
illumination of the retina. (Right) The optical paths of the illumination, observation and 
focusing system within the fundus camera. 
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Figure 2.3: Spectral transmission of the hyperspectral imaging system without the LCTF. 
 
 
2.2.2. Liquid Crystal tuneable filter (LCTF). 
 
Liquid crystal tuneable filters are based on a Lyot filter (Lyot, 1933) which consists of 
a series of birefringent retarders located between two parallel polarisers. A liquid crystal layer 
in each Lyot cell (Figure 2.4) enables variable changes to the retardance and provides the 
spectral tuning ability. Each Lyot cell transmits light that varies sinusoidally as a function of 
wavelength. Within the selected wavelength bandwidth, the transmitted light adds 
constructively and outside the bandwidth there is destructive interference. The typical 
transmission outside the bandwidth is 0.01% or less. The liquid crystal component enables 
the transparent bandwidth to be shifted throughout the spectral range of the filter. 
 The LCTF chosen to be incorporated into the fundus camera was a CRI VariSpec 
(Woburn, MA, USA). The LCTF filter is able to transmit wavelengths between the visible 
and near-infrared region (400 – 700 nm) with a wavelength dependent bandwidth of 
approximately 10 nm. Importantly, the LCTF is electronically tunable enabling fast random 
access of the desired wavelength via a personal computer, contains no moving parts and has 
and operating ambient temperature range of between 10 °C to 40 °C. The LCTF was 
integrated in an optimized position within the optical path of the incident light of the fundus 
camera. 
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Figure 2.4: A single Lyot cell consisting of two linear polarisers, a fixed birefringent retarder 
and a liquid crystal waveplate. 
 
 
2.2.3. Charge-Coupled Device. 
A low noise charge-coupled device (CCD) camera (Hamamatsu ORCA-ER, 
Hamamatsu Photonics K.K., Hamamatsu City, Japan) was incorporated into the fundus 
camera to enable the electronic capture of retinal images (Figure 2.5). The CCD has a high 
resolution of approximately 1.3 million pixels and a dynamic range of 12 bits. The CCD is 
peltier cooled with a vacuum seal to reduce dark noise and thermal drift, and has a high 
quantum efficiency in the visible and near-infrared wavelengths. A linear polarizer is 
attached to the front of the CCD to reduce a fixed pattern artefact caused by the specular 
reflection from the two surfaces of the objective lens within the fundus camera. A macro lens 
is inserted between the CCD and the fundus camera to maintain a field of view of 
approximately 40º onto the CCD detector chip with dimensions of 6.6 x 8.9 mm2 (Figure 2.5).  
 
Figure 2.5: Incorporation of the CCD and macro lens into the fundus camera. 
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2.2.4. LabView software interface 
 
A customized software programmed using LabView (National Instruments, Austin, 
Tx, USA) controls the LCTF, xenon flash and CCD camera. (Figure 2.6). The LCTF was 
controlled typically by changing the desired wavelengths in 10 nm increments or decrements. 
The xenon flash, engaged using the software, was integrated with the simultaneous capture of 
CCD images. A saturation histograph, live feed of the CCD recording and image of a 
captured image are displayed on the software interface (Figure 2.6, centre of the image). The 
captured images were stored onto a personal computer in 12-bit Portable Network Graphics 
(PNG) format. 
 
Figure 2.6: The customized LabView software interface. The control interface window (left), 
an acquired retinal image at 580 nm (bottom right) and the live feed window (top right; retina 
not displayed in the live feed) are shown on the computer screen. 
 
 
 
Wavelength selection button
Image acquisition button
Live image (retina not shown)
Acquired retinal image at 580 nm
Pixel intensity histogram of 
live and acquired images
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2.2.5. Spectrometer Measurements of the Hyperspectral Fundus Camera. 
 
To establish that the wavelengths of light transmitted through the LCTF corresponded 
to the wavelengths that were programmed in the LabView software, a series of 4 experiments 
were performed to characterize the spectral performance of the hyperspectral fundus camera. 
 A spectrometer (Ocean Optics S2000, Dunedin, Florida, USA) was positioned in the 
illumination path in front of the hyperspectral fundus camera to record the actual wavelength 
of light transmitted through the LCTF for a given programmed wavelength. During each 
spectrometer experiment, the LCTF was changed sequentially using the programmed 
software from “500 nm” to “700 nm” in 10 nm incremental steps. At each programmed 
wavelength the xenon flash was engaged five times to enable 5 spectrometer measurements 
to be recorded by the spectrometer. The LCTF was then changed to “502 nm” and the 
sequential spectrometer recording sequence was repeated up to “702 nm”. This process was 
repeated until sequence of programmed wavelengths from 500 nm to 708 nm in 2 nm 
incremental steps were recorded by the spectrometer. The importance of changing LCTF 
wavelengths in 10 nm steps was to ensure that the LCTF responded to the programmed 
commands. From initial experience with the hyperspectral fundus camera, the LCTF had a 
tendency to be unresponsive to the programmed commands when the wavelengths were 
changed too quickly (usually less than 3 seconds). Furthermore, by changing the LCTF in 10 
nm increments, it was possible to visually confirm the response of the LCTF by viewing the 
shift of the spectrometer signal on a computer display showing the transmission of the LCTF 
(from the tungsten light source) in real time. The spectrometer experiment was repeated on 
four occasions over three separate days. Two experiments were performed on the same day 2 
hours apart. 
 
2.2.6. Analysis of the Spectrometer Measurements. 
 
The processing and analysis of the spectrometer raw data was performed using 
Mathematica (ver. 5.2 Wolfram Research, Champaign, IL, USA). Each spectrometer 
measurement of a programmed wavelength was saved as a separate file consisting of the 
programmed wavelength (located in the filename) and the measured intensity data between 
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340.92 nm and 1000.07 nm (Figure 2.7). The spectrometer measurement data, therefore, 
represented the spectral transmission of the LCTF at the programmed wavelength. 
A systematic offset present in the intensity count of each spectrometer measurement 
was corrected by subtracting the mean intensity in the wavelength range between 900 nm and 
1000 nm from the raw data (Figure 2.7). The wavelength corresponding to the maximum 
intensity count (peak wavelength) was extracted from each corrected spectrometer 
measurement (Figure 2.8).  
The data points in each spectrometer file was fitted using a second degree polynomial 
curve fit (Figure 2.9A). The interpolation of the data points was used to calculate the two 
wavelengths of the spectrometer signal at half the intensity of the peak wavelength. The 
difference between the wavelengths was used to calculate the Full-Width Half Maximum 
(FWHM) value (Figure 2.9B). The peak measured wavelength and corresponding FWHM 
were calculated for each programmed wavelength between 500 and 700 nm (in 2 nm 
increments). 
 
Figure 2.7: A plot of a spectrometer measurement from the hyperspectral fundus camera 
programmed at 500 nm. Each spectrometer measurement data consists of the measured light 
intensity (y-axis) at each discrete wavelengths between 340.92 nm and 1000.07 nm (x-axis). 
A systematic offset in the intensity can be seen which was corrected by subtracting the mean 
intensity count in the wavelength range between 900 and 1000 nm. 
 
 
 
Intensity offset
Mean intensity offset calculated 
between 900 and 1000 nm
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Figure 2.8: Extracting the peak wavelength from the corrected spectrometer measurement 
data. A. Plot of the corrected spectrometer measurement from the hyperspectral fundus 
camera programmed at 500 nm. The measured peak wavelength is 497.57 nm (red filled 
circle). B. A magnified view of the corrected spectrometer measurement data between 480 
nm and 515 nm and the corresponding measured peak wavelength (red filled circle). 
 
 
 
 
Figure 2.9: Calculation of the Full-Width Half Maximum (FWHM) of a spectrometer 
measurement at one programmed wavelength. A. A second degree polynomial curve fit is 
used to interpolate the spectrometer data. B. Calculation of the FWHM from the spectrometer 
data. The wavelengths at the half maximum (green filled circles) were set to zero to displace 
the signal downwards enabling the calculation of the half maximum wavelengths which are 
in this example: 493.07 nm and 501.69 nm. The FWHM is 8.62 nm. 
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2.2.7. Statistical analysis 
 
All statistical analyses were performed using Mathematica (ver. 5.2 Wolfram 
Research, Champaign, IL, USA). The mean peak measured wavelength, and mean FWHM 
for each programmed wavelength (from all 4 experiments) was calculated to determine the 
actual wavelengths (and FWHM) transmitted through the LCTF. To determine the variation 
of the 5 measured peak wavelengths for each programmed wavelength, the SD of the 
respective peak wavelengths were calculated. The average SD across the programmed 
wavelength range was calculated to determine the variability of the peak measured 
wavelength. A Pearson correlation was calculated between the mean measured wavelength 
and respective programmed wavelength. The Bland-Altman method (Bland and Altman, 
1986) was used (programmed minus mean measured wavelength vs. average of the two 
wavelengths), for each experiment separately, to assess the agreement and variability 
between the programmed and measured wavelengths.  
 
 
2.3. Results 
 
The hyperspectral fundus camera is capable of illuminating the fundus with various 
user-selected wavelengths of light in the visible spectrum. The variability at each 
programmed wavelength was 0.32 nm. That is, for a given programmed wavelength, the SD 
of the measured peak wavelength was on average 0.32 nm. 
A strong positive correlation was observed between the programmed and measured 
peak wavelengths (R2 = 0.99, P = < 0.0001, Figure 2.10 filled circles). The mean FWHM of 
all four experiments for each programmed wavelength is also shown in Figure 2.10 (vertical 
error bars). The mean (± SD) FWHM across the full programmed wavelength range was 
12.59 nm (± 2.57 nm). 
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Figure 2.10: Plot of the programmed wavelength against the mean measured peak 
wavelength of all four experiments. Vertical error bars are the mean FWHM at each 
programmed wavelength. 
 
 
 
 
The agreement between the programmed and measured wavelength within each 
experiment are shown in the Bland-Altman plots in Figure 2.11. The mean difference (bias) ± 
SD between the programmed and measured wavelengths in Experiments 1 to 4 were 4.16 ± 
1.67 nm, 3.30 ± 0.89 nm, 3.40 nm ± 1.24 nm and 4.16 ± 1.07 nm respectively (95% limits of 
agreement were: 0.88 – 7.44 nm, 1.55 – 5.05 nm, 1.55 – 5.05 nm and 2.36 – 6.54 nm 
respectively). Overall, the mean difference (±SD) between the programmed wavelength and 
measured wavelengths in all four experiments across the full programmed wavelength range 
(500 – 700 nm) was 3.84 nm (± 1.34 nm). 
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Figure 2.11: Bland-Altman plot (programmed minus measured wavelength vs. average 
wavelength) demonstrating the agreement between the programmed and measured 
wavelength. The mean differences (bias) are shown in each plot as solid horizontal lines, and 
the 95% limits of agreement are shown as dashed horizontal lines. 
 
 
 
 
 
 
 
 
 
 
Experiment 1 Experiment 2
Bias 4.16 nm
SD of bias 1.67 nm
95%  Limits of Agreement 0.88 – 7.44 nm
Bias 3.30 nm
SD of bias 0.89 nm
95%  Limits of Agreement 1.55 – 5.05 nm
Bias 3.40 nm
SD of bias 1.24 nm
95%  Limits of Agreement 0.96 – 5.84 nm
Bias 4.45 nm
SD of bias 1.07 nm
95%  Limits of Agreement 2.36 – 6.54 nm
Experiment 3 Experiment 4
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2.4. Discussion 
 
This chapter has described the essential components used to construct the 
hyperspectral fundus camera. However, the ability of the hyperspectral fundus camera to 
generate light of various wavelengths is essential for it to function as a hyperspectral imaging 
system. Experiments to test this ability were performed to establish whether there was a 
difference between the programmed wavelength and the measured (actual) wavelength and 
study its characteristics. 
 
At a given programmed wavelength, the repeated spectrometer measurements 
indicated that the LCTF was stable with an average SD of the peak wavelength of 0.34 nm. 
That is, when the hyperspectral fundus camera was programmed to illuminate a scene 
repeatedly at one wavelength, the peak wavelength remained relatively constant over 5 
measurements. The stability of the LCTF is important as it would be undesirable to have 
large temporal fluctuations in the wavelength when the LCTF was set at one wavelength. The 
source of the variability is uncertain, but could originate from the detector of the 
spectrometer, the calculation of the peak wavelength from the spectrometer data and 
fluctuations in the structural properties of the LCTF. Although further research may be 
required to establish and correct for the source of the variability, this was considered to be 
small and possibly not significant. 
 
A strong positive correlation between the programmed and measured wavelengths 
was found (R2 = 0.99, P = < 0.0001) which demonstrates that, as expected, incrementally or 
decrementally changing the programmed wavelength resulted in corresponding changes in 
the measured wavelength. This demonstrates, to some extent, the controllability of the 
desired wavelength. However, as mentioned previously, it was found that changing the 
programmed wavelength too rapidly often led to the LCTF becoming unresponsive. This 
feature could originate from either the software (response of the program to a command) or 
hardware (response of the LCTF or computer). The practical importance of this finding was 
to ensure that imaging was conducted slowly to ensure that the LCTF had adequate time to 
respond to the commands. 
 
To evaluate the performance of the hyperspectral fundus camera in detail, further tests 
were conducted to assess whether the selected programmed wavelength accurately depicted 
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the actual measured wavelength of light emitted from the imaging system. This is of 
particular importance, since the operating routine of the hyperspectral fundus camera was to 
generate spectral images which were stored onto a computer and the wavelengths used to 
acquire them were labelled as the programmed wavelength. The correlation analysis did not 
analyze this adequately and further detailed investigation was warranted since the analysis of 
spectral images is critically dependent on the wavelengths used. Four experiments were 
conducted to compare the accuracy of the programmed wavelength to depict the actual 
measured wavelength and the Bland-Altman method was used to demonstrate the results 
(Figure 2.11). In each experiment, there is a systematic tendency of the measured wavelength 
to be less than the programmed wavelength (Figure 2.11). Amongst all the experiments the 
average overestimation of the measured wavelength by the programmed wavelength was 3.84 
nm (± 1.34 nm) across the wavelength range. A constant overestimation of the measured 
wavelength would be relatively simple to correct by adding a constant factor in the spectral 
analysis algorithm. However, closer inspection of the Bland-Altman plots reveals a number 
of important characteristics of the fundus camera. Firstly, the overestimation appears to 
increase as the programmed wavelength increases (particularly evident in Experiment 1 and 
4, Figure 2.11). Secondly, there is variability in the overestimation between the experiments. 
This overestimation and variability are unlikely to have been caused by the analysis of data as 
the measurements of each programmed wavelength was performed five times, averaged and 
the SD of each measurement for a given programmed wavelength was low. A possible cause 
for the overestimation is likely to be due to the inaccurate calibration of the software to the 
true wavelength. The variability of the overestimation, however, could also be explained by 
flaws in the LCTF which may be temperature dependent. This finding is critical as it 
indicates that the true wavelength cannot be accurately described by the programmed 
wavelength. Prior knowledge of the wavelengths used to acquire spectral images is crucial to 
hyperspectral image analysis algorithms, in particular that of oximetry which relies on 
incorporating the wavelength specific extinction coefficients of oxy- and deoxyhaemoglobin 
into the algorithms. This characteristic of the hyperspectral fundus camera was not ideal. 
Unfortunately, this phenomenon was not discovered until half-way through this research 
project during the creation of the oximetry algorithms. At this stage over half of the model 
eye experiments and retinal images had been collected, and changing the design of the 
camera (i.e. using a new filter) would have been time-consuming and would have made the 
existing data redundant. 
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To adjust for the design flaw of the hyperspectral camera, spectral images at 2 nm 
increments apart were acquired as part of the imaging protocol. Fortunately, this had already 
been performed at the outset of the research project and therefore existing data were available 
for analysis. The explanation for the compensation is reflected in Figure 2.10 which plots the 
mean measured wavelength and mean FWHM for each programmed wavelength. It can be 
seen that for a given wavelength there is an overlap of the measured FWHM (mean 12.59 
nm) with approximately four to five adjacent peak measured wavelengths. This would 
represent an oversampling of each wavelength thereby, to a limited extent, correcting for the 
variability of the measured wavelength which is in the order of 3.84 nm (mean bias of all 
experiments). In addition, as will be described in the next chapter, the algorithm used to 
calculate the OS incorporates a means of allowing the wavelength to be a free parameter 
thereby compensating for the variable offset in the wavelength. Although, these uncertainties 
in the hyperspectral imaging system are not ideal, it will be shown in later chapters that the 
acquired spectra of blood can be processed and is comparable to the published extinction 
coefficients of haemoglobin. Furthermore, from the acquired spectra, the oximetry algorithm 
can be applied to calculate the oxygen saturation of blood with some accuracy.   
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Chapter 3: Model Eye Experiments. 
 
3.1. Introduction. 
 
Numerous retinal oximeter designs using dual and multiple wavelength combinations 
sensitive to changes in oxygen saturation (OS) have been previously reported and was 
reviewed in Chapter 1. One of the main challenges of retinal vessel oximetry is the 
development of a robust and accurate oximetry technique that accounts for the complex 
interaction of light within the retinal vessels, retinal tissues and ocular media. As a result 
there is currently no agreed method of calculating the OS in the retinal blood vessels.  
 
Model eyes provide a means of simulating the ocular optical system and anatomy for 
various ophthalmic experiments. The design and complexities of model eyes are driven by 
the nature of the research which may require the simulation of a specific functional property 
of the real eye or require high anatomical fidelity. In relation to retinal oximetry, model eyes 
provide a useful platform to evaluate new imaging systems and establish the validity of the 
oximetry methods. In vitro validation of a number of retinal oximetry systems have been 
previously reported using various model eye configurations (Hickam and Frayser, 1949; 
Delori, 1988; Schweitzer et al., 1999; Drewes et al., 1999; de Kock et al., 1993; Ramella-
Roman et al., 2008; Hirohara et al., 2007; Smith et al., 2000) and most have been briefly 
described in Chapter 1.  
 
The purpose of this study were: 
 to determine the accuracy of our OS calculations of arterial and venous human 
blood of known OS from spectral images acquired by the hyperspectral fundus 
camera using a model eye 
 to establish the effects of the background reflectance, and blood column thickness, 
on the accuracy of the OS calculations. 
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3.2. Methods 
 
This study was approved by the Gloucestershire Research Ethics Committee (COREC 
reference: 06/Q2005/131) and all procedures were carried out in accordance with the tenets 
of the Declaration of Helsinki. 
 
3.2.1. The Hyperspectral Fundus Camera 
 
The hyperspectral fundus camera was described in detail in Chapter 2. In summary, it 
is a commercial fundus camera (Canon CF-60Z, Tokyo, Japan) in which a liquid-crystal 
tuneable filter (VariSpec, CRI, Woburn, MA, USA) enables the acquisition of spectral 
images between 400 nm to 700 nm on to a CCD digital camera.  
  
3.2.2. The Model Eye 
 
A model eye was constructed to simulate the salient optical properties of the human 
eye (Figure 3.1). It is comprised of a water-tight black aluminum outer casing and a +62.5D 
doublet convex achromatic lens (Thorlabs, Ltd. UK; AC080-016-A1 series) inserted through 
an opening in its front surface, such that when distilled water was instilled into the model eye 
chamber to simulate the vitreous, the effective focal length is approximately 22 mm. To 
determine the effects of the reflectivity on the accuracy of the OS calculation, a background 
surface was built using Spectralon (Labsphere Inc., New Hampshire, USA) segments with 
Lambertion albedos of 20%, 60% and 99% (Figure 3.2).  
Blood-filled, fused quartz tubes (VitroCom, New Jersey, USA) could be positioned 
vertically within the model eye approximately 300 μm in front of the surface of the 
Spectralon background surface. The refractive index of the quartz tube is 1.46. Data was 
recorded for quartz tubes with internal diameters of 50 μm, 100 μm and 150 μm (outer 
diameters of 80 μm, 170 μm and 250 μm respectively), which enabled evaluation of the 
influence of simulated vessel diameter on the accuracy of the OS calculations. 
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Figure 3.1: The model eye. A. The model eye viewed from the top containing the Spectralon 
background and human blood in 150 µm quartz tubes. B. Schematic cross-section of the 
model eye. 
 
 
 
 
A
B
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Figure 3.2: Configuration of the Spectralon background and internal components of the 
model eye. 
 
 
3.2.3. The Model-Eye Experiments. 
The model eye was located in the conventional imaging position in front of the 
hyperspectral fundus camera. A straight metal wire (approximately 100 µm in diameter) 
placed in front of the Spectralon was used to help achieve optimal focus. The position of the 
fundus camera was also adjusted to attain optimal diffuse illumination (i.e. with minimal 
vignetting) within the model eye.  
Two arterial and five venous blood samples, contained in a syringe lined with 2 ml of 
lithium heparin (Sarstedt, Monovette ® 2 ml LH), were collected from seven human subjects 
in the intensive care unit in Cheltenham General Hospital. Blood-gas analysis of each blood 
sample was performed using a CO-oximeter (Gem Premier 4000, Instrumentation 
Laboratory, MA, USA) at the time of collection. A small sample of the blood was inserted 
into 100 μm and 150 μm quartz tubes, the ends of the tubes were sealed with petroleum jelly 
Front view Top view
Side view
Quartz capillary 
containing human blood.
Spectralon  segments with 
Lambertian albedos of: 
20%
99%
60%
 100 
 
and the tubes were located in the model eye in front of the Spectralon background. Time-
sequential hyperspectral images were acquired at wavelengths from 500 to 650 nm at 2 nm 
intervals. The mean (± SD) time taken to acquire a complete set of images was 5 minutes 52 
seconds (± 1 minutes 22 seconds). This process was repeated using the same blood sample 
inserted into 50 μm quartz tubes. Several repeated attempts to fill 50 μm quartz tubes with 
blood yielded only broken blood columns in the tube which were considered unsuitable for 
oximetry and consequently these images were not included in the study.  
To enable the analysis of blood at intermediate OS between the higher and lower 
saturations commonly found in unmixed arterial, or unmixed venous blood respectively, three 
of the venous blood samples were mixed with varying volumes of atmospheric air over a 
period of thirty to forty-five minutes. This process resulted in an increase in the measured OS 
of the venous blood samples. Subsequent to the blood-gas analysis with the CO-oximeter, the 
small air bubbles were removed from the syringe, which was then sealed to maintain a stable 
level of oxygenation prior to its use in the model eye. Samples of this blood were then 
imaged within the quartz tubes, in the model eye, as described above.  
Blood-gas analyses of all of the blood samples were performed again by the CO-
oximeter after imaging and the mean spectrophotometric measurement of OS before and after 
imaging was calculated to determine the gold-standard measured OS. The mean (± SD) time 
taken to perform the initial blood-gas measurement before imaging and re-measurement after 
imaging was 51 minutes 31 seconds (± 10 minutes 31 seconds). The mean difference (± SD) 
between the measured OS before and after imaging was 0.49% (± 0.76%). 
In total 20 blood-filled quartz tubes (ten 100 µm quartz tubes and ten 150 µm quartz 
tubes) were imaged. Table 1 summarizes the number of blood samples that were imaged for 
each type of blood and tube size. The measured OS range (mean ± SD) of the arterial and 
venous blood samples were 97.9 - 98.9% (98.4 ± 0.7%) and 23.4 - 97.5% (69.7 ± 25.3%) 
respectively. The total hemoglobin concentration ranges (mean ± SD) were 9.9 – 10.7 g/dL 
(10.3 ± 0.5 g/dL) and 7.1 - 18.3 g/dL (13.7 ± 3.7 g/dL) for the arterial and venous blood 
samples respectively. The hematocrit range (mean ± SD) of the arterial and venous blood 
samples were 28.5 – 30.5% (29.5 ± 1.4%) and 32.5 - 57.5% (46.9 ± 8.1%) respectively. 
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Table 1. Number of blood sample types and quartz tubes used. 
 
Blood sample type 
 
Number of blood filled quartz tubes 
imaged 
 
 
100μm 
quartz tubes 
 
150μm 
quartz tubes 
 
Arterial 
 
2 
 
2 
 
4 
T
ot
al
 
Venous 8 8 16 
 
 
10 
 
10 
  
 Total   
 
 
3.2.4. Image Processing and Quantitative Oximetry Calculation. 
 
All raw spectral images of the model eye were saved as 12-bit Portable-Network-
Graphics (PNG) format. Further processing and analysis of the raw images was performed 
using Mathematica (ver. 5.2; Wolfram Research, Inc., Champaign, IL). Dark calibration of 
each raw image was performed to remove the dark-current offset from the CCD output. 
Figure 3.3 illustrates the subtraction of a dark image from a model eye image at the same 
wavelength (580 nm) to generate a dark calibrated image. In the dark image there is central 
annular artefact (not apparent in the model eye image due to the reflectivity of the 
Spectralon) which is fixed in position irrespective of the wavelength used and position of the 
fundus camera. The fixed pattern artefact is a result of reflections from the internal 
components of the fundus camera and is reduced, in addition to the CCD noise, as a 
consequence of the dark calibration. A vessel-tracking algorithm implemented in C++ 
(Microsoft, Inc., Redmond, WA) and integrated with the Mathematica software was used to 
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determine the centreline co-ordinates along the quartz tubes and a series transverse intensity 
profiles were obtained orthogonal to the tubes (Figure 3.4). 
 
 
 
Figure 3.3: Dark calibration of a model eye image obtained at 580 nm. A. A raw image of 
the model eye obtained at 580 nm and an intensity profile along a linear region of interest 
(red solid line). The annular central artefact is not apparent due to the high reflectivity of the 
Spectralon. B. A dark image obtained at 580 nm and an intensity profile along a linear region 
of interest (red solid line). The annular central artefact is apparent and its intensity profile is 
shown in the plot below. C. Subsequent dark calibrated image at 580 nm obtained by 
subtracting the dark image obtained at 580 nm from the raw image of the model eye obtained 
at 580 nm. An intensity profile along a linear region of interest (red solid line) is shown in the 
plot below.
 
 
 
 
- =Central artefact
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Figure 3.4: Linear profiles (red lines) orthogonal to the centreline of the tracked quartz tubes.  
  
 For each gray-scale intensity profile, fitting algorithms were used to estimate the 
intensity at the centre of the tube (minima of the non-linear curve) and intensity of the 
background adjacent to the tube (gray-scale value of the linear fit at the center of the tube) to 
enable an estimate the optical density of the tube center (Figure 3.5), given by: 
OD   Log10
I  
Io           (Eq. 1.4) 
where, I(λ) is the estimated intensity at wavelength λ at the center of the tube, and 
Io(λ) is the estimate of intensity at the same position obtained by interpolation of the 
intensities either side of the tube – that is an estimate of the intensity in the absence of the 
tube. The effects of reflections (e.g. specular reflection or refractive index mismatch between 
the water-quartz-blood interfaces) on the quartz tubes are minimized by the curve fitting 
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technique to used estimate the intensity at the centre of the blood column. The optical 
densities of a given point were estimated across the wavelength range (500 nm – 650 nm) to 
calculate the optical density spectral variation, OD() (Figure 3.6). This was repeated at 
multiple points along all the quartz tubes.  
 
Figure 3.5: Analysis of the grayscale intensity profile across a given point in the quartz tube 
at one wavelength. A. Image of the model eye containing blood filled quartz tubes acquired at 
500 nm. The location of the linear profile across a quartz tube (red solid line) to be analyzed 
is shown. B. A plot of the intensity values along the linear profile. A curve fitting algorithm 
(blue dashed line) is applied to the grayscale intensity profile to estimate the grayscale 
intensity at the center of the tube. The value I(λ) is determined from the minimum value of 
the curve. A linear fitting algorithm (green solid line) is used to estimate the intensity of the 
background in the absence of the quartz tube [Io(λ)]. 
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Figure 3.6: Calculation of the optical density profile. A. Analysis of the intensity along the 
linear profile is used to estimate the optical density in the centre of the quartz tube (blue dot). 
This analysis is performed on all the spectral images (500 - 650nm in 2nm increments). B. 
Plotting all the optical densities across the wavelength range generates an optical density 
profile at the respective location in the tube. 
 
 
  
 
Calculation of the OS along the length of the quartz tubes was performed using the 
complete set of OD(). Two oximetry models were tested to determine the most accurate 
model. The first oximetry model is given by the Equation 1.5 and the second oximetry model 
by the Equation 1.6. 
Oximetry model 1. 
OD(λ) = a + η(λ) CHbTotal d [cOS (εoxy(λ + b) - εde-oxy(λ + b)) + εde-oxy(λ + b)] (Eq.  1.5) 
Oximetry model 2. 
OD(λ) = a S(λ) + η(λ) CHbTotal d [cOS (εoxy(λ + b) - εde-oxy(λ + b)) + εde-oxy(λ + b)] (Eq. 1.6) 
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where, CHbTotal is the total concentration of haemoglobin, εoxy, and εde-oxy are the 
extinction coefficients of oxygenated and deoxygenated haemoglobin (van Assendelft, 1970) 
respectively corrected for convolution with the spectral response of the liquid crystal tunable 
filter, d is the vessel diameter, cOS is the calculated oxygen saturation, η is the effective 
optical path-length contribution (Smith et al., 2000) and a is a scaling constant of the curve 
along the y-axis. Importantly, b is a scaling constant of the curve along the x-axis which 
compensates for the variability of the liquid crystal tunable filter which was described in 
Chapter 2. The difference between the two oximetry models is the presence of a scattering 
function. In Oximetry model 1 there is no scattering function. In Oximetry model 2, the 
function S accounts for the backscatter by of red blood cells. Wavelength dependent optical 
scattering values published by Meinke et al. (2007) were used in this oximetry model. In 
essence, this algorithm estimates the free parameters based on the Levenberg-Marquardt non-
linear fit to OD() to yield an estimate of cOS. 
 
 
3.2.5. Statistical Analysis 
The normality of the data distribution was confirmed using the Shapiro-Wilk normality 
test, with the cutoff for non-normality set at P < 0.05. To determine the effect of the light 
scattering parameter (S) on the accuracy of the oximetry model, a two-tailed paired t-test was 
used to compare the mean OS difference (difference between the measured and calculated 
OS) calculated by Oximetry model 1 and 2 in the 100 µm and 150 µm quartz tubes. The most 
accurate oximetry model was used in subsequent analyses. 
A multiple linear regression analysis was performed for the mean OS differences along 
the length of each quartz tube with the independent variables capillary size and blood gas 
analysis parameters (total haemoglobin (tHb), pH, carbon dioxide tension (pCO2), PO2, 
sodium ion concentration ([Na+]), potassium ion concentration ([K+]), chloride ion 
concentration ([Cl-]), haematocrit (Hct) and lactate, using the “enter” method. 
To determine the effect of the background reflectivity and tube size, the mean OS 
differences for segments of the 100 µm and 150 µm quartz tubes overlying the three different 
background reflectivities were calculated. A repeated-measures, two-way analysis of variance 
(ANOVA) was performed to compare the effect of tube size and background reflectivity on 
the mean OS difference. A post-hoc power analysis using the mean OS difference in each 
 107 
 
group (n = 6; three background reflectivities for each tube size), the average observed SD and 
a 0.05 significance level was performed using a software program developed by Faul et al. 
(2009)(Gpower program ver. 3.1). Pearson’s correlation between the measured OS and mean 
calculated OS along the length of each tube were calculated.  
The Bland-Altman method was used to assess the agreement between the CO-
oximeter and the values obtained from the chosen oximetry model in 100 µm quartz tubes. 
The mean calculated OS of each segment of the tube overlying the 3 Spectralon background 
reflectivities was calculated and the mean of the measured and calculated OS was plotted 
against the difference between the two methods. Statistical analyses (except the power 
analysis) were calculated using commercial software (SPSS, ver. 16.0; SPSS Inc., Chicago, 
IL).   
 
 
3.3. Results. 
 
3.3.1. Hyperspectral Images of Arterial and Venous Blood in the Model Eye. 
Representative narrow-band images of the model eye containing human arterial and 
venous whole-blood in 150 µm quartz tubes obtained at wavelengths of 586, 600, 620 and 
650 nm are shown in Figure 3.7. The vertical dark lines are the quartz tubes containing 
human blood. Each of the blood-filled quartz tubes spans the three reflective grades of 
Spectralon. Figure 3.7A shows a tube containing arterial blood with a measured OS of 
97.9%. Figure 3.7B shows a tube containing venous blood with a measured OS of 23.6%. It 
can be observed, as expected, that at the isosbestic wavelength of 586 nm (where the 
absorbance of oxyhemoglobin and deoxyhemoglobin are equal), both arterial and venous 
blood appear to have similar optical densities, and, that the arterial blood has a lower optical 
density at wavelengths of 600, 620 and 650 nm compared to venous blood.  
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Figure 3.7. Cropped dark calibrated spectral images of the model eye containing (A) arterial 
and (B) venous blood filled 150 µm quartz tubes. The spectral images shown were acquired 
at 586, 600, 620 and 650 nm. Each tube is located in front of 3 reflective grades of 
Spectralon. 
 
 
 
3.3.2. Determining the effects of light scattering on the accuracy of the oximetry model. 
 
The mean OS differences calculated by the two oximetry models were significantly 
different in both 100 µm and 150 µm quartz tubes (P < 0.0001, two-tailed paired t-test) 
(Figures 3.8 and 3.9).  Table 2 summarises the mean OS differences in the 100 µm and 150 
µm tubes calculated using the two oximetry models. The mean (± SD) OS differences, using 
Oximetry model 1 (no scattering function), were -11.8% (± 6.0%) and -11.4% (± 9.7%) in the 
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100 µm and 150 µm tubes respectively. The mean (± SD) OS differences, using Oximetry 
model 2 (scattering function), were -7.1% (± 7.1%) and -6.2% (± 10.2%) in the 100 µm and 
150 µm tubes respectively. Oximetry model 2 was used for subsequent OS calculations 
because the mean OS difference was smaller than the mean OS difference in Oximetry model 
1. 
 
Figure 3.8: A scatter plot of the mean oxygen saturation (OS) differences calculated by 
Oximetry model 1 (no scattering function) and 2 (scattering function) in 100 µm quartz tubes. 
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Figure 3.9: A scatter plot of the mean oxygen saturation (OS) differences calculated by 
Oximetry model 1 (no scattering function) and 2 (scattering function) in 150 µm quartz tubes. 
 
 
 
Table 2. The mean oxygen saturation difference (OS) in 100 µm and 150 µm quartz tubes 
using oximetry model 1 (no scattering function) and 2 (scattering function). 
 
Oximetry Model 
100 µm quartz tubes 
Mean OS difference (± SD)  
150 µm quartz tubes 
Mean OS difference (± SD)  
1 (no scattering function) -11.8% (± 6.0%) -11.4% (± 9.7%) 
2 (scattering function) -7.1% (± 7.1% ) -6.2% (± 10.2%) 
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3.3.3. Oxygen Saturation Calculation of Blood Along the Quartz Tubes. 
 
Figures 3.10 and 3.11 show the variation of calculated OS along the length of 100 µm 
quartz tubes containing arterial (measured OS = 98%) and venous (measured oxygen OS = 
23%) blood respectively. Processing and analysis of the model eye images was used to 
produce a pseudocolour image with a coloured representation of the calculated OS overlaid 
on the tube and sequential calculated OS values shown to the left of the tube (Figures 3.10A 
and 3.11A). Examples of the non-linear fitting of the oximetry model (Figures 3.10B and 
3.11B red lines) to the mean optical density profile along the length of each tube are 
illustrated with the calculated oxygen saturation. The calculated OS values along the length 
of each tube are also shown in a plot (Figures 3.10C and 3.11C) and demonstrate small 
fluctuations along its length. These fluctuations were comparatively higher in segments of the 
arterial and venous blood overlying the 20% reflective background (SD 1.40% and 1.05% 
respectively), possibly due to the effect of increased texture in the Spectralon background, 
however these fluctuations were small. In the quartz tubes containing arterial and venous 
blood the mean calculated OS along their lengths (± SD) was 106% ± 1.13% (n = 1,891 
measurements) and 45% ± 0.94% (n = 1,940 measurements) respectively.  
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Figure 3.10: Calculated oxygen saturation (OS) along the length of a quartz tube containing 
arterial blood. (A) A cropped pseudocolour image of the model eye with a 100 µm tube 
containing arterial blood (measured OS = 98%). A coloured representation of the calculated 
OS has been overlayed on the tube with sequential calculated OS values to the left of the 
tube.  (B) Mean optical density profile (blue dots) of the whole tube and the non-linear fitting 
oximetry algorithm (red line) to derive the calculated OS (106%). (C) Calculated OS (red 
line) along the length of the tube (mean calculated OS ± SD was 106% ± 1.13%). The 
locations of the different Spectralon reflective backgrounds with respect to the calculated OS 
are indicated in the legends within the graph. The table shows the mean calculated OS (± SD) 
of the blood column over segments of the Spectralon and along the whole length of the quartz 
tube. 
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Figure 3.11: Calculated oxygen saturation (OS) along the length of a quartz tube containing 
venous blood. (A) A cropped pseudocolour image of the model eye with a 100 µm tube 
containing venous blood (measured OS = 23%). A coloured representation of the calculated 
OS has been overlayed on the tube with sequential calculated OS values to the left of the 
tube. (B) Mean optical density profile (blue dots) of the whole tube and the non-linear fitting 
oximetry algorithm (red line) to derive the calculated OS (45%). (C) Calculated OS (red line) 
along the length of the tube, (mean calculated OS ± SD was 45% ± 0.94%). The locations of 
the different Spectralon reflective backgrounds with respect to the calculated OS are 
indicated in the legends within the graph.  The table shows the mean calculated OS (± SD) of 
the blood column over segments of the Spectralon and along the whole length of the quartz 
tube.  
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3.3.4. Influence of the Blood Gas Parameters, Background Reflectivity and Quartz 
Tube Size on the Accuracy of the Calculated Oxygen Saturation. 
 
A significant multiple linear regression model was used (F = 4.54, P = 0.02, adjusted 
R squared = 0.65) to assess the relationship between the mean OS difference and capillary 
size and blood gas analysis parameters (tHb, pH, PCO2, PO2,[Na
+],[K+],[Cl-], Hct and 
lactate).  In Table 3 the standardized coefﬁcients of the independent variables - tHb, pH, 
PCO2, PO2,[Na
+],[K+],[Cl-], Hct and lactate are presented. The independent variables were 
not a significant predictor of the model. 
 
Table 3. Standardized regression coefﬁcients derived from multiple linear regression analysis 
with mean OS difference as the dependent variable. 
 
Predictor variable Standardized coefficients P 
Quartz tube internal diameter 
(100μm and 150μm) 0.05 0.71 
tHb 
0.36 0.42 
pH 
-1.54 0.11 
pCO2 
-1.34 0.33 
pO2 
0.07 0.86 
Na+ 
-1.23 0.38 
K+ 
-0.98 0.05 
Cl- 
1.45 0.18 
Hct 
-0.36 0.48 
lactate 
0.66 0.49 
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The mean differences between the measured and calculated oxygen saturations for 
segments of the 100 µm and 150 µm quartz tubes overlying the different reflective 
backgrounds are expressed as histograms ± SEM in Figure 3.12. A comparison between the 
groups using a two-way ANOVA showed that the Spectralon reflectance and quartz tube 
sizes had no significant effect on the mean OS difference (P = 0.18 and P = 0.99 
respectively). The post-hoc power calculation of the ANOVA analysis was 0.07. 
Figure 3.12: Mean differences between the measured and calculated oxygen saturations (± 
SEM) in segments of the 100 µm (n = 10) and 150 µm (n = 10) quartz tubes overlying the 3 
background reflectivities. 
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3.3.5. Correlation Between the Measured and Calculated Oxygen Saturation. 
 
A significant and strong correlation between the measured oxygen saturation and 
respective mean calculated oxygen saturation of all 10 blood-filled 100 µm (r2 = 0.96, P = 
0.000008) and 10 blood-filled 150 µm quartz tubes was found (r2 = 0.95, P = 0.000035). 
 
3.3.6. Accuracy of the Blood Oxygen Saturation Calculations in the Model Eye.  
 
Figure 3.13 shows Bland-Altman plots for segments of the 100 µm quartz tubes 
overlying the reflective backgrounds. The mean differences (± SD) between the measured 
and calculated OS in segments of the 100 µm and 150 µm tubes overlying the 20%, 60% and 
99% background reflectivities were -4.0% (± 13.4%), -6.4% (± 9.9%), -5.5% (± 10.2%) and -
5.3% (± 10.8%), -5.2% (± 10.7%), -5.2% (± 10.9%) respectively (95% limits of agreement 
were -30.2 – 22.3%, -25.9 - 13.0%, -25.4 – 14.8% for the 100 µm tubes and -26.5 – 15.9%, -
26.3 – 15.8%, -26.5 – 16.1% for the 150 µm tubes). 
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Figure 3.13: Bland-Altman plots showing the agreement between the measured and 
calculated oxygen saturations in 100 µm quartz tubes. Each plot represents separate analysis 
of segments of the quartz tubes overlying the 3 reflective backgrounds: (A) 20% (B) 60% and 
(C) 99%. The mean of each corresponding measured and calculated oxygen saturations are 
plotted against the difference between the measured and calculated oxygen saturations. 
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3.2. Discussion 
 
This study demonstrates the ability of our hyperspectral imaging system and oximetry 
analysis to yield oxygen saturation calculations and evaluates its accuracy using a model eye. 
The model eye provided a useful platform to acquire spectral images of blood samples 
with varying oxygenation. Although it represents a simple optical model of the eye, it has 
been a useful tool in determining the applicability of hyperspectral imaging to perform 
oximetry and determine the accuracy of our oximetry model using ground truth, a posteriori 
knowledge. Figure 3.7 illustrates an example where both arterial and venous blood can be 
visibly distinguished from the dark calibrated spectral images. In this example, both arterial 
and venous blood appear to have equal optical density at 586 nm,  however, at wavelengths 
of 600, 620 and 650 nm, the arterial blood appears to be optically, less dense than venous 
blood. This is due to lower extinction coefficients of oxygenated blood at these wavelengths. 
This correlates with published descriptions of the extinction properties of fully oxygenated 
and fully de-oxygenated hemolyzed blood (van Assendelft, 1970), however, these 
observations provide only qualitative information regarding the OS of blood. 
Our quantitative determination of the blood OS used a non-linear fitting oximetry 
model applied to the estimated OD() along a given column of blood. Importantly, we have 
made attempts to account for variables that influence the propagation of light in the retina, 
such as scattering by the red blood cells, the optical path length, hemoglobin concentration, 
and vessel diameter. In particular, this study has demonstrated that the incorporation of a 
scattering factor into the oximetry model improves its accuracy in calculating the OS of 
blood.  
We have shown that the optical density profiles of arterial and venous blood (Figures 
3.10B and 3.11B respectively) are spectrally distinguishable, and conforms to the published 
extinction coefficients of fully oxygenated and fully de-oxygenated hemoglobin (van 
Assendelft, 1970). This similarity of the optical density profiles to the published extinction 
coefficients suggests that the acquisition of spectral images at 2 nm intervals compensates, to 
some extent, for the variability of the liquid crystal tunable filter. Furthermore, the close 
approximation of the non-linear curve to the measured optical densities suggests that 
introducing a free parameter, b, into the oximetry model enables the non-linear curve to be 
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translated in a horizontal direction, thereby also compensating for the variability of the liquid 
crystal tunable filter. 
This study has demonstrated that the oximetry model is capable of producing 
consistent calculated OS values along the length of each quartz tube (Figures 3.10C and 
3.11C). The standard deviation of the calculated OS along each of the quartz tubes shown are 
small and the fluctuations in the calculated OS values can be explained by the texture in the 
background reflectance and/or physiological noise (scattering within the blood column due to 
red blood cells or other component of blood such as bilirubin, or physiological fluctuations in 
the oxygen saturation along the blood column). In the multiple linear regression analysis, no 
significant association was found between the OS difference and the blood gas parameters 
(tHb, pH, PCO2, PO2,[Na
+],[K+],[Cl-], Hct and lactate) indicating that these independent 
variables were unlikely to influence the accuracy of the OS calculation.  
Fluctuations in the calculated OS were more prominent in segments of the quartz 
tubes overlying the 20% reflective background and this can be explained by the increased 
contrast of the texture in the low albedo Spectralon. Further analysis of the effect of the 
background reflectivity and tube size on the mean OS differences in all quartz tubes was 
subsequently performed using a repeated measures, two-way ANOVA. The results indicated 
that the effect of the background reflectivity and tube size on the mean OS differences was 
not significant (P = 0.18 and P = 0.99 respectively). The consistency in the calculated OS 
along the length of the quartz tubes (Figures 3.10C and 3.11C) further illustrates the 
robustness of the oximetry model to variations in the background reflectivities. The oximetry 
model can, therefore, be considered to be robust to differences in the background reflectivity 
and tube diameter. These two features are commonly encountered in the retina where there 
are variable vessel diameters and variable amounts of fundal pigmentation resulting in 
different background reflectivities. The configuration of the Spectralon background within 
the model eye was specifically intended to broadly mimic the variability in fundal 
pigmentation (20% and 60% background reflectivity Spectralon) and the optic disc (99% 
background reflectivity) which is relevant to evaluating the applicability of the oximetry 
model to a wide population of subjects. The power of the ANOVA analysis was 0.07 
according to the post-hoc power calculation and an undetected real difference in the accuracy 
of the OS calculation due to the small sample size could also explain the non-significant 
effect of the background reflectivity and tube size. In addition, the reflectivity of the 
Spectralon cannot be considered as a precise simulant of the fundus, which has distinct 
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spectral characteristic due to the presence of visual pigments, blood and other retinal 
chromophors. Further, investigation is required to determine the accuracy of the oximetry 
technique in the human eye. A further limitation of this study was that tests of repeatability 
could not be performed with a high degree of precision. The main reasons for this were, 
firstly, that the oxygenation of a given blood sample changed (albeit by a small percentage) 
over a time period between re-imaging. Secondly, the process of imaging the blood samples 
was carried out within a few minutes. From experience, we found that prolonging the 
imaging process would lead to segmentation of the blood column in the quartz tubes which 
could lead to undesirable and uncontrolled changes in the OS of the blood column within the 
tube. 
We have demonstrated a significant and strong correlation between the measured and 
calculated OS in 100 µm and 150 µm quartz tubes (P < 0.01 in both tube sizes). However, to 
assess the agreement between the measured and calculated OS, the Bland-Altman method 
was used for each segment of the 100µm (Figure 3.13) and 150 µm quartz tubes overlying 
the different reflective backgrounds.  
The limits of agreement are high from a clinical point of view. It is unlikely that the 
limits of agreement were affected by the variability of the measured OS as the mean 
difference ± SD between the measured OS before and after imaging was small (0.49% ± 
0.76%). This figure may have been adversely affected by systematic effects; two plausible 
reasons are: the oxygenation of the blood in the tube may have changed upon transfer from 
the blood gas syringe to the quartz tube – however this is unlikely as the transfer of the blood 
samples to the quartz tubes occurs in a few seconds and secondly, and most plausibly, the 
oximetry model may be overestimating the true OS through an imperfect match between the 
optical model for OD() and the data. This is illustrated in Figure 3.11B in which a sample of 
venous blood with a measured OS of 23% is analyzed. The spectral variation in optical 
density for the whole tube (blue dots) appears to have a distinct “bell” shape; however the 
oximetry model fits a curve to the data which exhibits a distinctive “double-hump” (red line), 
which is redolent of fully oxygenated blood. It is therefore likely that a fitting error for 
venous blood may have contributed towards an overestimation of its true OS. However, this 
does not necessarily provide a full explanation of the wide limits of agreement as it can be 
observed in Figure 3.13 that there are two underestimates of the measured OS at the higher 
end of the oxygen saturation scale. It is unlikely that the limits of agreement were affected by 
the variability of the measured OS as the mean difference ± SD between the measured OS 
 121 
 
before and after imaging was small. Additionally, the systematic effect of a fitting error does 
not address the variability and high SD in the mean differences between the measured and 
calculated OS. Further experiments and evaluation of the fitting technique would be required 
to establish a comprehensive explanation for our findings. Our future research will initially 
focus on refining the physical model to remove the effects of this systematic error, 
particularly at lower oxygen saturations.  
The phenomenon of overestimating the true OS has been previously reported in 
studies on other types of photometric oximeters. Sarnquist et al. (1980) reported that pulse 
oximeters were overestimating the actual OS with an average reading of 70% at 50% actual 
OS. This overestimation in pulse oximeters is thought to be caused by the scattering of red or 
infrared light in the blood vessels (Shimada et al., 1984). Additionally, Drewes et al. (1999) 
reported an error of ±52% at 0% blood OS in a model eye using an Eye Oximeter and Delori 
et al. (1988). reported overestimations of the true OS, particularly at lower OS, in in vitro 
tests of the Retinal Vessel Oximeter. In light of this, the accuracy of our oximetry model is 
comparable to these reports. Errors of this magnitude are higher than is desirable since 
accuracy in the determination of both the arteriolar and venular oxygen saturation is 
important in determining the functional status of the inner retina. This limitation of our 
oximetry model to lower blood OS could be improved by further research to enable accurate 
characterization of scattering effects within and around the blood column. A comparison of 
the accuracy of the model eye experiments reported in this thesis to model eye experiments 
reported by other authors (described in Chapter 1) is shown in Table 4. 
Further limitations of this study include the lack of control of the blood sample 
properties such as its temperature during imaging, pH, haemoglobin concentration, 
haematocrit and mean corpuscular volume. In addition, the light scattering influences of 
segmentation within the blood column (including platelet aggregation) during imaging and 
the shape of the red blood cells in the quartz tubes of varying internal diameters requires 
further attention on  its effects on the accuracy of the oximetry technique in future studies. 
Further improvements to the model eye, to more accurately simulate the optical 
characteristics of the human retina, would be desirable in order to achieve a more detailed 
appraisal of the oximetry technique. 
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Table 4. Comparison of the accuracy of the model eye results reported in this thesis to the 
accuracy of model eye experiments reported by other authors. 
Author Accuracy 
This thesis The mean (± SD) OS differences were -7.1% (± 7.1%) and -
6.2% (± 10.2%) in the 100 µm and 150 µm tubes 
respectively. 
Laing and Cohen (1975) 
 
Cohen and Laing (1976) 
Better than 1% oxygen saturation. 
 
Oximetry model was comparable at high oxygen saturations. 
At low oxygen saturations the theoretical calibration line 
underestimated the actual oxygen saturations by up to 20%. 
Hickam and Frayser (1949) The standard deviations of the ODRs from the measured OS 
were relatively small: 6% and 9% OS in 500µm and 250µm 
glass capillaries respectively. 
Delori (1988) Oximetry model was most accurate in the range of 50 - 
100%. 
In the range between 0 - 50% there was a tendency towards 
overestimating the measured OS. 
Schweitzer et al. (1999) No accuracy reported. 
Drewes et al. (1999) 
(Denninghoff) 
The reported error was small at measured oxygen saturations 
of 83% (± 4% error) but increased with lower oxygen 
saturations to a maximum at measured oxygen saturations of 
0% (± 52%) 
de Kock et al. (1993) A linear relationship was demonstrated between the R/IR 
ratios and the measured blood oxygen saturations from 
100% to 85%.  
However, at blood oxygen saturations below 85%, a non-
linear relationship with the R/IR ratios. 
 
In summary, the model eye has been a useful test bed for evaluating our method of 
measuring the OS of blood using a hyperspectral fundus camera. Our oximetry technique was 
shown to be reasonably accurate and robust to variable features such as background 
reflectivity and quartz tube diameter. Further studies will be described in the subsequent 
chapters which apply these oximetry techniques on spectral images of the human retina. 
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Chapter 4: Human Imaging and Spectral Image 
Analysis. 
 
4.1. Introduction. 
 
The aims of this chapter are to describe: 
 the use of the hyperspectral fundus camera to acquire hyperspectral retinal images 
from healthy subjects  
 the application of the image processing and analysis algorithms to calculate the 
oxygen saturation (OS) of the retinal vasculature.  
 
 
4.2. Methods. 
 
This study was conducted in accordance with the ethical standards of the Declaration of 
Helsinki and was approved by the local Research and Ethics Committees at Gloucestershire 
Hospitals NHS Foundation Trust (REC reference number: 06/Q2005/132) 
 
4.2.1. Recruitment, Assessment and Preparation of Volunteers. 
 
Twenty-three healthy subjects were recruited from the eye departments in Cheltenham 
and Gloucester General Hospitals between 2006 and 2010. Healthy subjects also included 
staff members from Cheltenham and Gloucester General Hospitals who volunteered to 
participate in the research. These volunteers responded to poster advertising placed in the 
respective eye departments. Written informed consent was obtained from all volunteers. 
All normal subjects were assessed by the study investigator. The best corrected visual 
acuity (BCVA) was measured using a Snellen chart to record the distance vision. Intraocular 
pressures (IOP) of both eyes were measured using Goldmann applanation tonometry. Slit-
lamp biomicroscopy was used to assess the anterior segment. The pupils of the normal 
subjects were dilated with 1% tropicamide (Minims; Chauvin Pharmaceuticals, Romford, 
UK). The Lens Opacities Classification System III (LOCS III) (Chylack et al., 1993) was 
used to grade the degree of lens opacity. Dilated fundoscopy was performed by slit-lamp 
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biomicroscopy using a 78D lens. Oximetry measurements of the index finger were performed 
in all volunteers using a pulse oximeter (Biox 3740, Ohmeda, Louisville, CO). Brachial blood 
pressure of all normal subjects was measured using an aneroid sphygmomanometer (Accoson 
0342: A.C. Cossor & Son (Surgical) Ltd., Essex, UK). 
Inclusion criteria were BCVA 6/9 or better, open anterior chamber angle, absence of any 
ocular pathology, IOP <21 mm Hg, normal optic disc appearance. Exclusion criteria included 
history of intraocular surgery, ocular pathology, diabetes mellitus, stroke, hypertension, 
glaucoma family history.   
 
4.2.2. Acquisition of Hyperspectral Retinal Images. 
  
The hyperspectral fundus camera has been previously described in detail in Chapter 2. 
Spectral images of the retina were acquired using wavelengths between 500 nm and 650 nm 
at 2 nm intervals. To obtain the optimal focus of the retina, images at 580 nm were acquired 
and viewed in real time. Fine adjustments to the camera focusing was performed until the 
edges of the retinal blood vessels within and around the optic disc and macular appeared 
sharp. The subjects were instructed to maintain their head position on a head mount with their 
forehead firmly pressed against a forehead strap until the complete set of spectral retinal 
images were acquired. Eye fixation was maintained by instructing the subject to fixate on a 
red fixation light with the contralateral eye. The positioning of the optic disc within the 
retinal image was achieved by positioning the red fixation light in front of the contralateral 
eye such that the location of the optic disc in the retinal images in all normal subjects was 
approximately midway between the centre and the image border (right image border for the 
right eye and left image border for the left eye). This ensured that the macula region was 
captured within each image.  
At wavelengths between 500 – 550 nm and 620 - 650 nm the contrast of the retinal 
blood vessels to the retinal background was low. At these wavelengths, it was difficult to 
determine the focus of the images. Therefore the imaging sequence protocol started at 580 
nm and spectral images were acquired by changing the LCTF wavelengths in 10 nm steps up 
to 650 nm. The LCTF was then changed to 582 nm to ensure optimal focus and spectral 
images were again acquired by changing the LCTF wavelengths in 10 nm steps up to 648 nm. 
This procedure was repeated to obtain spectral retinal images between 580 nm and 650 nm in 
2 nm intervals.  The same procedure of changing the LCTF wavelengths was performed to 
 125 
 
obtain spectral retinal images between 580 nm and 500 nm in 2 nm intervals. Significant head 
movements and eye movements caused changes in the focus of the images. Defocused 
images were identified by viewing the captured images in turn on the computer screen. The 
defocused retinal image at the given wavelength was reacquired by adjusting the camera 
focus and/or repositioning the subject’s head.  
Early experience with the hyperspectral fundus camera showed that if the wavelength 
was changed too rapidly the LCTF had a tendency not to respond to the command resulting in 
an image acquired labelled with the wrong wavelength. Associating the retinal image with the 
corresponding wavelength is an essential part of the image processing and analysis 
algorithms. Therefore, a 3 - 4 second time interval between changing the LCTF wavelength, 
and acquiring an image was used to ensure that the LCTF had responded.  Furthermore, by 
imaging the retina in 10 nm intervals the characteristic spectral changes within the retinal 
image could be viewed to ensure that the LCTF had responded (Figure 4.1). Sequential 
imaging often resulted in images that are poor quality due to small eye movements, head 
movements and eyelid blinking. To ensure that the best quality images were obtained, two 
good quality images (determined by the operator) for each wavelength were acquired before 
the wavelengths were changed. This imaging protocol ensured that all spectral images of the 
retina were of the highest quality prior to processing. The mean (± SD) time to acquire a 
series of spectral images of the retina between 500 – 650 nm was 11 minutes 5 seconds (± 7 
minutes 41 seconds). 
 
4.2.3. Selection and Processing of Hyperspectral Retinal Images. 
 
Selection of the best retinal images for each wavelength was performed manually. 
This was done by inspecting the raw 12-bit retinal images on a computer using an image 
viewing software (Windows picture and fax viewer, Microsoft, Redmond, WA). Appendix 2 
illustrates examples of the image selection process. Appendix 3 illustrates histrogram of a 
sample raw retinal image acquired at 580 nm .  
 
The majority of the image processing algorithms applied to the retinal images were 
the same as the algorithms applied the model eye images described in Chapter 3. The specific 
image processing algorithms that were applied to the retinal images are described in the 
following sections. 
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Figure 4.1: Spectral images of a normal retina acquired using wavelengths between 580 and 
618 nm. Characteristic spectral changes of the optic disc and retinal blood vessels (appear 
lighter) are more obvious as the wavelengths are changed in 10 nm increments. The 
characteristic spectral changes are less obvious in 2 nm increments. 
 
 
 
  
4.2.3.1. Dark Calibration. 
 
The method of dark calibration was described in Chapter 3. However, the effectiveness of 
the dark calibration in removing noise from the optical system (especially the central annular 
artefact) was not obvious in the model eye images due to the presence of the highly reflective 
Spectralon in the centre of the image field. In the retinal images, the central annular artefact 
is located over the macular and can project onto the vascular structures. Figure 4.2 illustrates 
the effect of the dark calibration in reducing the signal of the central annular artefact in an 
example retinal image acquired at 580 nm.  
 
 
 127 
 
Figure 4.2: Dark calibration of a retinal image. An image of a normal right retina acquired at 
580 nm before (top left) and after (top right) dark calibration (subtraction of a dark image at 
the corresponding wavelength). Line profiles of the intensity across the fixed pattern artefact 
in the retinal image before (bottom left) and after (bottom right) dark calibration are shown 
below each image. The central artefact is less apparent in the dark calibrated image and its 
signature in the intensity line profile has been attenuated. 
 
 
 
4.2.3.2. Image Registration. 
 
Image registration is a method of aligning images of the same scene into one common 
coordinate system. Numerous methods have been used to align different types of images and 
various approaches have been applied to the registration of retinal images. An in depth 
discussion of these methods is beyond the scope of this thesis but they can be broadly 
categorized into intensity-based (Maes et al., 1997; Matsopoulos et al., 1999; Ritter et al., 
1999; Lloret et al., 2000; Cideciyan, 1995; Ballerini, 1997; Skokan et al., 2002) and feature –
based (Stewart et al., 2003; Sofka and Stewart, 2006; Xu et al., 2007; Li and Chutatape, 2007; 
Can et al., 2002; Zana and Klein, 1999) methodologies. The main problem in time-sequential 
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imaging is the misalignment of the raw spectral retinal images due to the saccadic movements 
of the eye. The alignment of the spectral retinal images is of paramount importance to enable 
the measurement of the oxygen saturation at a given point in the retinal image plane. 
The image registration method that was used in this research employed a cross-
correlation technique. A customized image processing routine written in Mathematica (ver. 
5.2; Wolfram Research, Inc., Champaign, IL) was used to perform the image registration.  
The cross-correlation technique measures the degree of similarity between two images. A 
reference image is chosen, usually at 580 nm where the appearances of the arterioles and 
venules are equally as dark and have a higher contrast in comparison to the retinal 
background. All of the other spectral retinal images are aligned to the coordinates of the 
reference image. The maximum of the cross-correlation of each image is searched by rotating 
and translating the images and comparing it to the reference image. The amount of translation 
and rotation required to align each image to the reference image is calculated from the 
maximum cross-correlation between each images and the reference image. The cross-
correlation technique requires features within each image to be similar in appearance 
irrespective of the wavelength. However, the appearance of the spectral retinal images change 
in relation to the wavelengths used to acquire them (Figure 4.3). Hence, a number of pre-
processing steps were implemented during the image registration process. Firstly, sequential 
spectral retinal images were acquired such that the main features of the retinal images (optic 
disc and large retinal vessels) were located in approximately the same position in the image 
field. Secondly, the vascular network and the optic disc were used as features within each 
image and enhanced to enable accurate cross-correlation between the reference retinal image 
and the sequential spectral images. These features were enhanced using customized passband 
and edge detection (Laplacian of Gaussian [Marr and Hildreth, 1980]) filters. Lastly, the 
enhanced images were converted into the frequency domain using fast Fourier transformation 
(FFT). These Fourier transformed enhanced images were used in the cross-correlation image 
registration process to reduce the time required for the calculation of the maximum 
correlation between the spectral images and the reference image. A flow chart of the image 
registration algorithm is shown in Figure 4.4. An illustration of 6 spectral images from one 
normal eye, before and after image registration is shown in Figures 4.5A and 4.5B 
respectively. In Figure 4.5, landmark retinal features were manually selected from a reference 
retinal image to illustrate the misalignment of the retinal images before the image registration 
(Figure 4.5A) and their alignment after image registration (Figure 4.5B). 
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Figure 4.3: Spectral images of a normal right retina at six wavelengths. 
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Figure 4.4: Flow chart of the registration algorithm.  
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Figure 4.5: Spectral retinal images before and after registration. A. Unregistered raw spectral 
images of a normal right retina at six wavelengths. Six coordinate points (red dots) selected 
manually from the reference image (580 nm – red square border) overlying the retinal blood 
vessels and the corresponding coordinate points are displayed in the retinal images acquired 
at 530, 560, 600, 620 and 640 nm. The images are misaligned. B. Registered dark calibrated 
spectral images of a normal right retina at the 6 wavelengths. The six manually selected 
coordinate points (red dots) overlie the same landmark structures demonstrating the 
alignment of the retinal images. 
 
 
 
Subsequent to the registration of all the spectral images, the registered images were 
checked visually by comparing the alignment of the registered images to the reference image. 
Images that appeared to be significantly misregistered were removed from further processing 
and analysis. In total 19 (0.01%) images were removed due to misregistration from all the 
images collected (n = 1784). 
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4.2.3.3. Vessel Detection and Tracking. 
 
The coordinates of the centreline of the retinal vasculature were calculated by 
manually detecting the retinal blood vessels and applying a semi-automated vessel tracking 
routine. The vessel tracking technique is based on the Fast Marching Method (Sethian, 1999) 
which searches for pixels between two points with the lowest intensities and finds its shortest 
path. To enable accurate tracking of the retinal vasculature a reference retinal image (580 nm) 
was converted into an image which highlighted the retinal blood vessels by assigning the 
lowest pixel values to the vessels in contrast to higher pixel values to the retinal background 
(Figure 4.6). Two points along the length of a given blood vessel segment within the 
reference image were manually selected and the vessel tracking algorithm was applied.  
 
Figure 4.6: Conversion of an image of a normal left retina into an image which highlights the 
retinal blood vessels. (Right) Dark calibrated registered reference image of a normal left 
retinal acquired at 580 nm. (Left) Processed image highlighting the retinal vasculature. 
 
 
 
The vessel tracking algorithm was frequently unable to distinguish between two 
vessels that were in close proximity to or crossed each other. The result lead to the vessel 
tracking of two different vessels. This often occurred when tracking arterioles in close 
proximity to or crossing over large venules resulting in the tracking of the larger venules.  
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To prevent this from occurring, my method was to select two points at short distances 
apart (as opposed to the whole length of a vessel), apply the vessel tracking algorithm and 
repeat the procedure along the length of a given blood vessel. This was particularly useful for 
arterioles and smaller venules. For the larger 1st degree venules, the vessel tracking algorithm 
was capable of following the course of the whole vessel along its length (Figure 4.7, top 
images in the third and fourth columns).  
 
Figure 4.7: Semi-automated vessel detection of the superotemporal and inferotemporal 
arterioles and venules. Each image illustrates the results of the vessel tracking for a segment 
of the retinal blood vessel. The vessel tracking program identifies coordinates in the centre of 
the vessel along the segment (red line). The coordinates of a series of linear profiles 
orthogonal to two adjacent centreline coordinates are subsequently calculated (blue lines). 
 
 
Arterioles Venules
Superotemporal Superotemporal InferotemporalInferotemporal
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The vessel tracking procedure was repeated until the majority of the retinal 
vasculature was identified (Figure 4.8). Small arterioles and venules were often the most 
difficult to obtain accurate tracking and therefore tracking of some of the smaller blood 
vessels were omitted due to vessel tracking errors. The vessel tracking algorithm enabled an 
estimate of the centreline coordinates of the retinal blood vessels. 
 
Figure 4.8: Completed vessel tracking of the retinal vasculature in an image of a normal left 
retina. The different colours indicate segments of the vessels that were tracked separately. 
 
 
4.2.3.4. Vessel Profile Extraction and Calculation of the Light Transmission of 
the Retinal Vasculature. 
 
The centreline coordinates along each blood vessel was subsequently used to calculate 
the coordinates of a series of linear profiles orthogonal to the vessels. This was performed by 
calculating the perpendicular of the gradient between two successive points along the centre 
of a given blood vessel (Figure 4.9). The result was a series of linear profiles perpendicular to 
the blood vessels in the retinal vascular network (Figure 4.10). The length of the profile was 
manually selected depending on the size of the blood vessel and was approximately 2-3 times 
the estimated width of the blood vessel. The intensity values along the length of each linear 
profile were extracted (Figure 4.11). This was repeated for all the spectral images (Figure 
4.12) such that for each linear profile in a given blood vessel the intensity values along that 
profile were extracted for all wavelengths. 
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Figure 4.9: Calculation of the perpendicular of the gradient between two successive points 
along the centre of a given blood vessel  
 
Figure 4.10: Linear profiles perpendicular to the retinal blood vessels in an image of a 
normal left retina. 
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Figure 4.11: Intensity along a given profile of a point in a retinal blood vessel at 580nm. 
 
 
Figure 4.12: Intensity of a given profile of a point in a retinal blood vessel at various 
wavelengths. 
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4.2.3.5. Optical Density Estimation. 
 
The method used to estimate the optical density in the centre of a given point in a 
blood vessel was the same as that described in Chapter 3 for the model eye experiments. 
Briefly, fitting algorithms were applied to each gray-scale intensity profile to estimate the 
intensity at the centre of the blood vessel (minima of the non-linear curve) and intensity of 
the background adjacent to the blood vessel (gray-scale value of the linear fit at the centre of 
the blood vessel). The optical densities of a given point were estimated across the wavelength 
range (500 – 650 nm) to calculate the optical density profile. This was repeated at all points 
along all the selected blood vessels.  
 
4.2.3.6. Oxygen Saturation Calculation. 
 
The method used to calculate the OS along the length of the retinal blood vessels was 
the same as that described in Chapter 3 for the model eye experiments. This was performed 
by using an algorithm based on the Levenberg-Marquardt non-linear fit to the complete set of 
OD(λ) for a given point on the tracked blood vessel in the equation,  
OD(λ) = a S(λ) + η(λ) CHbTotal d [cOS (εoxy(λ + b) - εde-oxy(λ + b)) + εde-oxy(λ + b)] (Eq. 1.6) 
where, CHbTotal is the total concentration of haemoglobin, εoxy, and εde-oxy are the 
extinction coefficients of oxygenated and deoxygenated haemoglobin (van Assendelft, 
1970)193 respectively corrected for convolution with the spectral response of the liquid crystal 
tunable filter, d is the vessel diameter, cOS is the calculated oxygen saturation, η is the 
effective optical path-length contribution (Smith et al., 2000) and a is a scaling constant of 
the curve along the y-axis. Importantly, b is a scaling constant of the curve along the x-axis 
which compensates for the variability of the liquid crystal tunable filter which was described 
in Chapter 2. Wavelength dependent optical scattering values published by Meinke et al. 
(2007). were used in this oximetry model.  
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4.2.3.7. Determining the Wavelength Range for Retinal Oximetry. 
 
An evaluation of the OS calculations in normal eyes at an early stage of the research 
project revealed that when a wavelength range between 500 and 650nm was used it 
frequently calculated lower than expected oxygen saturations of the retinal arterioles (about 
70 – 80%). It was therefore important to determine the wavelength range that would yield the 
most accurate OS calculations. 
 Retinal images from 3 normal subjects were used to determine the most accurate 
wavelength range. For each subject, optical density profiles (n = 101) were generated from 
selected segments of the retinal arterioles and averaged (Figure 4.13). The mean optical 
density profile was used to calculate the OS using the oximetry algorithm. 
 
Figure 4.13: Generation of the mean optical density profile of a selected segment of retinal 
arteriole in a normal subject. (Left) An image of the retina acquired using 580 nm. The 
location of the range of extracted optical density profiles are shown in the image (orange 
lines; red line: centre optical density profile). (Right) The mean optical density profile at 
wavelengths between 500 and 650 nm. 
 
 
 
Location of the selected optical density profiles Mean optical density profile
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The wavelength range of the mean optical density profile was changed and the 
oxygen saturations calculated for each range. Firstly, the starting wavelength of the range was 
changed from 500 nm to wavelengths in increments up to 640 nm. The end wavelength was 
kept at 650 nm. For each wavelength range the OS was calculated. Plots illustrating the effect 
of changing the starting wavelength in the wavelength range on the non-linear fit and OS 
calculation are shown in Figure 4.14. In the plots, the oximetry model (described by the curve 
fit; red line) was applied to the optical denisty data at specific wavelength ranges. To enable a 
visual comparison of the fitted curves between the wavelength ranges, the wavelength range 
of the fitting curves were kept constant between 500 – 650 nm. Figure 4.15 shows a plot of 
the wavelength range (the intial wavelength is modified, the last wavelength is kept constant 
at 650 nm) versus the calculated OS for the given optical density profile of the retinal 
arteriole shown in Figure 4.13 (right). 
The most appropriate starting wavelength of the wavelength range was decided to be 
556 nm. The rationale for this decision is multifactoral. Firstly, it yields the most appropriate 
OS of the retinal arteriole in a normal eye (wavelength range 556 - 650 nm; oxygen saturation 
94%). It can be seen in Figures 4.14 and 4.15 that using a wavelength range with the initial 
wavelength starting between 500 and 540 nm resulted lower than expected oxygen 
saturations for the retinal arterioles. Similarly, using a wavelength range with the initial 
wavelength starting between 560 nm and 640 nm resulted inaccurate oxygen saturation 
calculations for the selected retinal arteriole. Secondly, when the mean optical density profile 
(Figure 4.13, right) is compared to the modified extinction coefficient (Figure 4.16) an 
important difference exists. The first local maxima of the optical density profile appear to be 
lower than the second local maxima. In contrast, the first local maxima of the modified 
extinction coefficient is higher than the second local maxima. Thirdly, the wavelength range 
of 556 – 650 nm incorporates important features of the modified extinction coefficient curves 
of oxyhaemoglobin (local minima and the second local maxima) and deoxyhaemoglobin 
(local maxima), that could be used accurately calculate the oxygen saturation of a given point 
in a retinal blood vessel (Figure 4.16, right). 
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Figure 4.14: Nonlinear fitting (red line) of the mean optical density profile (blue dots) with 
incremental changes to the starting wavelength to generate the oxygen saturation (OS) 
calculation. The oximetry model (described by the curve fit; red line) is applied to the optical 
denisty data at specific wavelength range. The wavelength range of the fitting curves are kept 
constant between 500 – 650 nm to enable a visual comparison of the fitted curves between 
the wavelength ranges. In each plot the optical densities outside the wavelength range is show 
as gray dots. 
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Figure 4.15: A plot showing the effect of changing the starting wavelength in the wavelength 
range on the oxygen saturation calculation (OS). The range of the y-axis has been cropped 
from 0 – 150%. 
 
 
 
Figure 4.16: Modified extinction coefficients of oxyhaemoglobin (red line), 
deoxyhaemoglobin (blue line) and haemoglobin at 50% oxygen saturation (green line). (Left) 
Modified extinction coefficients at wavelengths between 500 and 650 nm. (Right) Modified 
extinction coefficients at wavelengths between 556 and 650 nm. 
 
Wavelength sequence from  500 – 650 nm Wavelength sequence from  556 – 650 nm 
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The end wavelength of the range was subsequently changed from 568 nm to 
wavelengths in sequential increments up to 640 nm. The starting wavelength was kept at 556 
nm. For each wavelength range the oxygen saturation was calculated. Plots illustrating the 
effect of changing the end wavelength in the wavelength range on the non-linear fit and OS 
calculation are shown in Figure 4.17. The oximetry model (described by the curve fit; red 
line) is applied to the optical denisty data at specific wavelength ranges. The wavelength 
range of the fitting curves are kept constant between 500 – 650 nm to enable a visual 
comparison of the fitted curves the between the wavelength ranges. Figure 4.18 shows a plot 
of the wavelength range (the intial wavelength is kept constant at 556 nm, the last wavelength 
is kept is modified from 568 nm) versus the calculated OS for the given optical density 
profile of the retinal arteriole shown in Figure 4.13 (right). 
The most appropriate end wavelength of the wavelength range was decided to be 650 nm 
because it yielded the most appropriate oxygen saturation for the retinal arteriole. It can be 
seen in Figures 4.17 and 4.18 that using a wavelength range with the end wavelength between 
568 and 620 nm yields less accurate calculations of the OS for the retinal arterioles. 
Therefore, to enable accurate calculations of the oxygen saturation of the retinal vessels, 
the optimal wavelength range of the optical density profiles used to calculate the OS were 
chosen between 556 and 650 nm. 
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Figure 4.17: Nonlinear fitting (red line) of the mean optical density profile (blue dots) with 
incremental changes to the end wavelength to generate the oxygen saturation (OS) 
calculation. The oximetry model (described by the curve fit; red line) is applied to the optical 
denisty data at specific wavelength ranges. The wavelength range of the fitting curves are 
kept constant between 500 – 650 nm to enable a visual comparison of the fitted curves 
between the wavelength ranges. In each plot the optical densities outside the wavelength 
range is show as gray dots. 
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Figure 4.18: A plot showing the effect of changing the end wavelength in the wavelength 
range (initial wavelength maintained at 556 nm) on the oxygen saturation calculation. The 
range of the y-axis has been cropped to 0 – 150%. 
 
  
 
4.2.3.8. Analysis of the Oxygen Saturation Data. 
 
The OS calculations and corresponding coordinates of the centre of the tracked retinal 
blood vessels were used to generate oximetric pseudocolour maps of the retinal vasculature. 
 
To enable further studies of the OS data, a semi-automated program was written in 
Mathematica (ver. 5.2; Wolfram Research, Inc., Champaign, IL) to enable the extraction of 
calculated OS values at given points in the retinal arterioles and venules defined by the 
distance from the optic disc margin (see Appendix 4 for the Mathematica programming 
code). 
 
 Initially, five circular “lines of interest” were generated to segment each retinal image 
(Figure 4.19).The first circle defined the margin of the optic disc. This was performed by 
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determining the centre of the optic disc and its radius (r). Four additional circles with 
increasing radii (2r, 3r, 4r, 5r) about the point in the centre of the optic disc corresponded to 
the regions ½ disc diameter (dd), 1 dd, 1½ dd and 2 dd from the disc margin respectively 
(Figure 4.20). 
 
Figure 4.19: Annular regions of interest defining regions of the retina corresponding to the 
disc margin, ½ disc diameter (dd), 1 dd, 1½ dd and 2 dd from the disc margin. 
 
 
 
The positions of the intersection between the retinal segmentation “lines of interest” and 
the main retinal blood vessels were identified manually. Only 1st and 2nd degree 
superotemporal, inferotemporal, superonasal and inferonasal blood vessels (arterioles and 
venules) were included. First degree vessels were preferentially chosen over 2nd degree 
vessels. The optical density profiles at these intersections and 10 consecutive optical density 
profiles proximal to and distal to these points were calculated. Where the positions of the 
intersection between the segmentation “lines of interest” and retinal blood vessel extended 
beyond the field of view of the retinal image, arbitrary positions were created at the periphery 
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of the vessels (to ensure that the software program would continue to execute the command) 
but were not included for further analysis. 
 
Figure 4.20: Segmentation “lines of interest” (yellow dots) overlaid on an image of a normal 
right retinal image. The linear profiles orthogonal to the centre of the blood vessels (red and 
orange lines) shown correspond to the positions of the intersection between the retinal 
segmentation “lines of interest” and the main retinal blood vessel. Only 1st and 2nd degree 
superotemporal, inferotemporal, superonasal and inferonasal retinal vessels were included. 
(The coloured lines overlying the retinal arterioles (left) and venules (right) indicate the 
locations of the semi-automated tracking of the centre of the blood vessels.)  
 
 
 
Each optical density profile was used to calculate the OS at their respective locations on 
the retinal blood vessels. OS calculations of the nasal arterioles and venules were excluded 
for two main reasons. Firstly, the majority of the segmentation lines often extended beyond 
the field of view of the retinal image. Secondly, the optical density profiles were often 
affected by noise, possibly from illumination variations towards the periphery of the nasal 
hemisphere in most retinal images. Therefore, only results from temporal arterioles and 
venules were included in the study. The mean optical density profiles at points along the 
blood vessel defined by the segmentation “lines of interest” of all 23 eyes were calculated 
and inspected visually. Subjects with “noisy” optical density measurements were excluded 
from further analysis (n = 9). 
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The mean OS of the superotemporal and inferotemporal retinal blood vessels (arterioles 
and venules) at the disc margin, ½ disc diameters (dd), 1 dd, 1½ dd and 2 dd from the disc 
margin were calculated in the remaining 14 eyes. 
To confirm the validity of the choice of the optimal wavelength range (556 – 650 nm), 
each optical density profile at wavelength ranges of  500 – 650 nm (wavelengths used in the 
model eye) and 556 - 650 nm was used to calculate separate OS values. This was performed 
at points along the blood vessel defined by the segmentation “lines of interest”. The mean OS 
for each subject was calculated and used to compare the OS calculations between the two 
wavelength ranges: 500 – 650 nm and 556 - 650 nm.  
The OS calculations of the 14 normal eyes that were included in the study were checked 
for outlying OS results which were deleted, this was defined by: negative OS calculations, 
OS calculations greater than 200% for arterioles and OS calculations greater than 100% for 
venules. Forty-five (32%) arteriolar and forty-five (32%) venular OS calculations were 
excluded from further data analysis. The summary of the clinical findings in the 14 normal 
subjects included in the study are presented in Table 5. 
 
Table 5: Summarized clinical data of the normal subjects included in the study. 
Number of subjects 14 
Mean age (range) 42.9 years (25 -74 years) 
Mean best corrected visual acuity (LogMAR 
Equivalent)( ± SD) 
-0.07 (± 0.09) 
Mean intraocular pressure (mmHg ± SD) 14.1 (± 2.0) 
Mean systolic blood pressure (mmHg ± SD) 124.1 (± 10.1) 
Mean diastolic blood pressure (mmHg ± SD) 78.5 (± 10.4) 
Mean pulse oximeter oxygen saturation (% ± 
SD) 
96.7 (± 0.8) 
M
ea
n 
le
ns
 o
pa
ci
ty
 
gr
ad
e 
Nuclear opalescence (± SD) 1.5 (± 0.8) 
nuclear colour (± SD) 1.3 (± 0.5) 
cortical (± SD) 1 (± 0) 
posterior subcapsular (± SD) 1 (± 0) 
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To study the OS of the macular circulation in more detail, the optical density profiles of 
selected macular branch arterioles and venules were evaluated. Fifty consecutive optical 
density profiles were generated proximal to and distal to (n = 101 optical density profiles) the 
selected point on each vessel. The mean optical density profile was calculated and used to 
calculate the OS of the macular vessel (and 95% confidence interval) from the nonlinear 
fitting oximetry algorithm. This was preferred to calculating the mean OS from each optical 
density profile separately to reduce the effect of outlying oxygen saturation calculations from 
spurious optical density profiles affecting the OS calculation of the macular vessels. 
 
4.2.3.9. Statistical Analysis. 
 
The normality of the data distribution were analyzed using the Shapiro-Wilk 
normality test, with the cutoff for non-normality set at P < 0.05. The calculated OS data for 
arterioles using 500 – 650 nm and 556 – 650 nm wavelength ranges and venules using the 
500 – 650 nm sequence were not significantly different from a normal distribution (P = 
0.173, 0.300 and 0.158 respectively). The calculated OS data for venules using the 556 – 650 
nm was significantly different to a normal distribution (P = 0.011 ). Differences in the mean 
OS calculation using the two wavelength ranges (500 - 650 nm and 556 – 650 nm) in the 
retinal arterioles and venules were examined with a Student’s t-test and Wilcoxon matched-
pair signed-rank test respectively. Pearson’s correlations between the mean OS calculation of 
the temporal retinal blood vessels (mean superotemporal and inferotemporal) and distance 
from the optic disc margin were calculated. Multiple linear regression (“enter” method) was 
used to determine the relationship between the mean OS of the temporal retinal vessels 
(calculated using the wavelength range 556 – 650 nm) and LOCS III grading scores (nuclear 
opalescence, nuclear colour, cortical and posterior subcapsular). To check for 
multicollinearity among the variables in the final model, the variance inflation factor  and 
Durbin-Watson statistic were calculated. All statistical analysis was performed using 
commercial software (SPSS, ver. 16.0; SPSS Inc., Chicago, IL).  In all statistical analyses, P 
< 0.05 was considered statistically significant. A summary of the methods and relevant 
statistical analyses are shown in a flow chart in Figure 4.21. 
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Figure 4.21: A flow chart of the image processing and analysis methods and the statistical 
analyses of the oxygen saturation (OS) data. 
 
 
Acquired spectral images of the retina 500 -650 nm
(n = 23 normal subjects)
Select the best quality image for each wavelength
Dark calibration of the spectral images 
Image registration of the spectral images to a reference image acquired at 580 nm
Vessel detection and tracking
Analysis of  linear profiles orthogonal to the retinal vessels:
• intensity at the centre of the vessel
• inensity of the retinal background adjacent to the vessel 
Optical density calculation for each wavelength (500 -650 nm) 
at tracked points along the retinal blood vessels
Non-linear fitting algorithm to the 
optical density profiles (556 -650 nm)
to calculate the OS calculation 
at each point along the retinal blood vessel
Generation of pseudocolour OS maps of the 
retina
Non-linear fitting algorithm 
Calculate mean OS at the intersection 
between the retinal vessels and segmentation 
lines  (n = 21 at each intersection)
Determine wavelength sequence 
to calculate the OS: 556 - 650 nm most 
appropriate wavelength sequence
Segmentation of the retina defined by
distance from the optic disc margin
Outlying OS calculations deleted: 
• negative OS
• OSgreater than 200% for arterioles 
• OSgreater than 100% for venules
Normal subject with “noisy” optical density 
profiles were excluded (n = 9 subjects)
Outlying OS calculations deleted: 
• negative OS
• OSgreater than 200% for arterioles 
• OSgreater than 100% for venules
Mean OS of the temporal 
arterioles and venules  in 
normal subjects (n = 14)
Correlation and linear 
regression to determine
the mean OS of the temporal 
vessels (arterioles and 
venules) at defined distances 
from the optic disc margin
Optical density wavelength sequence 
556 - 650 nm  
Optical density profiles (n = 101) of  
selected segments of temporal 
arterioles and venules:
• 1st degree vessels
• macular branches
Non-linear fitting algorithm 
Calculate mean OS at the intersection 
between the retinal vessels and segmentation 
lines  (n = 21 at each intersection)
Mean optical density profile
Wavelength sequence 556 - 650 nm  
OS calculation
Compare the mean optical density 
profiles and oxygen saturation 
calculation of the 1st degree vessels 
to the  macular branch arterioles and 
venules
Optical density  wavelength sequence 
500 - 650 nm  
Student’s t-test to compare  the mean OS 
calculation using two wavelength sequences 
500 – 650 nm and 556 – 650 nm
Normal subject with “noisy” optical density 
profiles were excluded (n = 9 subjects)
Normal eyes with “noisy” optical density 
profiles were excluded (n = 9 subjects)
Normal eyes with “noisy” optical 
density profiles were excluded (n = 9 
subjects)
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4.3. Results. 
 
4.3.1. Comparison of the Oxygen Saturation Calculations between Two Wavelength 
Ranges (500 - 650 nm and 556 - 650 nm). 
 
The mean OS calculation (± SD) of the temporal retinal arterioles and venules using a 
wavelength range of 500 - 650 nm were 61.7% (± 16.0%) and 30.4% (± 13.0.0%) 
respectively. The mean OS calculation (± SD) of the temporal retinal arterioles and venules 
using a wavelength range of 556 - 650 nm were 99.4% (± 16.6%) and 29.0% (± 10.2%) 
respectively. The mean OS calculation of the temporal retinal arterioles using a wavelength 
range of 500 - 650 nm were significantly lower than the mean OS calculation using a 
wavelength range of 556 - 650 nm (p < 0.0001, Student’s t-test, two-tailed; Figure 4.22). No 
significant difference was found between the mean OS calculation of the temporal retinal 
venules using the two wavelength ranges (p = 0.76, Wilcoxon matched-pair signed-rank test, 
two-tailed; Figure 4.23). 
 
Figure 4.22: A plot of the oxygen saturation (OS) calculations of the temporal 
(superotemporal and inferotemporal) retinal arterioles using a wavelength range of 500 - 650 
nm (filled circles) and 556 – 650 nm (filled squares). Crossbars are at the mean and whiskers 
are the standard deviations. 
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Figure 4.23: A plot of the oxygen saturations (OS) calculation of the temporal 
(superotemporal and inferotemporal) retinal venules using a wavelength range of 500 - 650 
nm (filled circles) and 556 – 650 nm (filled squares).  Crossbars are at the mean and whiskers 
are the standard deviations. 
 
4.3.2. Observational Features of the Retinal Blood Vessels in the Spectral Images of the 
Retina. 
 
Spectral images of the retina revealed characteristic optical features of the retinal 
blood vessels. Firstly, the retinal arterioles (Figure 4.24, red arrow heads) become less 
optically dense compared to the 1st degree retinal venules (Figure 4.24, blue arrow heads) at 
wavelengths greater than 590 nm. This feature indicates that the oxygenation of the 1st degree 
retinal arterioles can be differentiated by observation from the lower oxygenation of the 1st 
degree retinal venules. This feature is consistent with the modified extinction coefficients of 
oxy- and deoxyhaemoglobin, where the extinction (or optical density) of oxyhaemoglobin is 
lower than the extinction of deoxyhaemoglobin between 590 nm and 650 nm. Secondly, the 
macular branches of the retinal venules also appear to be less optically dense than the 1st 
degree retinal venules and suggest that the macular branches of the retinal venules appear to 
have oxygen saturations higher than that seen in the 1st degree retinal venules. Further, 
analysis to confirm this phenomenon is illustrated and discussed in later sections of this 
chapter. 
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Figure 4.24: The appearances of the arterioles and venules at 9 selected wavelengths (560, 
570, 580, 590, 600, 610, 620 and 630 nm) in the dark calibrated spectral images of the retina 
in 3 normal subjects. The retinal arterioles (red arrow heads) become less optically dense 
compared to the venules (blue arrow heads) at wavelengths greater than 590 nm. 
Subject 1.      Subject 2. 
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Subject 3. 
 
 
4.3.3. Oximetric Maps of the Retinal Vasculature in Normal Subjects. 
 
Figure 4.25 show pseudocolour images of the calculated oxygen saturations along the 
retinal arterioles and venules in 14 normal subjects. It can be observed that the retinal 
arterioles generally have calculated oxygen saturations between greater than 70%. The 
calculated oxygen saturations of the retinal venules appear to be more varied, ranging 
between negative values to values above 100%. 
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 The macular branches of the retinal venules generally appear to have higher 
calculated oxygen saturations compared to their respective main trunk 1st and 2nd degree 
retinal venules. This is consistent with the observations described previously, where the 
macular branches of the retinal venules appear to be optically less dense than the main retinal 
venules. 
Figure 4.26 shows the optical profiles at defined points in the retinal vasculature with 
the resulting mean OS calculation in 5 representative normal subjects. The mean (± SD) OS 
of the superotemporal and inferotemporal retinal vessels (arterioles and venules) at points 
defined by the distance from the optic disc margin are summarized in Table 6. A summary 
box-and-whisker plot of the OS calculations in the temporal retinal arterioles and venules of 
the 14 normal subjects are shown in Figure 4.27. The mean OS (± SD) of the temporal retinal 
arterioles and venules were 110.8% (± 11.8%) and 27.7% (± 3.2%) respectively. Figure 4.28 
shows the mean OS (and standard error of the mean) of the temporal retinal arterioles and 
venules at each defined distance from the optic disc margin (at the disc margin, ½ dd, 1 dd, 
1½ dd and 2 dd from the disc margin). There was no statistically significant correlation 
between the distance from the optic disc margin and the mean OS of the temporal retinal 
arterioles (r2 = 0.071, p = 0.66) and venules (r2 = 0.002, p = 0.95) 
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Figure 4.25: Pseudocolour images of the oxygen saturation (OS) calculations overlayed onto 
the retinal arterioles (left images) and retinal venules (right images) in 14 normal subjects. A 
colour scale of the quantitative OS values is shown to the left of the images. 
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Figure 4.26: An illustration of the mean optical density profiles of selected points along the 
arterioles and venules in 5 representative normal subjects. The points along the retinal vessels 
are shown in the retinal grayscale images (red and orange solid lines) and were determined 
by disc diameter distance from the optic disc margin (yellow dashed lines). The plots of the 
mean optical density profiles (± SD; red filled circle and whiskers) of the respective points 
are shown below each grayscale retinal image. The respective mean oxygen saturation (OS) 
calculation of each point along the blood vessel is indicated above each retinal grayscale 
image. 
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* Poor optical density profile and arteriolar OS calculation greater than 200%. These 
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** Poor optical density profile and negative OS calculation. These calculations were 
excluded from further analysis. 
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Table 6. Mean (± SD) oxygen saturation calculation of the temporal retinal arterioles and 
venules at points defined by the distance from the optic disc margin. 
 
Location 
Arterioles: mean oxygen 
saturation (± SD) (%) 
Venules: mean oxygen 
saturation (± SD) (%) 
Optic disc margin 
Supero-Temporal 114.7 (± 28.3) 28.3 (± 10.1) 
Infero-Temporal 121.3 (± 19.1) 30.7 (± 14.6) 
    
½ disc diameter 
from disc margin 
Supero-Temporal 99.0 (± 36.5) 30.7 (± 10.8) 
Infero-Temporal 112.8 (± 20.9) 24.6 (± 12.9) 
    
1 disc diameter 
from disc margin 
Supero-Temporal 101.4 (± 19.9) 30.9 (± 11.1) 
Infero-Temporal 110.92 (± 21.9) 26.4 (± 7.3) 
    
1½ disc diameter 
from disc margin 
Supero-Temporal 96.7 (± 22.1) 28.9 (± 14.2) 
Infero-Temporal 129.1 (± 40.7) 20.7 (± 13.7) 
    
2 disc diameter 
from disc margin 
Supero-Temporal 97.9 (± 26.4) 29.1 (± 11.6) 
Infero-Temporal 124.5 (± 33.9) 27.0 (± 19.1) 
Analysis of all temporal arterioles and venules  
Vessel Mean oxygen saturation (± SD) (%) 
All temporal arterioles 110.8 (± 11.8) 
All temporal venules 27.7(± 3.2) 
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Figure 4.27: A box-and-whisker plot of the oxygen saturation (OS) of the temporal 
(superotemporal and inferotemporal) retinal arterioles and venules in normal subjects. The 
plot shows the median, the interquartile range, 95% central range and the minimum and 
maximum values. 
 
Figure 4.28: Plot of the mean oxygen saturation (OS) of the temporal (superotemporal and 
inferotemporal) arterioles (left) and venules (right) at points defined by the distance from the 
optic disc: at the disc margin (0.0), ½ disc diameter (0.5), 1 disc diameter (1.0), 1½ disc 
diameter (1.5) and 2 disc diameters (2.0) from the disc margin. The mean oxygen saturation 
(central black filled circle), the standard error of the mean (vertical lines), the best-fit line 
(solid black line) and the 95% confidence interval of the best-fit line (dashed lines) are shown 
in the plots. 
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4.3.4. Relationship Between the Oxygen Saturation and LOCS III Grading Scores. 
 
The multiple linear regression model predicting the OS of the temporal vessels in 
normal subjects using the LOCS III grading scores as independent variables did not produce a 
significant model (F = 0.172, P = 0.843, adjusted R squared = -0.065). The variance inflation 
factor and Durbin-Watson statistic of the model did not indicate the presence of 
multicollinearity. Cortical and posterior subcapsular LOCS III grades were constant in 
normal subjects and were not used in the analysis. The influence of the nuclear opalescence 
and  nuclear colour lens grading scores were not statistically significant for OS in normal 
subjects (β = 0.135, P = 0.609 and β = -0.142, P = 0.591 respectively). 
 
4.3.5. Analysis of the Macular Branches of the Retinal Arterioles and Venules. 
 
Further analyses of the optical densities of the macular branches of the retinal 
arterioles and venules are illustrated in the Figure 4.29. The optical densities of the respective 
1st degree arterioles and venules are displayed as a reference. In all three normal eyes the 
optical density profiles of the retinal arterioles appear consistent with the modified extinction 
coefficient of oxyhaemoglobin, that is the presence of two local maxima with a local minima. 
The calculated OS of these vessels exceed 80%. The optical density profiles of the 1st degree 
retinal venules appear consistent with the modified extinction coefficient of 
deoxyhaemoglobin, that is the presence of a single local maxima. In contrast, the macular 
branches of the retinal venules appear to have optical density profiles consistent with that of 
the modified extinction coefficient of oxyhaemoglobin, indicating that the OS of these 
macular branches of the retinal venules are higher than the respective 1st degree retinal 
venules. The calculated OS of the 1st degree retinal venules and its macular branches range 
from 16% - 52% and 47% - 98% respectively.  
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Figure 4.29: Mean optical density profiles and oxygen saturation calculation of selected 1st 
degree arterioles and venules and their macular branches in the superotemporal and 
inferotemporal quadrant of the retina of 3 normal eyes. For each eye, a series of retinal 
images are displayed with the locations of the analyzed optical density profiles (orange are 
the first and last profile red solid lines are the centre profiles). The mean optical density 
profile (between 556 – 650 nm, red filled circle) of the selected optical density profiles in 
each selected region are plotted with the standard deviation of the optical density for each 
wavelength between 556 - 650 nm (red vertical lines). The non-linear fitting algorithms to 
the optical density profiles are also shown (red line).  The optical density profiles at 
wavelengths from 500 -554 nm are shown in gray in addition to the non-linear fitting at the 
respective wavelengths below 556 nm (gray dashed line). The oxygen saturation calculation 
from the non-linear fit is displayed above each retinal image and plotted together with the 
95% confidence interval of the oxygen saturation calculation. The images and plots are 
separated into four rows (superotemporal arterioles, inferotemporal arterioles, superotemporal 
venules, inferotemporal venules) and two columns (1st degree retinal vessels and macular 
branches of the respective vessels).  The red and blue arrows indicate the characteristic 
features of oxygenated blood (two local maxima and a local minima) and deoxygenated 
blood (single local maxima) respectively. 
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4.4. Discussion. 
 
4.4.1. Oxygen Saturation of the Retina in Normal Subjects: Observational Features. 
 
Dark calibrated registered spectral images of the retina from 3 normal subjects are 
illustrated in Figure 4.24. Direct observations of these images reveal similar optical features 
to that of the dark calibrated spectral images of the model eye (Figure 3.7, Chapter 3). The 1st 
degree arterioles and venules can be visibly distinguished from each other by their 
characteristic appearance as the wavelengths change. The arterioles appear less optically 
dense than the venules as the wavelengths used to acquire the retinal images are increased 
from 580 nm to 630 nm. This feature was seen in the model eye where quartz tubes 
containing arterial blood appeared less optically dense than tubes containing venous blood. 
This feature of the arterioles and venules is also consistent with that reported by Hardarson et 
al. (2006) and can be explained by the expected higher oxygen saturations of the retinal 
arterioles compared to the retinal venules which is consistent with the extinction coefficient 
of oxy- and deoxyhaemoglobin. The presence of this feature confirms that the hyperspectral 
camera is capable of detecting changes in the oxygen content of the retinal vasculature. 
 
4.4.2. Wavelength Selection for Oxygen Saturation Calculations in the Retinal 
Vasculature. 
 
The present study has described the acquisition of spectral images of the retina, the image 
processing and the analysis techniques used to calculate the OS of the retinal vasculature in 
normal subjects. The techniques used were similar to the techniques used in the model eye 
experiments described in Chapter 3. The important difference in the calculation of the OS in 
the model eye experiments and retinal images is that the wavelength range of the optical 
density profiles were shortened from 500 – 650 nm (model eye experiments) to 556 -650 nm 
(retinal images). The rationale for shortening the wavelength range of the optical density 
profiles has been illustrated in section 4.2.3.8. A wavelength range of 556 – 650 nm was 
decided to be the most appropriate wavelength range to accurately calculate the OS of the 
retinal vasculature. This wavelength range incorporates the important features of the 
extinction coefficient curves of oxyhaemoglobin (local minima and local maxima) and 
deoxyhaemoglobin (local maxima) to enable the non-linear fitting oximetry algorithm to 
accurately differentiate most optical density profiles of blood with varying oxygen 
 173 
 
saturations.  The evidence that using a wavelength range of 556 – 650 nm is more appropriate 
is supported by the finding that the oxygen saturations of  the retinal arterioles were 
significantly lower when a wavelength range of 500 - 650 nm is used in comparison to a 
wavelength range of 556 - 650 nm (mean 61.7% vs. 99.4%; p < 0.001, Student’s t-test). 
Furthermore, the mean OS calculation of the temporal retinal arterioles using a wavelength 
range of 556 - 650 nm is more consistent with the expected OS of the retinal arterioles.  
The reason for the difference in the calculated OS using the two wavelength ranges is 
unclear. However, it is likely that the inaccurate modifications to the extinction coefficients 
of oxy- and deoxyhaemoglobin may be a significant attributing factor to this finding. Figure 
4.16 illustrates the comparison between the modified extinction coefficients of oxy- and 
deoxyhaemoglobin and the published millimolar extinction coefficients of oxyhaemoglobin 
and deoxyhaemoglobin (van Assendelft, 1970). It can be seen that the extinction curves of 
deoxyhaemoglobin is similar. This may explain why the calculated oxygen saturations of the 
two wavelength ranges were comparable. The extinction curves of oxyhaemoglobin, 
however, appear to have two important differences. Firstly, the two local maxima at 542 nm 
and 577 nm of the published extinction coefficients of oxyhaemoglobin are greater than the 
two corresponding local maxima of the modified extinction coefficients. Secondly, the local 
maxima at 577 nm of the published extinction coefficients of oxyhaemoglobin is greater than 
the local maxima at 542 nm. This feature can also be observed in the optical density profiles 
of the temporal retinal arterioles in Figure 4.26. However, in the modified extinction 
coefficients of oxyhaemoglobin the reverse feature of the extinction curve is apparent: the 
local maxima at 577 nm is less than the local maxima at 542 nm. Therefore, the inaccuracy of 
the modified extinction coefficient may have contributed towards the underestimation of the 
OS of the temporal retinal arterioles when a wavelength range of 500 - 650 nm was used.  
A further advantage of using a wavelength range of 556 - 650 nm is that it utilizes 
features of the oxyhaemoglobin (local minima at 560 nm and local maxima at 577 nm) and 
deoxyhaemoglobin (local maxima at 555 nm) extinction coefficient curves to enable the non-
linear fitting algorithm to accurately distinguish a given optical density profile with a high OS 
from an optical density profile with a low oxygen saturation. Using a wavelength range of 
556 - 650 nm was therefore a valid choice.  
Interestingly, underestimation of the quartz tubes containing arterial blood in the model 
eye experiments (Chapter 3) did not occur when a wavelength range of 500 - 650 nm was 
used to calculate the OS. This could be explained by the shape of the calculated optical 
density profiles of the arterial blood samples whose two local maxima are approximately 
 174 
 
equal (Chapter 3, Figure 3.10). In contrast, the first local minima of the optical density 
profiles of the temporal retinal arterioles appear to be more variable and less than the second 
local maxima (Figure 4.29). The variability in the optical densities at wavelengths less than 
approximately 550 nm could be explained by the variable pigment concentration of the 
retinal tissues resulting in variable contrast of the retinal vessels to the background retina.  
Excluding wavelengths less than 556 nm in the optical densities of the retinal vasculature 
therefore further reduces the inaccuracy of the OS calculations. 
 
Figure 4.30: A comparison of the modified extinction coefficients of oxyhaemoglobin and 
deoxyhaemoglobin (red and blue solid lines respectively) to the published millimolar 
extinction coefficients of oxyhaemoglobin and deoxyhaemoglobin (red and blue dashed lines 
respectively)(van Assendelft, 1970). The wavelength at 556 nm is indicated as a gray dashed 
vertical line. 
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4.4.3. Oxygen Saturation of the 1st and 2nd Degree Vessels of the Retina in Normal 
Subjects: Quantitative features. 
 
Pseudocolour images of the OS calculations overlayed onto the retinal arterioles and 
venules in 14 normal eyes are illustrated in Figure 4.25. The oxygen saturations of the retinal 
arterioles are generally greater than 80%. Lower than expected oxygen saturations of the 
retinal arterioles can be observed frequently at locations where the arterioles are in close 
proximity to the larger venules. This error is due to errors of the vessel profile analysis. The 
orthogonal vessel profiles of tracked arterioles adjacent to the larger venules will cross-over 
onto the spatial coordinates of the venules resulting in the inadvertent calculation of the 
optical density of the venule. Careful selection of appropriate points along the arterioles at 
given distances from the optic disc margin was performed to prevent in the inclusion of 
inaccurate OS calculations. Furthermore, OS calculations of small segments of the vessels 
were obtained from the segmentation analysis as opposed to large segments of the vessels to 
reduce the influence of spurious outlying results. 
 The pseudocolour images reveal highly variable oxygen saturations of the main (1st 
and 2nd degree) retinal venules which is consistent with studies reported by Hickam et al. 
(1963). The variability of the OS in the retinal venules is unclear and could be attributed to a 
number of factors such as noise in the optical density calculations as a result of variability in 
the illumination of the retina images (vignetting), retinal background (variable pigmentation) 
and retinal vasculature. Additionally, it could be explained by physiological variability in the 
function of the retina in the photopic conditions used to acquire the spectral retinal images 
(variable consumption of oxygen and blood flow). The non-significant relationship between 
the LOCS III grading score and the OS calculation, analyzed by multiple linear regression, 
suggest that the influence of the lens status on the oximetry values was not an important 
factor.  
Analysis of the 1st and 2nd degree temporal retinal arterioles at defined points along its 
length determined by distances from the optic disc margin revealed a mean OS (± SD) of 
110.8 % (± 11.8%). This is comparable to OS measurements of the retinal arterioles in 
healthy subjects reported by previous authors which range from 90% - 102% (see Table 7). 
Correlation analysis indicated that the OS of the 1st and 2nd degree temporal retinal arterioles 
did not significantly change at varying distances from the optic disc margin of up to 2 disc 
diameters. This is consistent with the findings of constant retinal arteriolar oxygen saturation 
measurements in the retinal arterioles of normal subjects reported by Schweitzer et al. (1992). 
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However, the mean OS of the 1st and 2nd degree temporal retinal venules was 27.7% (± 
19.1%), which is a result much lower than the OS measurements of the retinal venules 
reported in previous studies (see Table 7). A possible explanation could be errors in the OS 
calculation caused by the inaccurate optical density profiles. However, this is unlikely as all 
the optical density profiles included in the analysis were carefully selected and examined. 
Poor optical density profiles were excluded from the analysis. Further analysis was warranted 
to investigate the OS calculations of the retinal venules. The constant OS measurements of 
the retinal venules at varying distances from the optic disc margin of up to 2 disc diameters 
indicate a consistency in the OS measurements. Furthermore, Figure 4.26 illustrates the mean 
optical density profiles and respective mean OS calculation of the retinal 1st degree vessels at 
selected points defined by the retinal segmentation in 5 representative normal subjects. It can 
be seen that the optical density profiles of the retinal venules with OS calculated at 
approximately 15 - 30% are consistent with the features of the modified extinction 
coefficients curves at the respective OS levels. Figure 4.31 illustrates the simulated modified 
extinction coefficient curves of haemoglobin at various oxygen saturations. The shapes of the 
optical density profiles are consistent with the shape of the modified extinction coefficients 
curves at the respective OS levels, i.e. the presence of a single local maxima at approximately 
555 nm. It can also be seen in Figure 4.31 that the morphology of the modified extinction 
coefficients curves changes as the OS increases from 0% to 100% such that at approximately 
40% OS the simulated modified extinction coefficient consists of 2 local maxima (at 542 nm 
and 577 nm) which becomes more apparent as the OS increases. The absence of the 2 
maxima and the presence of a single maxima in the optical density profiles of the retinal 
venules, at least, indicates that the OS is less than 40%. Therefore, we can assume some 
confidence in the accuracy of the OS calculations of the retinal venules.  
Previous retinal oximetry systems have reported retinal venous oxygen saturations 
ranging from 45% - 65% (Table 7). Most of these systems rely on two wavelength oximetry 
which has been reported to overestimate the true OS. It is possible that previous retinal 
oximetry systems may have been susceptible to the same flaws as those reported in two 
wavelength pulse oximeters (Sarnquist et al., 1980), i.e. scattering of red or infrared light in 
the blood vessels. However, Schweitzer et al. (1999) reported a mean OS of 57.9% (± 9.9). 
Their hyperspectral retinal oximetry system is the most comparable oximetry system to the 
one used in this present study. It is unclear why such a large difference in the OS calculation 
of the retinal venous system exists. A possible explanation could be the wavelengths used by 
Schweitzer et al. (1999) which ranged between 510 – 586 nm in 2 nm increments. At these 
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wavelengths, the hyperspectral retinal imaging system described in this present study yielded 
highly variable the optical densities of the retinal vessels which could contribute to errors in 
the OS calculations. Nonetheless, to date, no previous retinal oximetry studies have provided 
such an in depth demonstration and in vivo non-invasive validation of the OS calculation of 
the retinal venules. 
 
Table 7. Oxygen saturation (OS) measurements of the retinal vessels in normal subjects 
reported in previous studies. 
 
Authors 
Oxygen saturation (± SD) 
Wavelengths 
Comments 
Arterioles Venules 
This thesis 110.8% (± 11.8%) 27.7% (± 3.2%) 500 to 650 nm 
N = 14 
Hickam et al. 
(1963) 
 
58% (± 10%) 
60% (± 16%) 
640 and 800 nm 
640 and 505 nm 
N = 55 
N = 10 
Delori et al. 
(1988) 
98% (± 8%) 45% (± 7%) 
558nm, 569 and 
586 nm 
N = 22 
Schweitzer et al. 
(1998) 
92.2% (± 4.1%) 57.9% (± 9.9%) 510 - 586 nm 
N = 28 (30 eyes) 
 
Michelson et al. 
(2006). 
92.3% (± 3.4%) 55.7% (± 6.8%) 
522, 560, 569 and 
586 nm 
N = 58 
Denninghoff et al. 
(Drewes et al., 
1999) 
101-102% 
98% 
65% 
63% 
 
629, 678, 821 and 
899 nm 
N = 1 
On the optic disc 
Away from the 
optic disc 
Beach et al. 
(1999). 
 55% (± 3.38%) 569 and 600 nm 
N = 5 
Stefánsson et al. 
(Hardarson et al., 
2006). 
96% (± 9%) 55% (± 14%) 586 and 605nm 
N = 18 
Relative OS 
Hammer et al. 
(2008) 
98 (± 10.1 %) 65% (± 11.7 %) 
548 ± 10 nm and 
610 ± 10 nm 
(FWHM) 
N = 20 
Yoneya et al. 
(Ito et al., 
2008) 
90-98% 60-70% 480 -  600nm 
N = 4  
(normal fellow 
eyes of subjects 
with CRVO) 
Johnson et al. 
(2007) 
95% 60-65% 454 - 646 nm 
N = 2 
4nm bandwidth 
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Figure 4.31: Simulated modified extinction coefficients of haemoglobin at various oxygen 
saturations (green solid line). The extinction coefficient of oxyhaemoglobin (red dashed line) 
and deoxyhaemoglobin (blue dashed line) are shown for comparison. 
 
 
 
 
4.4.4. Oxygen Saturation of the Macular Branches of the Retinal Vasculature in 
Normal Subjects: Observational and Quantitative Features. 
 
 
The macular branches of the retinal venules in the dark calibrated registered spectral 
images shown in Figure 4.24 appear to be less optically dense than their respective 1st and 2nd 
degree venules. This observation suggests that the macular branches of the retinal venous 
system have higher oxygen saturations than their parent venules. This observation is 
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confirmed by the quantitative OS calculations of the macular branches of the retinal venules. 
Figure 4.25 shows a series of pseudocolour images of the OS calculations overlayed onto the 
retinal vessels of normal subjects. These images generally indicate that the macular branches 
of the retinal venules contain blood with higher OS compared to their respective 1st and 2nd 
degree venules. Further analysis of the optical density profiles of selected segments of the 
macular venules and OS calculations was performed to confirm this finding (Figure 4.29). 
The optical density profiles of the macular branches of the retinal venules appear to have 
features similar to that of the retinal arterioles (two local maxima) providing evidence that 
these small venules contain blood with higher OS compared to the larger 1st and 2nd degree 
retinal venules into which they drain. To date, this phenomenon has not been reported in 
previous retinal oximetry studies. It is conceivable that the high OS of the blood in the 
macular branch venules are a result of the collection of high concentrations of unused excess 
oxygen in the foveal and perifoveal region which originate from the retinal and choroidal 
circulations.  
 
4.4.5. Limitations of the Study. 
 
This present study has a number of limitations. One of the main limitations is the 
small number of normal subjects recruited into the study. Unfortunately this was unavoidable 
as the majority of the work was placed into creating the software algorithms necessary to 
perform the oximetry calculations and analysis. The acquisition and processing of the images 
to generate oximetry maps of the retinal vasculature of one eye took on average 
approximately 50 hours of cumulative processing on a computer with a 2.5GHz dual-core 
processor with 4 GB of RAM. The processing and analysis steps were semi-automated and, 
in addition to this, further analysis of the large volumes of data had to be performed for the 
statistical analyses. Hence, this hyperspectral retinal oximetry system would be too 
cumbersome to be used as a general tool in the ophthalmology clinic. In addition to this, data 
from 9 normal subjects (40%) had to be excluded from the study due to “noisy” optical 
density calculations. Statistical bias in this process was minimized by blinding my evaluation 
of the optical density profiles from the OS calculation.  
A further limitation of this study was that no investigation into the repeatability of the 
oximetry analysis has been performed. This would be desirable in future studies to evaluate 
the reliability of the hyperspectral retinal imaging system and image analysis algorithms to 
yield repeatable oxygen saturation calculations. Additionally, a number of previous retinal 
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oximetry studies have reported on the results of re-breathing exercises (Frayser and Hickam, 
1964; Beach et al., 1999; Hardarson et al., 2006; Hammer et al., 2008) with varying mixtures 
of oxygen to “validate” the ability of the oximetry systems to detect changes in the oxygen 
saturation of the retinal vasculature. We did not perform these studies as our imaging system 
was not suited to acquiring a full image dataset in a short space of time necessary to 
adequately perform the experiments. In addition, these exercises only provide information on 
relative changes and not absolute quantitative changes in the oxygen saturation of the retinal 
vasculature which cannot be easily validated. 
A significant amount of effort was applied to create the image processing and analysis 
algorithms to calculate the oxygen saturations of the retinal vasculature. However several 
aspects of the algorithms need to be addressed for future studies. Firstly, the dark calibration 
techniques applied to the images prior to oximetry analysis appear to significantly attenuate 
the gray scale intensity of the raw images. This can be seen in Figure 4.2 which compares the 
grayscale intensity profile of the linear region of interest before and after dark calibration. It 
is apparent that the dark calibration reduces the intensity profile to approximately 30% of its 
original value. This reduces the bit depth of the images from 12-bit to approximately 4-bits. It 
is possible that such a significant reduction in the bit depth of the images could affect the 
accuracy of the oximetry calculations. This is could explain frequent inaccuracies of the 
oxygen saturation calculations (negative values and values greater than 200%) of the smaller 
retinal vessels whose optical densities appear to be significantly attenuated. Careful 
evaluation of the optical density profiles and OS calculations were imposed when examining 
the oxygen saturation of the macular branches of the retinal vessels. Inaccurate optical 
densities and oxygen saturations were excluded. 
The registration of the retinal images was perhaps the most challenging part of the 
image processing. A full series of retinal images with a wavelength range of 500 - 650 nm 
(76 spectral images) took on average approximately 8 to 10 hours to obtain the calculations 
of the offsets. This algorithm was designed to be automated; however, frequent errors in the 
calculations of the rotation, translational and scaling offsets due to features of the spectral 
images required the algorithm to be restarted. Furthermore, the results of the image 
registration had to be checked by visually inspecting the registered retinal images to remove 
significantly misregistered retinal images. As a result approximately 43% (10/23) of eyes had 
at least 1 retinal image of the wavelength range removed due to poor image registration. 
However, it is unlikely that small numbers of missing wavelengths would significantly affect 
the oxygen saturation calculation. 
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The detection and tracking of the retinal vessels is an integral part of the analysis of 
the retinal images. However, the Fast Marching Method preferentially tracks the darkest 
pixels in the filtered retinal image which frequently resulted in the tracking of the larger 
retinal venules instead of either retinal arterioles or smaller retinal vessels. A technique of 
tracking segments of the arterioles and smaller venules by trial-and-error was used as shown 
in Figure 4.7. As a consequence not all retinal vessels in the field of view of the retinal 
images were tracked. However, in this study sufficient numbers of retinal vessels were 
tracked for the analyses. Nonetheless, a further particular problem was that the analysis of the 
vessel profiles of the retinal arterioles in close proximity to the retinal venules often resulted 
in erroneous optical density and subsequently OS calculations often resulting in lower than 
expected OS calculations. This effect can be seen in the pseudocolour oximetry maps of the 
retinal vasculature (Figure 4.25). Careful evaluation of the optical density profiles and OS 
calculations was implemented to ensure that these erroneous measurements were not 
incorporated into the statistical analyses. Furthermore, inaccuracies of the optical density and 
OS calculations were frequently encountered in regions of the retinal images where there was 
poor illumination of the retina, particularly towards the periphery and nasal retina. As a 
result, analysis of segments of the retinal vasculature was limited to two disc diameters and 
analysis of the nasal retinal vasculature was not performed. 
 The non-linear fitting oximetry algorithm was used to calculate the free parameters 
such as the OS, vessel diameter, haemoglobin concentration, optical path length and scaling 
constants. In this study, the free parameters other than the OS were not evaluated. These free 
parameters would be difficult to validate and their influence on the accuracy of the OS 
calculation need further investigation. Furthermore, this study has shown that the oximetry 
algorithm frequently calculates OS beyond its physiological range (0 – 100%): negative 
values and OS greater than 100%. Further modifications to the oximetry algorithm to 
incorporate constraints on the OS (and other free parameters) would need to be implemented 
and evaluated. Additionally, the use of more accurate extinction coefficients needs to be 
addressed. 
 In this study, shortening of the wavelength range of the optical densities prior to 
oxygen calculations of the retinal vasculature was required to prevent gross underestimation 
of the arteriolar OS. The variability of the optical densities at wavelengths less than 556 nm is 
unclear. At these wavelengths, the retina appears dark in the spectral images. The lack of 
contrast between the retinal background and retinal vessels could be a plausible explanation 
for the variability in the optical density calculations at these wavelengths. This could indicate 
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that, the method of using the intensity of the retinal background as an estimate of the intensity 
of the incident light could possibly introduce a significant amount of noise in the calculations 
which is may be dependent on the amount of pigmentation in the retina. Although, shortening 
the wavelength range has reduced the effects of this variability, the wavelengths between 556 
nm and 650 nm are possibly still susceptible to variations in the retinal pigmentation. This 
was noticeable in the analysis of 2 normal subjects (one Asian, one black Afro-Caribbean) 
with highly pigmented retina. These subjects had to be excluded because of erroneous 
calculations of the optical density and oxygen saturations. Further research is required to 
evaluate alternative methods of estimating the optical densities of the retinal vasculature 
which is not susceptible to the influence of retinal pigmentation. 
 
4.4.6. Summary. 
 
This present study has described the techniques used to perform OS calculations of 
the retinal vasculature in normal subjects. Retinal arteriolar OS calculations are consistent 
with previous studies. However, retinal venular OS calculations are considerably lower than 
the majority of those reported in the literature. Additionally, the OS of the macular branches 
of the retinal venules are higher than their respective 1st and 2nd degree retinal venules. This is 
an interesting, and novel finding, which needs further confirmation, but could be an important 
feature in understanding the normal physiology of the retina. 
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Chapter 5: Retinal Oximetry in Retinal Artery 
and Retinal Vein Occlusion. 
 
5.1. Introduction. 
 
In Chapter 4, the methods of calculating the oxygen saturation (OS) in the retinal 
vasculature in normal eyes were described. In particular, the method of validating the OS 
calculations by inspecting the retinal vasculature from the dark calibrated spectral images and 
the optical density profiles (used to calculate the OS) was described. 
The applicability of the spectral imaging and the oximetry analysis techniques to diseased 
eyes required evaluation. An overview of retinal artery and venous occlusion has been 
provided in Chapter 1. These conditions are associated with altered blood flow (ischaemia) or 
stasis within the retinal vasculature which is thought to result in reduced oxygen supply to the 
retina from the systemic circulation. Additionally, histopathological studies have shown that 
retinal artery and vein occlusions are associated with inner retinal atrophy (Frangieh et al., 
1982; Green et al., 1981; Wolter, 1961; Hayreh et al., 2004; Zimmerman, 1965). Therefore, 
these conditions, provide an opportunity to test the ability of a retinal oximeter to detect 
changes in the oxygenation of the retinal vasculature in terms of its supply (arteriolar 
oxygenation) and demand (venular oxygenation). 
The aim of this study was: 
 to demonstrate the ability of the hyperspectral fundus camera and our oximetry 
techniques to detect OS abnormalities in the retinal vasculature in patients with 
retinal arterial and venous occlusion.  
 
5.2. Methods. 
 
5.2.1. Recruitment of Subjects. 
 
Nine patients previously diagnosed embolic retinal artery occlusion and 17 patients 
previously diagnosed with retinal vein occlusion were included in the study. The study 
protocol received institutional review board approval and adhered to the tenets of the 
Declaration of Helsinki. 
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All subjects underwent full clinical ophthalmic evaluation; visual acuity testing using a 
Snellen chart and intraocular pressure measurement (IOP) using Goldmann applanation 
tonometry. The pupils were dilated with 1% tropicamide (Minims; Chauvin Pharmaceuticals, 
Romford, UK) and slit lamp stereo biomicroscopy was performed to grade the degree of lens 
opacity (using the Lens Opacities Classification System III) (Chylack et al., 1993) and 
examine the fundus (at high magnification with a fundus +78D lens). Brachial blood pressure 
of all normal subjects was measured using an aneroid sphygmomanometer (Accoson 0342: 
A.C. Cossor & Son (Surgical) Ltd., Essex, UK).  
 
5.2.2. Hyperspectral Retinal Image Processing and Oximetry Analysis. 
 
The images acquisition techniques, processing and oximetry algorithms used to 
measure the OS of the retinal vasculature were the same as that described in Chapter 4. 
Briefly, retinal images were acquires at wavelengths using the time sequential hyperspectral 
fundus camera. The best quality images for each wavelength was selected, dark calibrated 
and aligned to a reference image obtained at 580 nm. The retinal vasculature of each eye was 
detected, and tracked to enable a vessel profile analysis algorithm to calculate optical density 
profiles of the tracked centreline points along the vessels.  
The optical density profiles at wavelengths from 556 – 650 nm were used to calculate 
the OS of the respective centreline points along the tracked retinal vessels using a non-linear 
oximetry model. Pseudocolour maps of the OS calculations (oximetry maps) overlayed onto 
the retinal vasculature were generated. Six patients with retinal arterial occlusion and 8 
patients with retinal vein occlusion were excluded from further analysis due to poor image 
quality, failed image registration and/or inaccurate optical density profile calculations. The 
remaining patients with retinal venous occlusion (n =9) were divided into two group: 
ischaemic and non-ischaemic. 
In patients with retinal artery occlusion (n = 3) and retinal vein occlusion (n = 9) the 
mean optical density profile (n = 101 profiles) of selected segments of the temporal vessels 
were calculated and used to calculate the OS of the vessel segment. The mean optical density 
profiles of the selected segments of the arterioles and venules were studied and compared to 
those seen in corresponding regions in normal eyes.  
In patients with ischaemic retinal vein occlusion (n = 6), the mean OS at points along 
the 1st and 2nd degree superotemporal, inferotemporal vessels (disc margin, ½ disc diameter 
(dd), 1 dd, 1½ dd and 2 dd from the disc margin) were calculated. The OS calculations were 
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checked for outlying OS results which were deleted and were defined by the same criteria as 
that described in Chapter 4 for normal subjects: negative OS calculations, OS calculations 
greater than 200% for arterioles and OS calculations greater than 100% for venules. Thirteen 
(14%) arteriolar and twenty-two (24%) venular OS calculations were excluded from further 
data analysis. 
 
5.2.3. Statistical Analysis. 
 
The normality of the data distributions were tested using the Shapiro-Wilk normality test, 
with the cutoff for non-normality set at P < 0.05. The OS data of the retinal arterioles in 
normal subjects and retinal arterioles and venules in patients with ischaemic retinal vein 
occlusion were not significantly different from a normal distribution (P = 0.158, 0.188, and 
0.876 respectively). Multiple linear regression (“enter” method) was used to determine the 
relationship between the mean OS of the temporal retinal vessels and LOCS III grading 
scores (nuclear opalescence, nuclear colour, cortical and posterior subcapsular). To check for 
multicollinearity among the variables in the final model, the variance inflation factor and 
Durbin-Watson statistic were calculated. The OS data of the retinal venules in normal 
subjects was significantly different from a nomal distribution (P = 0.011). An unpaired t-test 
with Welch’s correction (two-tailed) was used to compare the OS of the temporal arterioles 
between the normal subjects and patients with ischaemic retinal vein occlusion. A Mann-
Whitney test (two-tailed) was used to compare the OS of the temporal venules between the 
normal subjects and patients with ischaemic retinal vein occlusion. A P < 0.05 was 
considered statistically significant. Statistical analyses were calculated using commercial 
software (SPSS, ver. 16.0; SPSS Inc., Chicago, IL).   
 
5.3. Results. 
 
This study included 3 patients with embolic retinal arterial occlusion (branch retinal 
artery occlusion n = 2, and central retinal artery occlusion n = 1) and 9 patients with retinal 
vein occlusion (6 ischaemic and 3 non-ischaemic). The baseline characteristics of the retinal 
vein occlusion patients included in this current study are presented in Table 8. 
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Table 8. Baseline characteristics of the patients with ischaemic and non-ischaemic retinal 
vein occlusion. 
 
 Ischaemic Non-ischaemic 
Number 6 3 
Mean age (years; range) 68.3 (53 - 81) 69 (68 - 70) 
Male:Female ratio 2:4 3:0 
Mean duration of retinal vein occlusion (months ± SD) 14.5 (± 13.4) 52 (± 79.2) 
Mean best corrected visual acuity (LogMAR Equivalent)(± SD) 0.51 (± 0.21) 0.17 (± 0.13) 
Mean intraocular pressure (mmHg ± SD) 14.5 (± 1.0) 14.7 (± 3.5) 
Mean lens opacity grade 
Nuclear opalescence (± SD) 2 (± 0.7) 2 (± 1.7) 
nuclear colour (± SD) 2 (± 0.7) 2 (± 1.7) 
cortical (± SD) 1 (± 0) 1.7 (± 0.6) 
posterior subcapsular (± SD) 1 (± 0) 1 (± 0) 
Mean systolic blood pressure (mmHg ± SD) 155.8 (± 28.7) 166.7 (± 22.5) 
Mean diastolic blood pressure (mmHg ± SD) 83.3 (± 12.9) 71.7 (± 5.8) 
Mean pulse oximeter oxygen saturation (% ± SD) 96.5 (± 1.0) 96.7 (± 1.52) 
 
 
 
5.3.1. Oxygen Saturation of the Retinal vasculature in Patients with Retinal Arterial 
Occlusion: Observational Features, Optical Density Profile Analysis and Quantitative 
Oximetry of the Retinal Vasculature. 
 
The observational features, mean optical density profiles and OS calculation of the 
retinal blood vessels in 2 representative patients with retinal artery occlusion are presented in 
Figures 5.1 to 5.8. The third patient is illustrated in Appendix 5. 
  
Subject A1 is a 79 year old male with a 25 day history of a left inferior branch retinal 
artery occlusion (Figure 5.1). The BCVA of the left eye was 6/18 at the time of imaging. The 
dark calibrated spectral images of the left retina at 9 selected wavelengths (560, 570, 580, 
590, 600, 610, 620 and 630 nm) show two important features. Firstly, the inferotemporal 
arterioles appear more optically dense than in normal eyes at wavelengths greater than 590 
nm indicating a lower OS (Figure 5.2; yellow arrow heads), and secondly the inferotemporal 
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venule appear to be less optically dense than in normal eyes at wavelengths greater than 600 
nm indicating a higher OS (Figure 5.2; green arrow heads). Confirmation of these 
observational features can be seen when the optical density profiles and OS of selected 
segments of the arterioles and venules are assessed (Figure 5.3). The optical density of the 
inferotemporal arterioles (Figure 5.3, red bordered images) contrasts to the optical density 
profiles of the superotemporal arterioles and appear similar to that venous blood. This is 
confirmed by the lower OS calculations in the inferotemporal arterioles compared to the 
superotemporal arterioles. The optical density profiles of the 1st degree superotemporal and 
inferotemporal venules are relatively more “noisy” with calculated OS of 51% and 56% 
respectively. The pseudocolour oximetry maps of the retinal vessels show lower than normal 
OS in the inferotemporal retinal arterioles and slightly higher than normal OS in the 
inferotemporal venules (Figure 5.4). 
 
Subject A2 is a 69 year old female with a 2 day history of a left central retinal artery 
occlusion (Figure 5.5). The BCVA of the left eye was detection of hand movements at 1 
metre at the time of imaging. The dark calibrated spectral images of the left retina at the 9 
selected wavelengths show abnormal appearances of the retinal arterioles and venules related 
to the OS. The arterioles appear to be more optically dense than in normal eyes at 
wavelengths greater than 590 nm indicating a lower OS (Figure 5.6; yellow arrow heads). 
The venules appear to be less optically dense than in normal eyes at wavelengths greater than 
600 nm indicating a higher OS (Figure 5.6; green arrow heads). Confirmation of these 
observational features can be seen when the optical density profiles and OS of selected 
segments of the macular arterioles and venules are calculated (Figure 5.7, red bordered 
images). The optical density profiles of the macular branches arising from the superotemporal 
and inferotemporal arterioles have similar optical density profiles to the selected venules and 
extinction of deoxyhaemoglobin (single local maxima) indicating low OS which is confirmed 
by the OS calculations of 54% and 31% respectively. In contrast, the optical density of the 
cilio-retinal arteriole (traversing from the optic disc towards the fovea through the “spared” 
retina) is similar to that seen in a normal arteriole and extinction of oxyhaemoglobin (single 
local maxima) indicating that the OS is unaltered, this is confirmed by the OS calculation of 
101%. The optical density profiles and OS of the 1st and 2nd degree venules are comparable to 
the venules in normal eyes. The optical density profiles and OS of the macular branches of 
the superotemporal and inferotemporal 1st degree venules adjacent to the cilio-retinal artery 
are similar to that seen in the macular venules in normal eyes. The pseudocolour oximetry 
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maps of the retinal vasculature suggest slightly lower OS in the inferotemporal retinal 
arteriole compared to the superotemporal retinal arteriole (Figure 5.8). The 1st and 2nd degree 
venules appear unremarkable when compared to the same vessels in normal eyes; however, 
the macular branches (except branches in close proximity to the cilio-retinal artery) appear to 
be generally lower than that seen in normal eyes. 
 
In subject A1 (branch retinal artery occlusion), the pseudocolour oximetry maps of 
the retinal vasculature indicate that abnormally low oxygen saturations in the macular 
branches of the retinal venules are localised to the retinal hemisphere of the branch artery 
occlusion (Figure 5.4). In subject A2 (central retinal artery occlusion), the majority of the 
macular venules in both superior and inferior hemispheres appear to have lower oxygen 
saturation (Figure 5.8). This contrasts to the group of central retinal venules that traverse the 
central macular from the optic disc to the fovea which have comparatively higher OS than the 
other macular venules.  
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Figure 5.1. A colour image of the left 
fundus of subject A1. A 79 year old male 
with a 25 day history of a left inferior 
branch retinal artery occlusion (BCVA: 
6/18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Subject A1: dark calibrated 
spectral images of the left retina at 9 
selected wavelengths (560, 570, 580, 590, 
600, 610, 620 and 630 nm). First degree 
retinal arterioles and venules are indicated 
by red and blue arrow heads respectively. 
Abnormal appearances of the retinal 
arterioles and venules related to the OS are 
indicated by the yellow and green arrow 
heads respectively. 
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Figure 5.3. Subject A1: mean optical density profile (± SD; red filled circle and whiskers) of 
selected segments of the temporal arterioles and venules and the respective OS calculations 
(and 95% confidence interval). Locations of the analysis (red and orange lines) are shown in 
the grayscale image. Abnormal optical density profiles are indicated by red borders.  
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Figure 5.4. Subject A1: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). A colour scale of the quantitative OS values is shown to 
the left of the images. 
 
 
 
Figure 5.5. A colour image of the left fundus of subject A2. A 69 year old female with a 2 
day history of a left central retinal artery occlusion (BCVA: hand movements at 1 metre). 
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Figure 5.6. Subject A2: dark calibrated spectral images of the left retina at 9 selected 
wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree retinal arterioles 
and venules are indicated by red and blue arrow heads respectively. Abnormal appearances 
of the retinal arterioles and venules related to the OS are indicated by the yellow and green 
arrow heads respectively.  
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Figure 5.7. Subject A2: mean optical density profile (± SD; red filled circle and whiskers) of 
selected segments of the temporal arterioles and venules and the respective OS calculations 
(and 95% confidence interval). Locations of the analysis (red and orange lines) are shown in 
the grayscale image. Abnormal optical density profiles are indicated by red borders.  
 
Location 1st degree vessels  Other vessel segments and macular branches  
A
rt
er
io
le
s 
S
u
p
er
ot
em
p
or
al
 
 
In
fe
ro
te
m
p
or
al
 
  
V
en
u
le
s 
S
u
p
er
ot
em
p
or
al
 
 
 
 
In
fe
ro
te
m
p
or
al
 
 
 
 
 
 194 
 
Figure 5.8. Subject A2: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). A colour scale of the quantitative OS values is shown to 
the left of the images. 
 
 
 
5.3.2. Oxygen Saturation of the Retinal vasculature in Patients with Retinal Vein 
Occlusion: Observational Features, Optical Density Profile Analysis and Quantitative 
Oximetry of the Retinal Vasculature. 
 
Figures 5.9 to 5.28 present the observational features of the retinal vasculature, mean 
optical density profiles of selected segments of the retinal vessels and the respective OS 
calculations in 4 representative patients with retinal vein occlusion. (See Appendix 6 for the 
oximetry results of the remaining 5 patients). Pseudocolour oximetry maps of the retinal 
vasculature are also illustrated. No obvious abnormality of the oxygen distribution in the 
retinal arterioles is evident in patients with ether ischaemic or non-ischaemic retinal vein 
occlusion.  
In patients with ischaemic retinal vein occlusion (subjects V1-V3), localized segments 
of the venules can be observed to have abnormal spectral characteristics indicating higher 
than normal venous oxygenation. These abnormal venules are commonly located in the 
ischaemic region of the retina (Figures 5.11, 5.16 and 5.21; green arrow heads). Optical 
density profiles and OS calculations of selected segments of the retinal venules confirm the 
presence of higher than normal venous oxygen saturations in 5 of the 6 patients with 
ischaemic retinal vein occlusion. Further, illustrations of abnormally high OS of the retinal 
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venules in regions of the afflicted retina are shown in the pseudocolour oximetry maps of the 
retinal vasculature (Figures 5.12, 5.17 and 5.22).  
Figure 5.26 illustrates a selection of  dark calibrated spectral images of the retina, the 
mean optical density profiles of selected segments of the retinal vessels and the respective OS 
calculations in a representative patient with a non-ischaemic retinal vein occlusion (subject 
V4). No abnormalities of the venular oxygen saturation could be identified from observing 
the retinal vasculature, inspecting the optical density profiles and pseudocolour oximetry 
maps of the retinal vasculature. This finding was seen in 2 of the 3 patients with non-
ischaemic retinal vein occlusion. 
 
Figure 5.9. A colour image of the left fundus of subject V1.  A 46 year old female with a 9 
month history of a left ischaemic superotemporal branch retinal vein occlusion (BCVA: 
6/12).  
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Figure 5.10. Subject V1: fluorescein angiograms of the left fundus. There is a region of 
reduced background fluorescence (yellow arrow head; capillary “non-perfusion”) associated 
with hyperfluorescent segments of the superotemporal vessels (red arrow head; vessel wall 
staining). 
 
27 seconds
56 seconds
4 minute 4 seconds
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Figure 5.11. Subject V1: dark calibrated spectral images of the left retina at 9 selected 
wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree retinal arterioles 
and venules are indicated by red and blue arrow heads respectively. Abnormal appearances 
of the retinal venules relating to the OS are indicated by the green arrow heads. These 
venules appear less optically dense than in normal eyes at wavelengths greater than 600 nm 
indicating a higher OS.  
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Figure 5.12. Subject V1: mean optical density profile (± SD; red filled circle and whiskers) 
of selected segments of the temporal arterioles and venules and the respective OS 
calculations (and 95% confidence interval). The locations of the optical density analysis (red 
and orange lines) are shown in the grayscale image. Abnormal optical density profiles are 
indicated by red borders.  
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Figrure 5.13. Subject V1: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). There is high venous oxygenation in the superotemporal 
venules. A colour scale of the quantitative OS values is shown to the left of the images. 
 
 
Figure 5.14. A colour image of the left fundus of subject V2. A 53 year old female with a 3 
month history of a left ischaemic superotemporal branch retinal vein occlusion (BCVA: 
6/12).  
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Figure 5.15. Subject V2: fluorescein angiograms of the left fundus. There is a region of 
reduced background fluorescence (yellow arrow head; capillary “non-perfusion”) associated 
with hyperfluorescent segments of the superotemporal vessels (red arrow head; vessel wall 
staining).  
 
 
 
43 seconds
1 minute 37 seconds
3 minutes 21 seconds
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Figure 5.16. Subject V2: dark calibrated spectral images of the left retina at 9 selected 
wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree retinal arterioles 
and venules are indicated by red and blue arrow heads respectively. Abnormal appearances 
of the retinal venules relating to the OS are indicated by the green arrow head. These venules 
appear less optically dense than in normal eyes at wavelengths greater than 600 nm indicating 
a higher OS.  
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Figure 5.17. Subject V2: mean optical density profile (± SD; red filled circle and whiskers) 
of selected segments of the temporal arterioles and venules and the respective OS 
calculations (and 95% confidence interval). Locations of the analysis (red and orange lines) 
are shown in the grayscale image. Abnormal optical density profiles are indicated by red 
borders.  
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Figure 5.18. Subject V2: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). There is high venous oxygenation in segments of the 
superotemporal venules. A colour scale of the quantitative OS values is shown to the left of 
the images. 
 
 
 
 
 
 
Figure 5.19. A colour image of the left fundus of subject V3. A a 61 year old male with a 36 
month history of a left ischaemic superotemporal branch  retinal vein occlusion  with 
neovascularization of the temporal retina (BCVA: 6/24).  
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Figure 5.20. Subject V3: fluorescein angiograms of the left fundus. There are retinal new 
vessels (red arrow heads; vessel wall staining) and laser scars (light blue arrow head; 
capillary “non-perfusion”).   
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Figure 5.21. Subject V3: dark calibrated spectral images of the left retina at 9 selected 
wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree retinal arterioles 
and venules are indicated by red and blue arrow heads respectively. Abnormal appearances 
of the retinal venules relating to the OS are indicated by the green arrow head. Theses 
venules appear less optically dense than in normal eyes at wavelengths greater than 600 nm 
indicating a higher OS.  
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Figure 5.22. Subject V3: mean optical density profile (± SD; red filled circle and whiskers) 
of selected segments of the temporal arterioles and venules and the respective OS 
calculations (and 95% confidence interval). Locations of the analysis (red and orange lines) 
are shown in the grayscale image. Abnormal optical density profiles are indicated by red 
borders. 
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Figure 5.23. Subject V3: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). There is high venous oxygenation in the superotemporal 
venules. A colour scale of the quantitative OS values is shown to the left of the images. 
 
 
 
 
 
Figure 5.24. A colour image of the right fundus of subject V4. A 68 year old male with a 10 
month history of a right non-ischaemic retinal vein occlusion (BCVA: 6/9).  
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Figure 5.25. Subject V4: Fluorescein angiograms of the right fundus.  
 
 
 
 
 
 
24 seconds
1 minute 41 seconds
3 minutes 47 seconds
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Figure 5.26. Subject V4: dark calibrated spectral images of the left retina at 9 selected 
wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree retinal arterioles 
and venules are indicated by red and blue arrow heads respectively. Abnormal appearances 
of the retinal venules relating to the OS are not seen.  
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Figure 5.27. Subject V4: mean optical density profile (± SD; red filled circle and whiskers) 
of selected segments of the temporal arterioles and venules and the respective OS 
calculations (and 95% confidence interval). Locations of the analysis (red and orange lines) 
are shown in the grayscale image.  
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Figure 5.28. Subject V4: pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). A colour scale of the quantitative OS values is shown to 
the left of the images. 
 
 
 
 
 
 
5.3.3. Relationship Between the Oxygen Saturation in Eyes with Ischaemic Retinal 
Vein Occlusion and LOCS III Grading Scores. 
 
The multiple linear regression model predicting the OS of the temporal retinal vessels 
in eyes with ischaemic RVO using the LOCS III scores as independent variables did not 
produce a significant model (F = 0.156, P = 0.857, adjusted R squared = -0.110). Posterior 
subcapsular cataract grade were constant in eyes with ischaemic RVO and were not used in 
the analysis. Nuclear opalescence scores were excluded due to multicollinearity. The variance 
inflation factor and Durbin-Watson statistic of the final model did not indicate the presence of 
multicollinearity. The influence of the nuclear colour cataract and cortical grading scores 
were not statistically significant for temporal arteriolar OS in eyes with ischaemic RVO (β = 
0.109, P = 0.693; β = -0.135, P = 0.625 respectively). 
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5.3.4. Comparison of the Oxygen Saturation between Normal Subjects and Patients 
with Ischaemic Retinal Vein Occlusion. 
 
The mean (± SD) OS of the temporal retinal arterioles and venules in patients with 
ischaemic retinal vein occlusion were 103.0% (± 20%) and 37.9% (± 21.0%) respectively. 
Comparisons of the OS between normal subjects and patients with ischaemic retinal vein 
occlusion are shown in Figures 5.29 and 5.30 respectively. No significant differences were 
found in the OS of the temporal arterioles and venules between the patients with ischaemic 
retinal vein occlusion and normal subjects (P = 0.54 and 0.30 respectively; two-tailed, 
unpaired t-test with Welch’s correction and Mann-Whitney test respectively). 
 
Figure 5.29: A box-and-whisker plot of the oxygen saturation (OS) of the temporal 
(superotemporal and inferotemporal) retinal arterioles in normal subjects and patients with 
ischaemic retinal vein occlusion. The plot shows the median, the interquartile range, 95% 
central range and the minimum and maximum values. 
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Figure 5.30: A box-and-whisker plot of the oxygen saturation (OS) of the temporal 
(superotemporal and inferotemporal) retinal venules in normal subjects and patients with 
ischaemic retinal vein occlusion. The plot shows the median, the interquartile range, 95% 
central range and the minimum and maximum values. 
 
 
 
5.4. Discussion. 
 
In this study, we have recruited patients with retinovascular pathologies to determine 
whether changes in the OS of the retinal vasculature can be detected using the hyperspectral 
fundus camera and our retinal oximetry techniques. These conditions are thought to result in 
damage to the inner retinal layers as a result of the vascular insufficiency (Frangieh et al., 
1982; Green et al., 1981; Hayreh et al., 2004). This study has shown that OS abnormalities of 
the retinal vasculature can be detected in these patients from the spectral retinal images 
acquired by hyperspectral fundus camera. Three techniques have been described in analyzing 
the images to detect these changes. The first relies on observations of the spectral 
appearances of the retinal arterioles and venules in the dark calibrated images at different 
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wavelengths. In particular, arterioles with low OS appear optically more dense at 
wavelengths greater than 590 nm and venules with high OS appear optically less dense at 
wavelengths greater than 600 nm. The second technique involves inspecting the shape of the 
optical density profile from segments of the retinal vasculature. The third technique relies on 
the oximetry model to calculate the OS along the retinal vasculature. The observational 
features of the retinal vessels correspond (in most cases) with the calculated optical density 
profiles and OS. However, caution is required when interpreting the oximetry results because 
of the small numbers of patients included in this study. 
 
5.4.1. Oxygen saturation in Retinal Artery Occlusion. 
 
The patients with retinal artery occlusion presented in this study were shown to have 
abnormal segments of arteriolar and venular OS. Low calculated OS of selected arterioles and 
high calculated OS of selected venules in the region of the affected retina were validated by 
inspecting the shape of the optical density profiles. 
The low OS of the retinal arteriole (arteriolar hypoxaemia) seen in subjects A1 and A2 
(Figures 5.2 to 5.4 and 5.6 to 5.8 respectively) was confirmed by the similar appearance of 
the optical density profiles to that seen in normal retinal venules (single maxima). This 
finding of arterial hypoxaemia is supported by a recent study by Gehlert et al. (2010) who, 
using a two wavelength retinal oximeter, reported a mean arteriolar OS of 73% in affected 
arterioles of 10 patients with branch retinal artery occlusion. The lower OS of the arterioles in 
patients with retinal artery occlusion could be explained by the reduced blood flow resulting 
in the increased diffusion of oxygen from the slow flowing blood into the vitreous and 
surrounding retina. Alternatively, it could also reflect the consumption of oxygen in the slow 
flowing blood by the cells that comprise the arteriolar wall (such as the smooth muscles).  
High OS of the small number of retinal venules (venular hyperoxaemia) were seen in 
subjects A1 and A2 (Figures 5.2 to 5.4 and 5.6 to 5.8 respectively). In subject A3 (see 
Appendix 5), this was confirmed by the similar appearance of its optical density profile to 
that seen in normal retinal arterioles (two maxima). However, this was less convincing in 
subject A1 as the optical density profiles were considerably “noisy” and errors in the OS 
calculation could not be excluded. Reduced metabolic consumption of oxygen due to 
dysfunction of the inner retina could explain the increase in the OS of the venules which may 
be collecting “unused” oxygenated blood. To date, no studies have reported high venular OS 
in retinal artery occlusion.  
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An interesting feature of the pseudocolour oximetry maps of the retinal vasculature in 
these patients with retinal arteriolar occlusion was the suggestion of a lower OS in the 
macular venules corresponding to the regions of the retina affected by the artery occlusion. In 
contrast, the OS of the macular venules in normal subjects were shown to be typically higher 
than that of the 1st and 2nd degree venules (ranging from 47% - 98%; see Chapter 4). Tissue 
hypoxia in laser induced occlusion of the retinal arteries in rats have been demonstrated using 
oxygen sensitive microelectrodes by Yu et al. (2007) The low OS in the macular branches of 
the venules could reflect the collection of hypoxaemic blood from the affected arterioles and 
regions of anoxic/hypoxic retinal tissues. Further research is required to confirm this 
observation to clarify the relationship between retinal blood flow, hypoxaemia and tissue 
hypoxia which is currently not well understood. 
 
5.4.2. Oxygen saturation in Retinal Vein Occlusion. 
 
The patients with ischaemic retinal vein occlusion presented in this study commonly had 
higher than normal venular OS in the venules supplying the regions of the “ischaemic” retina. 
In patients with non-ischaemic retinal vein occlusion this feature was not observed. No 
obvious oximetric abnormalities of the retinal arterioles were seen in patients with ischaemic 
or non-ischaemic retinal vein occlusion. The higher than normal venular OS in patients with 
retinal vein occlusion could reflect the reduced metabolic consumption of the oxygen 
supplied to the dysfunctional inner retina via the patent inner retinal arterial circulation or the 
choroid. However, this finding is not supported by previous studies. Hardarson and 
Stefánsson (2010), using a two wavelength retinal oximeter, reported lower OS in the retinal 
venules of eyes (n = 8) affected by central retinal vein occlusion (mean ± SD; 49% ± 12%) 
compared to the contralateral unaffected eye (65% ± 6%). Arteriolar OS was unaffected. 
Yoneya et al. (2002) using a Fourier transform-based spectral retinal imaging system 
demonstrated a correlation between the fluorescein angiogram and a decrease in retinal tissue 
oxygenation in patients (n =10) with ischaemic central retinal vein occlusion. In the latter 
study, it remains unclear as to the relationship between tissue hypoxia and intravascular 
oxygen saturation. 
Multiple linear regression analysis demonstrated a non-significant relationship between 
the OS of the temporal vessels in eyes with ischaemic RVO and LOCS III grading scores 
suggesting that the influence of the lens status on the oximetry values was not an important 
factor. 
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A comparison of the OS of the temporal arterioles and venules between normal subjects 
and subjects with ischaemic retinal vein occlusion showed no significant differences between 
the two groups. This could be due to the lack of power of the statistical analysis as a result of 
the small numbers of subjects included in the study. Additionally, the nature of the analysis 
used calculated mean oxygen saturations of points along the temporal arterioles and venules 
(superotemporal and inferotemporal) at pre-defined distances from the optic disc margin of 
up to 2 disc diameters from the disc margin. Abnormalities of the retinal venular oxygen 
saturations were seen in localized venules typically more than 2 disc diameters from the optic 
disc margin which could explain the non-significant results. Furthermore, the oxygen 
saturations of the non-affected venules were included in the analysis. This limitation of the 
analysis technique indicates that further refinement is required in future studies to accurately 
characterize the oximetric abnormalities seen in patients with retinal vein (and artery) 
occlusion. 
 
5.4.3. Summary. 
 
The aim of this present study to demonstrate the ability of hyperspectral retinal imaging 
to detect abnormalities in the oxygen saturation of the retinal arterioles and venules has been 
achieved. Further studies are required to confirm the proposed theories which explain the 
detection of abnormally low arteriolar, and abnormally high venular oxygen saturations 
respectively in patients with retinal arterial and vein occlusion. 
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Chapter 6: Retinal Oximetry in Primary Open 
Angle Glaucoma. 
 
6.1. Introduction. 
. 
The results in Chapter 5 demonstrated that abnormalities in the oxygen saturation (OS) of 
the retinal arterioles and venules can be detected and measured in patients with retinal arterial 
and venous occlusion. These oximetric abnormalities of the retinal vasculature were 
associated with localized areas of the retina where a disruption of the retinal blood supply 
was likely. In particular, hyperoxia of localised retinal venules suggested inner retinal 
dysfunction of the retina subserved by the affected venules.  
Our subsequent interest was to evaluate whether the retinal oximetry techniques 
would be able to detect oximetric abnormalities of the retinal vasculature in other ophthalmic 
pathologies involving the inner retina. 
Glaucoma is the second leading cause of blindness globally (Roodhooft, 2002) and in 
the UK (Bunce and Wormald, 2006) and is characterized by a combination of structural 
changes to the optic disc and nerve fibre layer and visual field deficits. Primary open-angle 
glaucoma (POAG) is the most common form of the disease accounting for 90% of glaucoma 
patients, and its onset is often insidious and progresses slowly with visual symptoms 
occurring in the late stage of the disease. The most important identifiable risk factor for 
POAG is an elevated IOP (above 21 mm Hg)(AGIS Investigators, 2000; Heijl et al., 2002; 
Gordon et al., 2002) which is the basis of current therapeutic strategies in the management of 
glaucoma to prevent progressive visual field loss and optic disc cupping. The clinical tools 
commonly used to aid in the management of glaucoma include IOP measurements, optic disc 
and nerve fibre layer evaluation and visual field analysis. However, specific limitations of 
these instruments in the management of glaucoma have been well documented and discussed 
in detail in Chapter 1. In essence, these limitations revolve around their respective sensitivity 
and specificity that relates to the ability to detect and monitor the progression of 
glaucomatous damage. 
It is currently acknowledged that in glaucoma, the inner retinal layer is the site of 
primary damage manifested by retinal ganglion cell (RGC) death. Mounting evidence 
indicate that the mode of RGC death is characterized by apoptosis (Cordeiro et al., 2004; 
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Kerrigan et al., 1997; Quigley et al., 1995; Garcia-Valenzuela et al., 1994; Garcia-Valenzuela 
et al., 1995). Numerous mechanisms have been implicated but their role in relation to RGC 
apoptosis in glaucoma are yet to be fully understood. 
Hypoxic stress, possibly as a result of blood flow abnormalities, in the tissues of the 
optic nerve head and retina is considered to be an important factor in the pathogenesis of 
glaucoma (Tezel and Wax, 2004; Semenza, 1999; Yamazaki and Drance, 1997; Fontana et 
al., 1998; Sugiyama et al., 2000). Currently, instruments designed to measure ocular/retinal 
blood flow are limited because of the uncertainty of the measurements and its relationship 
and relevance to glaucomatous damage and progression which remain poorly understood. As 
a consequence the usefulness of blood flow measurements in the management of glaucoma 
has yet to be established. 
Measurements of tissue oxygenation could be a more informative method of 
determining the metabolic function of optic nerve and retina in health and in glaucoma. 
Measurements of oxygen tension overlying the optic nerve and retina have been reported in 
numerous animal studies (Ernest, 1973; Ernest, 1974, Stefánsson et al., 1999; la Cour et al., 
2000; Pedersen et al., 2005). However, the technique involves the intraocular insertion of 
microelectrodes which is technically demanding and invasive. Phosphorescence imaging 
technique has been performed in experimental glaucoma in animals (Blumenröder et al., 
1997; Shonat et al., 1992). However, this technique requires the injection of a bolus of an 
oxygen chemical probe whose safety in humans have yet to be determined.  
Spectrophotometric techniques are currently the commonest non-invasive means of 
measuring the oxygen content of the retinal vasculature, retina and optic nerve head. Studies 
using various retinal oximetry devices to measure the OS of the retinal vasculature in 
glaucoma have been reported.  Koobehi et al. (2004) demonstrated the use of a hyperspectral 
retinal imaging system to detect changes in the reflectance spectra of the optic nerve head 
tissue and vessels of cynomologus monkeys upon experimentally increasing the intraocular 
pressures. However, the hyperspectral retinal imaging system was only capable of measuring 
relative OS changes of a limited area overlying the optic nerve head.  
The dual wavelength automatic retinal oximeter, used by Stefansson and co-workers, 
has shown that arteriolar and venular OS changes can be detected when using and changing 
topical glaucoma medications (Hardarson et al., 2006; Siesky et al., 2008). However 
following glaucoma filtration surgery the system did not detect oximetric changes in the 
retinal vasculature (Hardarson et al., 2009). Additionally, from these studies it appears that 
only small segments of the retinal vessels near the optic disc were measured and an 
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evaluation of the whole retinal vascular network is required since the disease process can 
affect various regions of the retina as well as the optic disc.  
Retinal oxygen saturation measurements, using a Fourier transform-based spectral 
retinal imaging system, have found lower OS in the retinal tissue adjacent to the optic disc in 
patients with open angle glaucoma (particularly low tension glaucoma) compared to normal 
subjects (Ito et al., 2008). Additionally, reduced retinal tissue OS was shown to be associated 
with the severity of the visual field defects. However, this system is only capable of studying 
small areas of the retina (approximately 40 μm2) and validation of the technique is both 
difficult and has yet to be performed. 
Michelson and Scibor (2006), using the imaging ophthalmospectrometer, reported that the 
OS of the retinal arterioles was significantly lower in patients with normal tension glaucoma 
compared to normal subjects. Additionally, decreased retinal arteriolar OS was found to be 
associated with decreased optic rim area. The measurements in the study were restricted to 
retinal vessels located approximately 1-3 mm from the optic disc. Furthermore, the imaging 
system appears to be only capable of measuring a small section of a given retinal arteriole 
and venule in close proximity.  Data regarding the OS of the retinal arterioles and venules in 
other parts of the retina was not reported.  
Retinal oximetry studied of the retinal vascular network using a hyperspectral imaging 
system in glaucoma has not yet been reported.  
The aims of this chapter are: 
 to present the use of our hyperspectral fundus camera and oximetry algorithms in 
patients with asymmetrical primary open angle glaucoma (POAG) 
 to determine whether there are detectable differences in the OS of the retinal 
vasculature between normal eyes and glaucomatous eyes 
 to investigate whether oximetric differences could be detected between eyes with 
less advanced and eyes with more advanced glaucoma. 
 
 
6.2. Methods. 
 
This study was conducted in accordance with the ethical standards of the Declaration of 
Helsinki and was approved by the local Research and Ethics Committees at Gloucestershire 
Hospitals NHS Foundation Trust (REC reference number: 06/Q2005/132) 
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6.2.1. Recruitment, Assessment and Imaging of Subjects with Asymmetrical Primary 
Open Angle Glaucoma. 
 
Seventeen subjects with a diagnosis of asymmetrical POAG were recruited prospectively 
from the eye departments in Cheltenham and Gloucester General Hospitals between 2007 and 
2010. The subjects were diagnosed with POAG based on a history of IOP higher than 21 mm 
Hg, presence of visual field defects and/or optic disc cupping, normal irido-corneal angles on 
gonioscopy and no history of other ocular disease. 
All subjects underwent full clinical ophthalmic evaluation; visual acuity testing using a 
Snellen chart; intraocular pressure measurement (IOP) using Goldmann applanation 
tonometry. The pupils were dilated with 1% tropicamide (Minims; Chauvin Pharmaceuticals, 
Romford, UK) and slit lamp stereo biomicroscopy was performed to grade the degree of lens 
opacity (using the Lens Opacities Classification System III) (Chylack et al., 1993) and 
examine optic nerve head (at high magnification with a fundus +78-D lens) using cup-to-disc 
ratio estimation and the disc damage likelihood scale (Bayer et al., 2002). All patients had 
been tested with SITA Standard 24-2 perimetry (Humphrey Field Analyzer II 740; Carl Zeiss 
Meditec, Inc.). The mean deviation (MD, a measure of the average deviation at each test 
location between the patient’s sensitivity and that of the age-corrected normal value), the 
pattern standard deviation (PSD, measure of the variability in the shape of the tested field 
relative to the age-corrected normal reference field), Glaucoma Hemifield Test (measure of 
asymmetry between the superior and inferior hemifield) and reliability indices results were 
obtained automatically from a printout from the Humphrey Field Analyzer II. The stage of 
glaucoma was defined using the MD index. The eyes of each POAG subject were divided 
into two categories according to the MD index: eyes with more visual field loss (lower MD 
value) and eyes with less visual field loss (higher MD value).  
Oximetry measurements of the index finger were performed in all volunteers using a 
pulse oximeter (Biox 3740, Ohmeda, Louisville, CO). Brachial blood pressure of all normal 
subjects was measured using an aneroid sphygmomanometer (Accoson 0342: A.C. Cossor & 
Son (Surgical) Ltd., Essex, UK). 
Inclusion criteria included previously diagnosed open angles on gonioscopy, ocular 
hypertension (untreated IOP  22 mm Hg), glaucomatous optic neuropathy (GON) and 
glaucomatous visual field loss (at least two consecutive abnormal visual field test results, 
demonstrating a threshold sensitivity loss on the pattern deviation outside the 95% normal 
confidence limits, three or more such contiguous test locations with P < 0.05 with at least one 
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of the points depressed to P < 0.01, or a 10-dB difference across the nasal horizontal midline 
at two or more test locations). A reliable visual field perimetry result was defined as less than 
20% fixation loss and less than 33% false-positive and false-negative responses. Exclusion 
criteria included other previous or current ocular pathology and previous ocular surgery 
(except successful cataract surgery and trabeculectomy). One patient was a current smoker 
and 7 patients were treated with anti-hypertensive therapy.  
 
6.2.2. Hyperspectral Retinal Image Acquisition, Processing and Oximetry Analysis. 
 
The acquisition, processing and algorithms used to measure the OS of the retinal 
vasculature were the same as that described in Chapter 4. Briefly, retinal images were 
acquired at wavelengths using the time sequential hyperspectral fundus camera. The best 
quality images for each wavelength selected, dark calibrated and aligned to a reference image 
obtained at 580 nm. The retinal vasculature of each eye was detected and tracked to enable a 
vessel profile analysis algorithm to calculate optical density profiles of  the tracked centreline 
points along the vessels.  
The optical density profiles at wavelengths from 556 – 650nm were used to calculate 
the OS of the respective centreline points along the tracked retinal vessels using a non-linear 
oximetry model. Pseudocolour maps of the oxygen saturation calculations (oximetry maps) 
overlayed onto retinal vasculature were generated. Six patients were excluded from further 
analysis due to poor image quality, failed image registration and/or inaccurate optical density 
profile calculations. 
The mean OS at points along the 1st and 2nd degree superotemporal, inferotemporal 
vessels (disc margin, ½ disc diameters (dd), 1 dd, 1½ dd and 2 dd from the disc margin) were 
calculated in the remaining 11 patients. The OS calculations were checked for outlying 
oxygen saturation results which were deleted and were defined by the same criteria as that 
described in Chapter 4 for normal subjects: negative OS calculations, OS calculations greater 
than 200% for arterioles and OS calculations greater than 100% for venules. Twenty-five 
(32%) arteriolar and twenty-eight (25%) venular OS calculations were excluded from further 
data analysis. 
The eyes of the POAG patients were divided into two categories according to the 
mean deviation index: eyes with worse mean deviation (more advanced POAG) and 
contralateral eyes with better mean deviation (less advanced POAG). 
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6.2.3. Statistical Analysis. 
 
The normality of the data distributions were tested using the Shapiro-Wilk normality test, 
with the cutoff for non-normality set at P < 0.05. The OS data of the temporal retinal 
arterioles in normal subjects, temporal retinal arterioles and venules in less advanced 
glaucomatous eyes and temporal retinal arterioles and venules in more advanced 
glaucomatous eyes were confirmed to be normally distributed (P = 0.158, 0.329, 0.882, 
0.868, 0.058 respectively). Multiple linear regression (“enter” method) was used to determine 
the relationship between the mean OS of the temporal retinal vessels and LOCS III grading 
scores (nuclear opalescence, nuclear colour, cortical and posterior subcapsular). To check for 
multicollinearity among the variables in the final model, the variance inflation factor and 
Durbin-Watson statistic were calculated. The OS data of the temporal retinal venules in 
normal subjects was significantly different from a nomal distribution (P = 0.011).  Unpaired 
t-tests with Welch’s correction (two-tailed) tests were used to compare the OS of the 
temporal arterioles between the normal subjects and less advanced and more advanced 
glaucomatous eyes of patients with POAG. Mann-Whitney (two-tailed) tests were used to 
compare the OS of the temporal venules between the normal subjects and less advanced and 
more advanced glaucomatous eyes of patients with POAG. Paired t-tests (two-tailed) were 
used to compare the OS of the temporal arterioles and venules between the eyes with more 
advanced POAG and the contralateral eyes with less advanced POAG. The association 
between mean OS of the temporal arterioles and venules of both eyes of POAG patients and 
visual field global indices were characterized by computing Pearson correlation coefficients. 
Linear regression analysis was performed to investigate the correlation between the OS 
calculations of the temporal arterioles and venules and perimetry indices (mean deviation and 
pattern standard deviation) and optic nerve head measurements (cup-to-disc ratio and disc 
damage likelihood scale). In all statistical analyses, P < 0.05 was considered statistically 
significant. 
 
6.3. Results. 
 
The baseline characteristics of the POAG patients (n = 11) included in this current study are 
presented in Table 9. 
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6.3.1. Oxygen Saturation of the Retinal Vasculature in Subjects with Asymmetrical 
POAG: Observational Features and Quantitative Oximetry Maps of the Retinal 
Vasculature. 
 
Abnormalities in the spectral appearances of the retinal arterioles and venules could 
not be observed from the dark calibrated spectral images in patients with POAG. Figure 6.1 
presents a 76 year old male POAG patient with asymmetrical glaucomatous visual field 
defect affecting the right eye more than the left eye. The spectral appearances of the arterioles 
and venules appear to be similar to that of normal subjects. Abnormal appearances of the 
retinal arterioles and venules that were seen in eyes with retinovascular conditions (Chapter 
5: arterial hypoxaemia – arterioles appear more optically dense, venular hyperoxaemia – 
venules appear less optically dense) were not evident upon direct observation of the dark 
calibrated spectral images. In this case, the optical density profiles and OS of selected 
segments of the retinal arterioles and venules are illustrated which supports the observational 
findings. The optical density profiles of the supero- and inferotemporal retinal vessels and 
their respective macular branches were similar to that seen in normal eyes at the same 
locations.  
 
Pseudocolour images oximetry maps of the retinal vasculature together with the 
respective colour fundus image and perimetry results of 4 representative POAG patients are 
illustrated in Figure 6.2 (see Appendix 7 for the results of the remaining 7 patients). 
Interpretation of the pseudocolour oximetry images in relation to the clinical findings is 
difficult due to the variability of the calculated OS in the retinal vasculature. The calculated 
OS of the retinal arterioles appear to be frequently greater than 100%. The calculated OS of 
the retinal venules appear to be more varied with frequent OS calculations below 0%. On 
direct inspection of the pseudocolour oximetry images were no characteristics pattern of 
oximetric abnormalities that corresponded with the severity of the disease, optic nerve head 
damage and visual field deficits.  
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Table 9. Summarized clinical data of the glaucoma subjects included in the study. 
Number 11 
Mean age (years; range) 61.6 (37 - 82) 
Male:Female ratio 8:3 
Mean systolic blood pressure (mmHg ± SD) 146.5 (± 17.5) 
Mean diastolic blood pressure (mmHg ± SD) 75.1 (± 13.3) 
Mean pulse oximeter oxygen saturation  
(% ± SD) 
96.4 (± 0.8) 
Ophthalmic assessment Eye with less 
visual field loss 
Eye with more 
visual field loss 
Mean best corrected visual acuity  
(LogMAR Equivalent)(± SD) 
0.10 (0.10) 0.17 (0.12) 
Mean intraocular pressure (mmHg ± SD) 15.2 (± 3.6) 16.0 (± 3.3) 
Mean lens 
opacity 
grade 
Nuclear opalescence (± SD) 1.4 (± 0.5) 1.8 (± 1.0) 
nuclear colour (± SD) 1.4 (± 0.7) 1.7 (± 1.1) 
cortical (± SD) 1.4 (± 0.7) 1.3 (± 0.7) 
posterior subcapsular (± SD) 1 (± 0) 1.2 (± 0.4 ) 
Mean optic 
disc 
measurement 
Vertical cup–to-disc ratio 0.74 (± 0.22) 0.88 (± 0.06) 
Horizontal cup–to-disc ratio 0.70 (± 0.21) 0.79 (± 0.11) 
Disc damage likelihood scale 2.55 (± 2.66) 5.45 (± 1.37) 
Mean visual 
field global 
indices 
MD (dB ± SD) -6.0 (± 6.8) -15.9 (± 8.9) 
Pattern Standard Deviation  
(dB ± SD) 
5.2 (± 4.3) 10.0 (± 3.2) 
Glaucoma treatment 
(either single or combination therapy) 
 
Xalatan (n = 5) 
 Lumigan (n = 2) 
Timolol (n = 3) 
Betagan (n = 1) 
Travatan (n = 1)  
 
Trabeculectomy  
(n = 2) 
Xalatan (n = 9) 
Lumigan (n = 2) 
Timolol (n = 3) 
Betagan (n = 1) 
Travatan (n = 1) 
Xalacom (n = 1) 
Trabeculectomy 
(n = 3) 
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Figure 6.1: Subject G1: a 76 year old male POAG patient with visual field defects affecting 
the right eye more than the left eye. Colour images and visual fields of both eyes are shown 
with corresponding dark calibrated spectral images at 9 selected wavelengths (560, 570, 580, 
590, 600, 610, 620 and 630 nm). There is optic disc cupping in both eyes. There is a superior 
arcuate visual field defect in both eyes affecting the right eye more than the left. No obvious 
abnormalities of the retinal vasculature can be seen in the spectral images. The mean optical 
density profile (± SD; red filled circle and whiskers) of selected segments of the temporal 
arterioles and venules and the respective oxygen saturation calculations (and 95% confidence 
interval) are also illustrated. No abnormalities in the optical density profiles and oxygen 
saturation calculation are evident. 
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Figure 6.2: Colour images, Humphrey visual field analyses and pseudocolour quantitative 
oximetry maps of the retinal vasculature in 4 representative patients with asymmetrical 
POAG.  
Subject G1 is a 76 year old male with asymmetrical POAG affecting the right eye more than 
the left. In both eyes there is optic disc cupping and superior arcuate visual field loss.  
Subject G2 is a 77 year old female with asymmetrical POAG affecting the right eye more 
than the left. In both eyes there is optic disc cupping. Superior arcuate visual field loss is 
evident only in the right eye.  
Subject G3 is a 47 year old male with asymmetrical POAG affecting the right eye more than 
the left. There is evidence of optic disc cupping in the right eye only. The Left optic disc 
appears normal. There is diffuse visual field loss in the right eye and an inferior nasal step in 
the left eye. 
Subject G4 is a 63 year old female with asymmetrical POAG affecting the right eye more 
than the left. In both eyes there is optic disc cupping. There is diffuse visual field loss in both 
eyes affecting the right eye more than the left. 
Pseudocolour quantitative oximetry maps of the retinal vasculature in all subjects are 
variable. There are no obvious characteristic features in the distribution of intravascular 
oxygen in these subjects that correlate with the morphology of the optic nerve head and 
visual field defects.  
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6.3.2. Relationship Between the Oxygen Saturation in Glaucomatous Eyes and LOCS 
III Grading Scores. 
 
The multiple linear regression model predicting the OS of the temporal retinal vessels 
in glaucomatous eyes using the LOCS III scores as independent variables did not produce a 
significant model (F = 0.602, P = 0.664, adjusted R squared = -0.040). The variance inflation 
factor and Durbin-Watson statistic of the final model did not indicate the presence of 
multicollinearity. The influence of the nuclear opalescence, nuclear colour, cortical and 
posterior subcapsular lens grading scores were not statistically significant for OS in 
glaucomatous eyes (β = -0.233, P = 0.532; β = 0.328, P = 0.418, β = -0.079, P = 0.733 and β 
= 0.181, P = 0.367 respectively). 
 
6.3.3. Comparison of the Oxygen Saturation Between Normal Subjects and Patients 
with Asymmetrical POAG. 
 
Figures 6.3 and 6.4 summarizes the OS calculations of the temporal retinal arterioles 
and venules in normal subjects and patients with asymmetrical POAGs. In normal subject, 
the mean OS (± SD) of the temporal retinal arterioles and venules were 110.8% (± 11.8%) 
and 27.7% (± 3.2%) respectively. The mean (± SD) OS of the temporal retinal arterioles were 
119.2% (± 21.9%) and 130.3% (± 21.33%) in the less advanced and more advanced 
glaucomatous eyes respectively. The mean (± SD) OS of the retinal venules were 35.8% (± 
13.9%) and 44.8% (± 24.2%) in the less advanced and more advanced glaucomatous eyes 
respectively. The mean OS of the temporal retinal arterioles and venules were significantly 
higher in POAG eyes with more advanced visual field loss compared to the eyes of normal 
subjects (P = 0.012 and 0.046 respectively; unpaired t-test with Welch’s correction (two-
tailed) and Mann-Whitney test (two-tailed) respectively). No significant differences were 
found between the mean OS of the temporal retinal arterioles and venules in POAG eyes with 
less advanced visual field loss and the eyes of normal subjects (P = 0.186 and 0.218 
respectively; unpaired t-test with Welch’s correction (two-tailed) and Mann-Whitney test 
(two-tailed) respectively). Analysis of the two POAG sub-groups (less vs. more advanced 
visual field loss) showed no significant difference in the mean arteriolar and venular OS 
between the groups (P = 0.202 and 0.203 respectively (two-tailed); paired t-test). 
 
 
 234 
 
Figure 6.3: A box-and-whisker plot of the oxygen saturation (OS) of the temporal 
(superotemporal and inferotemporal) retinal arterioles in normal subjects and POAG subjects 
with less advanced and more advanced visual field loss. 
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Figure 6.4: A box-and-whisker plot of the oxygen saturation (OS) of the temporal 
(superotemporal and inferotemporal) retinal venules in normal subjects and POAG subjects 
with less advanced and more advanced visual field loss. 
 
 
 
6.3.4. Correlation and Linear Regression Between the Oxygen Saturation of the 
Temporal Retinal Arterioles and Visual Field Global Indices. 
 
The Pearson correlation analyses between the global indices (mean deviation and 
pattern standard deviation) and the mean OS of the temporal retinal arterioles and venules are 
presented in Table 10. The linear regression between the mean deviation and mean OS of the 
temporal retinal arterioles and venules was not statistically significant (P = 0.06 and 0.07 
respectively; R2 = 0.17 and 0.15 respectively; Figure 6.5 left). Similarly, the linear regression 
between the pattern standard deviation and mean OS of the temporal retinal arterioles and 
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venules was not statistically significant (P = 0.06 and 0.16 respectively; R2 = 0.17 and 0.10 
respectively; Figure 6.5 right).  
 
Table 10. Correlation between the global indices and the mean oxygen saturation of the 
temporal arterioles and venules in POAG eyes (n = 22). 
 
Global indices  Temporal arterioles Temporal venules 
MD 
r (95% CI) -0.41 (-0.71 – 0.02) -0.39 (-0.70 – 0.04) 
R2 0.17 0.15 
p-value 0.06 0.07 
PSD 
r (95% CI) 0.41 (-0.01 – 0.71) 0.31 (-0.13 – 0.65) 
R2 0.17 0.10 
p-value 0.06 0.16 
 
 
Figure 6.5: Scatter plots illustrating the relationship between the mean oxygen saturation 
calculation and visual field global indices. (Left) The relationship between the mean deviation 
(MD) and the mean oxygen saturation of the temporal arterioles (red) and venules (blue). 
(Right) The relationship between pattern standard deviation (PSD) and the mean oxygen 
saturation of the temporal arterioles (red) and venules (blue). The best-fit line (solid black 
line) and 95% confidence interval of the best-fit line (dashed lines) are shown in the plots. 
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6.3.5. Correlation and Linear Regression Between the Oxygen Saturation of the 
Temporal Retinal Arterioles and Optic Nerve Head Evaluation. 
 
The Pearson correlation analyses between the optic disc measurements (vertical and 
horizontal cup-to-disc ration and the disc damage likelihood scale) and the mean OS of the 
temporal retinal arterioles and venules are presented in Table 11. The linear regression 
between the disc damage likelihood scale and mean OS of the temporal retinal arterioles and 
venules was not statistically significant (P = 0.09 and 0.23 respectively; R2 = 0.14 and 0.07 
respectively; Figure 6.6). 
 
Table 11. Correlation between the optic disc measurements (vertical and horizontal cup-to-
disc ratio and the disc damage likelihood scale) and the mean retinal vessel oxygen saturation 
of the temporal arterioles and venules in POAG eyes (n = 22). 
 
Global indices  Temporal arterioles Temporal venules 
Vertical cup-
to-disc ratio 
r (95% CI) 0.25 (-0.19 – 0.61) -0.17 (-0.27 – 0.55) 
R2 0.06 0.03 
p-value 0.26 0.46 
Horizontal 
cup-to-disc 
ratio 
r (95% CI) 0.11 (-0.33 – 0.51) 0.03 (-0.40 – 0.45) 
R2 0.01 0.0009 
p-value 0.62 0.89 
Disc damage 
likelihood 
scale 
r (95% CI) 0.37 (-0.06 – 0.69) 0.26 (-0.18 – 0.62) 
R2 0.14 0.07 
p-value 0.09 0.23 
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Figure 6.6: Scatter plots illustrating the relationship between the retinal vessel oxygen 
saturation calculations and disc damage likelihood scale. The relationships are shown 
between the disc damage likelihood scale and the mean oxygen saturation of the temporal 
arterioles (red) and venules (blue). The best-fit line (solid line) and 95% confidence interval 
of the best-fit line (dashed lines) are shown in the plots. 
 
 
 
 
6.4. Discussion. 
 
6.4.1. Oxygen Saturation of the Retina in POAG Patients: Observational Features, 
Quantitative Analysis and Oximetry Maps of the Retinal Vasculature. 
 
The application of hyperspectral imaging to detect OS changes in the retinal vasculature 
of POAG patients has been presented in this study. Observational spectral features of the 
retinal vasculature, optical density profile and OS calculations of selected segments of the 
retinal vasculature in POAG patients have been illustrated in addition to the presentation of 
the pseudocolour oximetry maps of the retinal vasculature. 
In contrast to the findings of patients with retinovascular occlusion presented in Chapter 
5, the dark calibrated registered spectral images of the retina in patients with POAG did not 
reveal apparent spectral characteristic features of abnormal oxygenation in the retinal 
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vasculature upon inspection. This may indicate that either no abnormality was present or that 
only subtle abnormalities were present which could not be detected on visual inspection of 
the retinal vasculature. Further analysis of the retinal vasculature in POAG patients was 
necessary to determine whether abnormal OS within the blood vessels could be detected. 
Mean optical density profile analyses and OS calculations of selected segments of the retinal 
arterioles and venules in POAG patients were performed. These latter analyses did not reveal 
detectable OS abnormalities in the selected retinal vasculature. An illustration of the 
unremarkable spectral features of the retinal vasculature, optical density profiles and OS in a 
patient with asymmetrical POAG is presented in Figure 6.1 (subject G1).  
Pseudocolour oximetry maps of the retinal vasculature in patients with POAG are 
presented together with the respective colour fundus images and Humphrey visual field 
analyses (Figure 6.2). These images were difficult to interpret in relation to the clinical 
investigations. There were no obvious patterns (on visual inspection of the pseudocolour 
images) to the distribution of the calculated OS in the retinal vasculature that correlated with 
the severity of glaucoma or localized glaucomatous damage. Structured analysis of the 
oximetry data was required to discern whether oximetric differences could be detected in 
glaucomatous eyes. This was subsequently performed. 
 
6.4.2. Quantitative Oxygen Saturation: Comparison Between Normal Subjects and 
POAG Patients. 
 
Statistical methods were subsequently used to determine the presence of abnormal 
oxygen saturations in the retinal vasculature of POAG patients. Structured collection of OS 
data from selected points along the retinal vessels in POAG patients was performed and 
compared to OS data performed using the same technique in normal subjects (described in 
Chapter 4). The results show that the mean OS of the temporal arterioles and venules were 
significantly higher in eyes with more advanced glaucomatous visual field loss compared to 
normal eyes (Figures 6.3 and 6.4). The mean OS of the temporal arterioles and venules of the 
contralateral POAG eyes were higher than in normal subjects, however this was not 
statistically significant. Similarly, sub-group analysis revealed no significant differences in 
the OS of the temporal arterioles and venules between POAG eyes with less advanced and 
more advanced visual field loss. 
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6.4.3. Retinal Arterioles. 
 
The significantly higher OS of the temporal retinal arterioles in glaucomatous eyes is 
surprising and unclear. A possible explanation could be due to inaccuracies in the optical 
density profile and OS calculations in the population of normal subjects and patients with 
glaucoma included in the study which may have skewed the results. We anticipated no 
significant differences in the OS of the 1st and 2nd degree arterioles between our cohort of 
glaucoma patients and normal subjects. This is supported by comparing recent studies on 
normal subjects and glaucoma patients with the dual wavelength retinal oximeter. Hardarson 
et al. (2006) reported a mean (± SD) arterial OS of 96% (± 9%) in normal subjects. 
Traustason et al. (2009) reported a mean (± SD) OS of the 1st and 2nd degree retinal arterioles 
of 96% (± 2%) and 97% (± 2%) in glaucoma patients on topical timolol monotherapy and 
timolol-dorzolamide combination therapy respectively. Hardarson et al. (2009) reported a 
significant increase in the mean (± SD) OS of the 1st and 2nd degree retinal arterioles of 97% 
(± 4%) to 99% (± 6%) in glaucoma patients before and after glaucoma filtration surgery. In 
consideration of these studies, using the same retinal oximeter, it appears that the arteriolar 
OS are similar in normal subjects and patients with glaucoma. 
In contrast, a study by Michelson and Scibor (2006), using a multi-wavelength imaging 
spectrometer, reported lower arteriolar OS in patients with normal tension and primary open 
angle glaucoma (89.7% ± 5.4% and 91.4% ± 4.0% respectively) compared to normal subjects 
(92.3% ± 3.4%). However, their measurements were limited to localized superotemporal 
arterioles approximately 1-3 mm from the optic disc. It is difficult to understand these 
findings as the commonly recognized causes of arterial hypoxaemia are pulmonary 
pathologies (alveolar hypoventilation, ventilation-perfusion mismatch, low inspired oxygen 
partial pressure) and right-to-left shunts. In Chapter 5, two cases of retinal arteriolar 
hypoxaemia were demonstrated in association with embolic retinal artery occlusion. 
Hypoxaemia of the retinal arterioles was explained by the presumed reduced blood flow and 
subsequent extraction and/or diffusion of oxygen from the intravascular haemoglobin into the 
adjacent vitreous and retinal tissues. Consumption of the intravascular oxygen by the vessel 
wall is another possibility. The quantitative relationship between blood flow in the 1st and 2nd 
degree retinal arterioles and extraction of oxygen leading to arteriolar hypoxaemia is not 
known. However, it would be reasonable to expect that arteriolar hypoxaemia would occur at 
extremely low blood flow rates in the 1st and 2nd degree retinal arterioles. Such conditions are 
unlikely to be present in the glaucoma patients included in this study.  
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6.4.4. Retinal Venules. 
 
A higher mean oxygen saturation of the temporal retinal venules in glaucomatous eyes 
compared to normal eyes was observed in this study. A possible explanation could be a 
systematic error in the OS calculation, indicated by a concurrent higher mean arterial OS 
calculation in glaucomatous eyes, which could have offset the OS calculation of the retinal 
venules to a higher value. A plausible argument for a systematic error would be a difference 
in the fundal reflectance between normal and glaucomatous eyes where there is a loss of 
neuronal tissue in the inner retina. However, our model eye experiments described in Chapter 
3 demonstrated that background reflectance had no significant influence on the OS 
measurements and did not appear to affect its accuracy. Other physiological factors that could 
contribute towards a systematic error, such as blood flow and vessel diameters differences 
between normal subjects and glaucoma patients, are unlikely as these factors do not 
significantly change the characteristic shapes of the optical density profile that enable the 
calculation of the OS. These physiological factors were previously studied by Schweitzer et 
al. (1999) who demonstrated that in vitro changes to the blood flow and blood column 
thickness resulted in a vertical displacement of the spectral transmission profile of fully 
oxygenated blood without a significant change to the shape of the transmission profile. 
Therefore, the curve fitting technique used in this study to generate the OS value is unlikely 
to be affected by such physiological features as each OS value is calculated from the specific 
shape of the optical density profiles. However, further research would be necessary to 
evaluate and confirm these statements. 
Nonetheless, higher mean OS of the temporal retinal venules in glaucomatous eyes 
compared to normal eyes are contrary to the oximetry study in glaucoma reported by 
Michelson and Scibor (2006), where a mean (± SD) venular OS of 56.0% (± 8.3%) and 
58.3% (± 10.5%) in patients with normal tension and primary open angle glaucoma were 
observed. These measurements were not significantly different to measurements made in 
normal subjects where a mean (± SD) venular OS of 55.7% (± 6.8%) was reported. However, 
combining the studies reported by Hardarson et al. (2006 and 2009) and Traustason et al. 
(2009), which used the same retinal oximeter, the mean (± SD) OS of the retinal venules in 
glaucoma patients on topical medical therapy were 66% (± 5%) and 65% (± 6%) 
respectively. In glaucoma patients undergoing filtration surgery the mean retinal venular OS 
were 63% (± 5%) before surgery and 64% (± 6%) after surgery (Hardarson et al., 2009). 
Importantly, an earlier study by Hardarson et al. (2006, 2009) found comparatively lower 
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retinal mean (± SD) venous OS in normal subjects of 55% (± 14%). As mentioned in 
previous chapters, a commonly accepted limitation of the two wavelength oximetry technique 
is the overestimation of the true blood oxygen saturation particularly at lower oxygen 
saturations (Sarnquist et al., 1980). This could explain the higher venular OS in glaucoma 
patients reported in these latter three studies compared to this study. The relative difference in 
the venular OS between normal subjects and glaucoma subjects (higher venular oxygen 
saturation in glaucoma patients), however, appear to support the findings in this study. 
The increase in the OS of the temporal retinal venules could indicate reduced metabolic 
consumption of oxygen in the retinal tissues in glaucomatous eyes. However, 
microcirculatory shunting of arterial blood into the venous system and physiological changes 
within the tissue causing a left-shift of the haemoglobin oxygen dissociation curve in the 
capillaries (increased affinity of haemoglobin for oxygen) cannot be excluded from our 
findings. Increased venous OS is thought to be an indicator for reduced oxygen utilization as 
well as arteriovenous shunting (Marx and Reinhart, 2006). In normal human physiological 
conditions, the OS of the veins draining their respective organs within the body are highly 
variable which is thought to reflect variations in the oxygen extraction levels or metabolic 
activity of the tissues (Reinhart, 1989). This is most evident in the renal venules whose OS is 
approximately 92% as a result of relatively low oxygen extraction in the renal tissues which 
derives its energy requirements from non-oxidative phosphorylation (Byrick and Rose, 1990). 
In contrast, the OS of venous drainage from the heart is approximately 37% which reflects 
high oxygen extraction as a result of oxidative phosphorylation in the cardiac muscles 
(Reinhart, 1989). Rivers et al. (1992) reported venous hyperoxia in patients with following 
cardiac arrest which was hypothesized to be a result of deranged systemic oxygen 
consumption. 
In glaucoma, the reduced metabolic consumption of the retina could reflect neuronal loss 
and/or dysfunction. Numerous studies have reported the loss of ganglion cells in glaucoma 
(Quigley and Addicks, 1981; Quigley et al., 1981; Morgan et al., 2000; Glovinsky et al., 
1991; Glovinsky et al., 1993; Weber et al., 1998; Hitchings, 2000; Quigley et al., 1987) and 
the underlying process is thought to involve apoptosis (Kerrigan et al., 1997; Quigley et al., 
1995; Garcia-Valenzuela et al., 1995; Guo et al., 2005). Further, ganglion cell drop out is 
thought to be preceded by structural morphological changes of the dendrites (Morgan et al., 
2006; Shou et al., 2003; Weber et al., 1998)  and reduced sensitivity to light stimuli (Porciatti, 
2006; North et al., 2010) which suggests the presence of neuronal dysfunction which could be 
manifested by reduced oxygen consumption. At an intracellular level, it has been postulated 
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that mitochondrial function in the retinal ganglion cells are compromised by a multitude of 
insults which results in reduced energy production (reduced oxygen consumption) which 
subsequently induces cellular apoptosis (Osborne, 2008). Ganglion cell loss and/or 
dysfunction on its own may not necessarily result in increased venous OS as other neuronal 
cells and supportive cells within the retinal layers require oxygen to fuel their metabolic 
demands. There is emerging evidence from histological, electrophysiological and OCT 
studies that the processes involved in glaucomatous damage could also involve other 
neuronal cells such as amacrine cells (Raz et al., 2003), bipolar cells (North et al., 2010; Lei 
et al., 2008), horizontal cells (Janssen et al., 1996) and photoreceptors (Lei et al., 2008; Nork 
et al., 2000; Panda and Jonas, 1992; Velten et al., 2001; Guo et al., 2010). Therefore reduced 
mass tissue extraction of oxygen within the retinal layers would support our explanation of 
retinal venous hyperoxia. 
However, regional intravenous hyperoxia associated with focal loss of perimetric 
sensitivity and/or neuroretinal rim in glaucoma patients was not observed in this study. It 
would be anticipated that, for example, a superior arcuate scotoma and/or inferior 
neuroretinal rim loss would be associated with higher OS of the inferotemporal retinal 
venules compared to the superotemporal retinal venules. In addition, with the increased 
density of retinal ganglion cells closer to the fovea compared to the peripheral retina (Perry 
and Cowey, 1985; Dacey and Peterson, 1992), it would be anticipated that localized visual 
field defects in regions close to fixation in glaucomatous eyes would result in higher OS of 
the respective venules draining the affected region of the retina. The absence of finding such 
features in this study could be explained by the lack of sensitivity of our oximetry technique 
to detect these differences or errors in the OS calculations. However, regional variations in 
the OS of the 1st degree venules in relation to visual field deficits may not necessarily be 
present as a given venule could be collecting blood from both hemispheres. Furthermore, 
Grewal et al. (2009) demonstrated diffuse patterns of reduced retinal nerve fibre layer 
thickness and retinal sensitivity in the normal regions of the perimetric tests in glaucoma 
patients with localized standard automated perimetry deficits. Therefore, despite focal visual 
field and neuroretinal rim loss, the presence of dysfunctional ganglion cells (and possibly 
other neuronal cells) in other regions of the retina could be manifested by higher venous OS 
in both the supero- and inferotemporal arcades. 
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6.4.5. Relationship Between Retinal Vascular Oxygen Saturation, LOCS III scores, 
Visual Field Analysis and Optic Nerve Head Measurements. 
 
Multiple linear regression analysis demonstrated a non-significant relationship between 
the OS of the temporal vessels in glaucomatous eyes and LOCS III grading scores suggesting 
that the influence of the lens status on the oximetry values was not an important factor. 
An intriguing finding in this study is the impression of an increasing trend of the mean 
venular OS calculation amongst normal subjects, glaucomatous eyes with less advanced 
visual field loss and glaucomatous eyes with more advanced visual field (Figure 6.4). 
Although no significant difference in the mean venular oxygen saturation was found between 
normal subjects and glaucomatous eyes with less advanced visual field loss and between 
glaucomatous eyes with less advanced visual field loss and glaucomatous eyes with more 
advanced visual field loss, the increasing trend implies some consistency with the results. The 
non-significant finding could reflect the presence of a mixture of eyes with little or no 
glaucomatous dysfunction in the less advanced visual field loss group. This is evident by the 
presence of 4 out of 11 eyes (36%) with normal Glaucoma Hemifield Tests in this group.  
 
Further analysis was performed in this study to investigate the relationship between the 
OS calculations and both global indices of the automated perimetry (mean deviation and 
pattern standard deviation) and optic nerve head morphology (vertical and horizontal cup-to-
disc ratio and disc damage likelihood scale) glaucoma patients. Both mean arteriolar and 
venular OS were negatively correlated with the mean deviation and positively correlated with 
the pattern standard deviation and optic nerve head measurements (Tables 8 and 9 and 
Figures 6.5 and 6.6 respectively). Although these findings were not statistically significant, 
the trends are consistent with the results of the aforementioned group comparisons. These 
observations, could lend support to the hypothesis that increasing retinal venular OS indicate 
decreasing tissue consumption of oxygen due to ganglion (and other neuronal) cell loss 
and/or dysfunction.  
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6.4.6. Limitations of the Study and Future Research. 
 
A major limitation of this study, in addition to the limitations of the oximetry technique 
detailed in Chapter 4, is the small sample size of patients included in this study and low 
statistical power. Therefore, caution should be used when interpreting the results of the study. 
Further studies would be useful to fully investigate the relationship between the OS of the 
retinal vessels and glaucomatous damage with a larger population of matched subjects. This 
would reduce the potential for type 1 and type 2 errors which are likely to be present in this 
study. If the relationship between increasing venous oxygen saturation and increasing 
glaucomatous damage is confirmed it would indicate that measuring the venular OS could be 
a useful functional parameter in detecting and monitoring disease progression in glaucoma. 
A further limitation of this study is that the oximetry technique was not capable of 
measuring the oxygen saturation of the retinal capillaries which is likely to be a more 
important indicator of oxygen supply and demand to the retinal tissues. Tissue hypoxia as a 
consequence of vascular dysregulation and reduced ocular blood flow are thought to be 
important in the pathogenesis of glaucoma (Tezel and Wax, 2004). Spectrophotometric 
techniques have previously been described to detect and characterize tissue and capillary 
oxygenation in animal and human studies. Selbach et al. showed that the OS of the capillaries 
of the anterior optic nerve head rim and centre was stable at experimentally induced 
intraocular pressures of up to 60 mm Hg and 40 mm Hg respectively in rabbits eyes (Selbach 
et al., 1999). Beyond these respective intraocular pressures the OS was shown to decrease 
presumably due to reduced (autoregulation) of blood flow and the resultant extraction of 
oxygen from haemoglobin located in the capillaries. Khoobehi et al. (2004) reported relative 
oxygen desaturation in the optic nerve head tissues and overlying arteriolar vessels in 
monkeys with experimentally increased intraocular pressures of up to 60 mm Hg. Ito et al. 
(2008) demonstrated lower OS in the retinal tissue adjacent to the optic disc in human 
patients with normal tension glaucoma and POAG compared to normal subjects. These 
studies are supported by a phosphorescence imaging technique performed by Shonat and 
colleagues (1992) who demonstrated that the oxygen tension of the optic nerve head and 
capillary bed in cats was stable at moderate increases in IOP. Hypoxia of the optic nerve head 
and capillary bed was only found when the IOP was increased and the blood flow, measured 
by laser Doppler flowmetry, stopped. It is apparent from these studies that measurements of 
oxygen content at the microvascular and tissue level could be important in contributing to our 
understanding of the vascular mechanisms which are thought to play a role in the 
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pathogenesis of glaucoma such as reperfusion injury and oxidative stress. From a clinical 
aspect, these measurements may be important in explaining the pressure dependent and 
pressure independent mechanisms of diffuse and focal visual field loss which have been 
postulated by Caprioli et al (1987). Furthermore, it is conceivable that full field oximetry of 
the retinal microvasculature and tissues could be a valuable tool in detecting and monitoring 
the progression of glaucoma. The oximetry technique presented in this study involved 
measuring the OS of the macular branches of the arterioles and venules. These measurements 
could potentially be used as a surrogate of indirectly estimating the oxygen saturation of the 
retinal capillaries. Further studies would be required to explore its usefulness.  
Arterio-venous (AV) difference in OS of vessel pairs is thought to reflect tissue extraction 
of oxygen. This was not performed in study because of the errors in the OS calculation of 
retinal arterioles located in close proximity to the venules – this was described in detail in 
Chapter 4. Additionally, it is uncertain whether AV differences truly reflect oxygen 
extraction of a particular tissue region, as the contribution of oxygen from other regions of 
the retina collected by measured venule could compound the results. 
An alternative method of measuring the oxygen content of the capillaries would involve 
hyperspectral image analysis techniques to quantify the relative amounts of oxy- and 
deoxyhaemoglobin within each hyperspectral voxel (volumetric pixel with the third 
dimension representing sequential wavelengths) of the retinal image plane. This was 
attempted in our early hyperspectral image analysis research using linear spectral unmixing 
of the hyperspectral retinal images obtained from glaucoma patients (Boardman, 1989), 
however, our results were highly variable, difficult to interpret and could not be accurately 
validated. (Mordant DJ et al. IOVS 2007;148: ARVO E-Abstract 148). Further research, and 
in particular, refinements to the registration of the retinal images and analysis of the 
hyperspectral images are required to establish the value of this alternative oximetry 
technique. 
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6.4.7. Summary. 
 
This present study has described the application of the oximetry techniques to patients 
with primary open angle glaucoma. Retinal arteriolar and venular OS were significantly 
higher in eyes with more advanced visual field loss compared to normal eyes. We postulate 
that the increased OS of the retinal venules in glaucomatous eyes suggests reduced 
consumption within the retinal tissues. A trend of increasing OS within the retinal venules 
was associated with decreasing visual field sensitivities and increasing optic nerve head 
cupping and damage was observed in this study. However, the correlation was not 
statistically significant. To our knowledge, this is the first report of such findings and further 
research is required to support our results. Nonetheless, this study has provided a useful 
insight into the potential applications of retinal oximetry using spectral imaging in detecting 
glaucomatous damage and monitoring its progression. 
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Chapter 7: Summary and Future Work. 
 
7.1. Summary 
 
This thesis investigated the use of a hyperspectral fundus camera to measure the 
oxygen saturation (OS) of the retinal vasculature in humans. Initially, experiments were 
carried out to characterize the wavelengths of light emitted from the hyperspectral fundus 
camera. The results showed that the actual measured wavelength differed by several 
nanometres from the programmed wavelengths. Additionally, it was found that the difference 
between the measured and programmed wavelengths varied between imaging sessions. This 
was an important finding because the calculation of blood OS by photometric methods 
utilizes the extinction coefficient data of oxy- and deoxyhaemoglobin which is wavelength 
dependent. This finding contributed towards the modification of the OS algorithm which 
accounted for the difference between the measured and programmed wavelengths. The 
variability of the wavelengths emitted from the hyperspectral fundus camera provided a 
useful insight into the potential limitations of the fundus camera. 
 A subsequent experiment was performed which principally aimed at establishing the 
accuracy of our oximetry technique using a model eye. Whole arterial and venous human 
blood at varied measured OS were inserted into quartz tubes, placed within the model eye and 
imaged by the hyperspectral fundus camera using sequential wavelengths between 500 nm 
and 650 nm in 2 nm increments. Visible characteristic differences between arterial blood and 
venous blood (with low oxygen saturation) could be seen in the spectral images. This 
demonstrated that the hyperspectral fundus camera was capable of qualitatively detecting OS 
related differences in blood samples of varying oxygenation. The main steps in our oximetry 
technique were illustrated. The OS of the blood samples were calculated by our oximetry 
technique and compared to the gold standard measurement. We found that the accuracy of the 
OS calculation of the blood samples was reasonable and was not significantly influenced by 
the size of the quartz tube and the background reflectivity. We also found that at lower OS of 
blood, the oximetry technique had a tendency to overestimate the actual OS. We believed that 
this could have been attributed to by imperfections of our oximetry algorithm, in particular, 
the non-linear fitting to the optical density profiles. This overestimation of the true OS was 
comparable to previous studies. We believe that this overestimation of lower measured OS 
could have influenced the overall accuracy of the OS calculation.  
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 Spectral images of the retina were acquired from normal subjects to determine 
whether our oximetry techniques could be applied to humans. The image processing and 
analysis techniques that were created in this research specifically for human retinal oximetry 
were illustrated. Visible characteristic features of the retinal arterioles and venules could be 
seen from the acquired spectral retinal images. These features were similar to that seen in the 
model eye and indicated that the differences in the OS of the retinal vasculature could be 
observed from the spectral retinal images. An important discovery was the effect of the 
choice of the optical density wavelength range on the accuracy of the OS calculation. We 
established that the wavelength range of 500 nm - 650 nm underestimated the OS in the 
retinal arterioles. Consequently, the wavelength range of the optical densities was changed to 
556 nm – 650 nm for retinal oximetry calculations . This was determined to be an acceptable 
wavelength range. Our oximetry technique was used to generate pseudocolour oximetry maps 
of the retinal vasculature which was useful in providing an overview into the characteristic 
distribution of oxygen in the normal retinal vasculature. A more detailed examination of the 
oximetry technique was performed by evaluating the non-linear fitting of the oximetry model 
to the mean optical density profiles along segments of the retinal vessels. We found that the 
OS of the retinal venules in normal subjects were much lower than measurements reported in 
previous studies. We were able to support our findings by comparing the optical density 
profiles of the retinal venules of a normal subject to an interpolation of the published 
extinction coefficients of oxy- and deoxyhaemoglobin. We proposed that the OS calculation 
of the retinal venules in normal subjects using our oximetry technique was relatively more 
accurate and that it could reduce the possibility of overestimating the true OS of the retinal 
venules which may be inherent in other retinal oximetry systems. A new finding in our 
research which, to our knowledge, has never been previously reported relates to the observed 
and measured higher than anticipated oxygen saturation of the macular branches of the retinal 
venules. We were able to support our findings by demonstrating similarities between the 
optical density profiles of selected segments of the macular venules and the optical density 
profiles of the macular arterioles. We postulated that the higher than expected OS of the 
macular branches of the retinal venules could be explained by the collection of “un-used” 
oxygen in the venous system from an oxygen rich environment generated by both the 
choroidal and retinal supply of oxygen. However, there were a number of limitations of our 
study design and oximetry technique which requires further attention to confirm our findings.  
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  Our subsequent studies involved evaluating whether the oximetry techniques were 
capable of detecting abnormal OS in the retinal vasculature in diseased eyes. Patients with 
retinal arterial and vein occlusions were imaged using the hyperspectral fundus camera. In 
patients with retinal arterial occlusion, we detected observable and measurable decreases in 
OS within selected retinal arterioles in regions of damaged retina. We proposed that the 
oxygen is lost either through diffusion into the surrounding vitreous, retina and/or 
consumption by the vessel walls. Additionally, in patients with retinal artery and vein 
occlusion we detected observable and measurable increased venular OS in selected vessels. 
This finding could be explained by the reduced consumption of oxygen in the damaged 
retina, shunting of arteriolar blood into the retinal venules or changes to the haemoglobin 
oxygen dissociation curve at the microvascular level. The study design involved a small 
cohort of patient and therefore further studies need to be performed to confirm our findings. 
Nonetheless, this study demonstrated that changes in the OS of the retinal arterioles and 
venules can be detected using our oximetry techniques. 
 The oximetry technique was subsequently applied to spectral images acquired from 
patients with primary open angle glaucoma, a common sight threatening condition which is 
thought to primarily cause damage to the ganglion cells located in the inner retina. We aimed 
to determine whether the oximetry technique was able to detect changes in the OS of the 
retinal vasculature. We found that the OS in the retinal venules were significantly higher in 
glaucomatous eye with more advanced visual field loss compared to normal subjects. Our 
finding was indirectly supported by reviewing the results of separate previously published 
peer-reviewed papers using the same dual wavelength retinal oximeter. We proposed that this 
finding, as with our cohort of patients with retinovascular occlusion, suggests reduced 
consumption of oxygen by damaged tissues in the retina. However, the main limitation of this 
study was the small sample size and further research is required to fully establish whether our 
oximetry techniques would be useful in the detection and monitoring of disease progression 
in glaucoma. 
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7.2. Future Work. 
 
This thesis demonstrates that oxygen saturation measurements of the retinal 
vasculature can be performed using the described spectral imaging and image analysis 
techniques. Furthermore, our results suggest OS measurements of the retinal vasculature 
reflect the functional status of the retina and could be a potentially useful clinical tool to aid 
in the detection of ocular pathologies, such as glaucoma, and monitor its progression and 
response to treatment. It is hoped that this thesis would provide a framework for the direction 
of future research in this interesting and potentially useful topic. 
The technical limitations have been addressed in detail in previous chapters. In 
relevance to its clinical applicability, the hyperspectral fundus camera and the oximetry 
techniques described are not suited for high volume imaging required for large scale 
population studies and use in a clinical setting. To achieve this, refinements to the imaging 
and analysis techniques needs to be addressed. A potential solution would be to implement 
multi-spectral imaging techniques without sacrificing the accuracy of the OS measurements. 
Currently, we are testing a snap-shot multispectral fundus camera which is capable of 
generating 8 registered spectral images of the fundus simultaneously which is achieved by 
using an Image Replicating Imaging Spectrometer system attached to a conventional fundus 
camera (Figure 7.1). The advantage is the rapid acquisition of retinal images (Figure 7.2) and 
generation of oximetry data with the omission of time-consuming processing steps such as 
image registration (Figure 7.3). Model eye experiments are being performed to validate the 
accuracy of a shortened number of wavelengths. 
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Figure 7.1: The multispectral fundus camera with the Image Replicating Imaging 
Spectrometer (IRIS) component attached to the viewing port of a fundus camera (left). The 
IRIS component functions by replicating a scene (retinal plane) into 8 images each image 
representing a defined wavelength. 
   
 
 
Figure 7.2: Raw images of a normal left retina obtained from the multispectral fundus 
camera. The wavelengths are shown on the bottom right of each image. 
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Figure 7.3: Oxygen saturation map of the retinal vasculature of a normal left retina. The 
oxygen saturation values are colour coded as shown in the scale bar to the right of the image. 
 
 
 
A further important aspect to retinal oximetry, which was alluded to in Chapter 6, is 
the requirement to explore a means to non-invasively measure the oxygen content within the 
tissues and capillaries. This can best be achieved using a snap-shot technique as the errors of 
misregistration are minimized.  This would enable the characterization of oxygen distribution 
of in the whole retina in health and disease and provide a useful insight into the mechanisms 
of retinal pathologies. A different approach to the image analysis would need to be 
undertaken and is likely to involve the analysis of each voxel in the retinal image plane. This 
has been explored by our research group using a linear spectral unmixing approach and 
further research needs to be performed to determine the most accurate method of achieving 
tissue and capillary oximetry. Spectral analysis of each voxel in the image plane is 
particularly attractive because it has the potential of identifying other intracellular or 
extracellular chromophores, such as neuroglobin and cytochrome which could be a useful 
indicator of intracellular retinal function in severe sight-threatening ocular pathologies such 
as glaucoma, diabetic retinopathy and age-related macular degeneration. 
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Appendix 1: Mathematical Concept of the Two 
Wavelength Method of Calculating the Oxygen 
Saturation. 
 
The Lambert-Beer law in transmission blood oximetry assumes that for any given 
wavelength of light its absorption is dependent on the extinction coefficient of the blood 
solution (ε), its concentration or haematocrit (c) and the distance (d) the light has to travel 
through the solution (path length): 
      (Eq. A1.1) 
Where IT is the amount of light transmitted through a solution and IO is the amount of 
incident light.  
The optical density (OD) of a solution is a measure of its transmittance, and is defined by: 
       (Eq. A1.2) 
Therefore the optical density of a solution of blood is a function of its extinction coefficient, 
concentration and the path length the light has to travel. 
The two main haemoglobin derivatives in blood are deoxyhaemoglobin (Hb) and 
oxyhaemoglobin (HbO2), also known as the functional haemoglobin derivatives. 
       (Eq. A1.3) 
Therefore the optical density of blood (ODBlood) at a given wavelength can be expressed as a 
function of the extinction coefficients (εHb and εHbO2) and concentrations (cHb and cHbO2) of the 
functional haemoglobin derivatives: 
  (Eq. A1.4) 
Functional oxygen saturation (OS) is defined as: 
      (Eq. A1.5) 
Equation A1.5 can be rearranged to obtain the following: 
IT  IO  10
   c  d
OD  log10 
IT
IO
    c  d
Blood  Hb  HbO2
ODBlood  Hb  cHb  d  HbO2  cHbO2  d
OS 
cHbO2
cHb  cHbO2

cHbO2
cHbTotal
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      (Eq. A1.6) 
       (Eq. A1.7) 
Equation A1.4 can be rewritten using Equations 1.6 and 1.7 to include the oxygen saturation: 
  
(Eq. A1.8) 
This can be simplified to: 
    (Eq. A1.9) 
In Equation A1.9 there are 2 known variables (the extinction coefficients), 1 measurable 
variable (the optical density of blood) and 3 unknown variables (concentration of blood, path 
length and oxygen saturation). A minimum of two wavelengths of light (λ1 and λ2) are 
required to perform oximetry which enables the calculation of the oxygen saturation which is 
not assumed to be independent on the concentration of blood and the path length: 
   (Eq. A1.10) 
These two equations (1.10) can be solved for s, resulting in the oximetry equation: 
  (Eq. A1.11) 
The oximetry Equation A1.11 no longer require values for the haemoglobin concentration or 
path length and oxygen saturation can be calculated from optical density measurements and 
the extinction coefficients of the haemoglobin derivatives at the two wavelengths.  
This equation can be further simplified when one isobestic wavelength (where the absorption 
of light by Hb and HbO2 is equal; oxygen insensitive) is chosen. Therefore if λ1 is the 
isobestic wavelength: 
        (Eq. A1.12) 
cHbO2  OS  cHbTotal
cHb  cHbTotal  1  OS
ODBlood  Hb  cHbTotal  1  OSd  HbO2 OS  cHbTotal  d
ODBlood  cHbTotal dOSHbO2  Hb  Hb
OD1  cHbTotal  dOS HbO2
1  Hb
1  Hb
1
OD2  cHbTotal  dOS HbO2
2  Hb
2  Hb
2
OS 
OD1  Hb
2 OD2  Hb
1
OD2HbO2
1  Hb1 OD1HbO2
2  Hb2
HbO2
1  Hb
1
HbO2
1  Hb
1  0
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Substituting Equation A1.12 into Equation A1.11 can further simplify the oxygen saturation 
equation to: 
   (Eq. A1.13) 
Equation A1.13 is a linear equation: 
       (Eq. A1.14) 
Where: 
       (Eq. A1.15) 
 
 
 
 
 
 
 
 
 
 
OS 



OD2
OD1

HbO2
1
HbO2
2  Hb2


 



Hb
2
HbO2
2  Hb2



OS  
OD2
OD1
A  B
A 



HbO2
1
HbO2
2  Hb2



B 



Hb
2
HbO2
2  Hb2



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Appendix 2. Image Selection. 
 
All raw retinal images for each eye were saved onto a computer hard disk as 8-bit bitmap and 
12-bit PNG (signed integer) images for further processing. Selection of the best retinal 
images for each wavelength was performed manually. This was done by inspecting the raw 
12bit retinal images on a computer using image viewing software (Windows picture and fax 
viewer, Microsoft, Redmond, WA). Images of the same wavelength were compared.  
Features within each image such as the presence of artefacts (Figure A2.1), focus (Figures 
A2.3 and A2.4) and illumination pattern (Figures A2.5 and A2.6) were evaluated to 
determine the best quality image for each wavelength. The other images were removed from 
further image processing.  
The images shown in Figures A2.1 – A2.6 are the saved raw 12-bit PNG images 
displayed in the Windows picture and fax viewer software (Microsoft, Redmond, WA). The 
light grey background of the retina in the 12-bit PNG images is a consequence of the 
incompatibility of the Windows viewing software and the raw images. Although the saved 8-
bit bitmap images can be viewed using the Windows viewing software without compatibility 
issues, the low contrast of the 8-bit images made it too difficult to effectively determine 
differences in the features of the images to enable the selection of the best quality retinal 
image for each wavelength. Displaying the 12-bit PNG images was determined to be the 
quickest and most effective way of selecting the best quality images. 
 
Figure A2.1: Retinal images of a normal left eye obtained at 536 nm. Images with artefacts 
are deleted. Image A has no artefact. Image B contains an artefact and was removed from 
further processing. 
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Figure A2.3: Retinal images of a normal left eye obtained at 542 nm. Images that are out of 
focus or comparatively more out of focus were removed from further processing. The edges 
of the retinal blood vessels appear sharper in image A than in image B. Image A is more in 
focus compared to image B. Image B was removed from further processing.  
 
. 
 
 
 
Figure A2.4: Retinal images of a normal left eye obtained at 580 nm. The focus of the 
images can also be determined by the edges of the retinal blood vessels and sharpness of the 
retinal reflex.  Image A has a sharp retinal reflex and the blood vessels appear in focus. 
Image B has a faint retinal reflex and was removed from further processing. Image C has no 
retinal reflex and was removed from further processing. Image D has sharp edges to the 
retinal blood vessel and the retinal reflex appears sharp but the illumination pattern was 
skewed with darker areas inferiorly. This image was removed from further processing. Image 
E has a clear retinal reflex but its sharpness and the edges of the blood vessels appear to be 
less sharp compared to image A and therefore more out of focus. This image was removed 
from further processing. 
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FigureA 2.5: Retinal images of a normal left eye obtained at 532 nm. Illumination of the 
optic disc and its surroundings is comparatively better in image A compared to image B. 
Image B is removed from further processing. 
 
 
 
Figure A2.6: Retinal images of a normal left eye obtained at 574 nm.  The illumination 
pattern in image A is more uniform around the optic disk compared to image B where the 
illumination is brighter in the superotemporal region adjacent to the optic disc. Image A 
was used for processing and image B was removed from further processing.  
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Appendix 3: Histogram of a sample raw retinal 
image acquired at 580 nm (portable network 
graphics format) 
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Appendix 4: Retinal Image Segmentation and Vessel 
Intersection Detection - Mathematica Programming 
Codes 
 
SETTING THE DIRECTORY AND DEFINING FILES 
<< ImageProcessing` 
Needs["LinearRegression`"] 
Needs["NonlinearRegression`"] 
Needs["ErrorBarPlots`"]; 
pn = P24 (* THE PATIENT RESEARCH NUMBER *) ; 
(* CHANGE *) 
es = L; (* THE SIDE OF THE EYE *) 
(* CHANGE *) 
SetDirectory[ 
  name = "G:\\2010_02_15 MD Normals\\P24 [L] images coreg\\"]; 
(* CHANGE *) 
 
THE RESULTS OF THE VESSEL DETECTION 
pic = Import[ 
   ToString[name] <> "DC_" <> ToString[pn] <> ToString[" ["] <>  
    ToString[es] <> ToString["]"] <> " REF VESSEL DETECTION 2.bmp"]; 
aa = FileNames["xy_P*.txt"]; 
bb = FileNames["xy_n*.txt"]; 
xys = Table[Round[Get[aa[[i]]]], {i, 1, Length[aa]}]; 
xyn = Table[Round[Get[bb[[i]]]], {i, 1, Length[bb]}]; 
Show[pic, ListPlot[xys, PlotStyle -> {RGBColor[1, 1, 0]}],  
 ImageSize -> 500, PlotLabel -> “Location of Detected Vessels”] 
 
 
 
 
 
 
 
 
Location of Detected Vessels
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SEGMENT THE IMAGE FOR OXIMETRY ANALYSIS 
 
r=92 ;(* RADIUS OF THE OPTIC DISC *) 
(* DIAMETER IS 2r, 1DD = 3r FROM CENTRE OF THE CIRCLE *) 
{x1,y1}={235,482}; (* X, Y COORDINATES OF THE CENTRE OF THE OPTIC DISC - USED 
MATHEMATICA 7 TO DETERMINE CO-ORDINATES *) 
p1={x1,y1}; 
dm=Circle[Round[{x1,y1}],r]; (* DISC MARGIN *) 
dd05=Circle[Round[{x1,y1}],2r]; 
dd1=Circle[Round[{x1,y1}],3r]; 
dd15=Circle[Round[{x1,y1}],4r]; 
dd2=Circle[Round[{x1,y1}],5r]; 
(*ImageDimensions[ImageRead["G:\\2010_02_15 MD Normals\\P11 [R] images coreg\\DC_P11 [R] REF 
VESSEL DETECTION.bmp"]][[2]] 
l1=Line[Round[{{0,y1},{1061,y1}}]];*) 
segtext1={Text["Disc\nmargin",{x1+r,y1}],Text["0.5dd",{x1+2r,y1}],Text["1dd",{x1+3r,y1}],Text["1.5dd",{x
1+4r,y1}],Text["2dd",{x1+5r,y1}]}; 
 
segimage=Show[pic,ImageSize 500,PlotLabel "Location of retinal image 
segmentation",Epilog {Dotted,Yellow,PointSize[0.015],{dm,dd05,dd1,dd15,dd2,Point[p1],segtext1 
     }}] 
 
 
 
LOCATE COORDINATES OF THE INTERSECTIONS BETWEEN THE  RETINAL BLOOD 
VESSELS AND SEGMENTATION RINGS 
 
 
(* LOAD THE PROFILES *) 
prosa = Get[ 
   smoothedprosa =  
    ToString[name] <> "smoothed_pros_" <> ToString[pn] <>  
     ToString["["] <> ToString[es] <> ToString["]"] <> "_art.txt"]; 
prosv = Get[ 
   smoothedprosv =  
    ToString[name] <> "smoothed_pros_" <> ToString[pn] <>  
     ToString["["] <> ToString[es] <> ToString["]"] <> "_vein.txt"]; 
pros = Join[prosa, prosv]; 
 
(* DEFINE THE VESSEL PROFILE LOCATION AND REGION FOR MEAN PROFILE \ 
Location of retinal image segmentation
Disc
margin
0.5 dd 1dd 1.5 dd 2dd
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ANALYSIS-ARTERIOLES AND VENULES *) 
aaart = FileNames["xy_P*a00*.txt"]; 
bbart = FileNames["xy_n*a00*.txt"]; 
xysart = Table[Round[Get[aaart[[i]]]], {i, 1, Length[aaart]}]; 
xynart = Table[Round[Get[bbart[[i]]]], {i, 1, Length[bbart]}]; 
 
aavein = FileNames["xy_P*v00*.txt"]; 
bbvein = FileNames["xy_n*v00*.txt"]; 
xysvein = Table[Round[Get[aavein[[i]]]], {i, 1, Length[aavein]}]; 
xynvein = Table[Round[Get[bbvein[[i]]]], {i, 1, Length[aavein]}]; 
 
(* SHOW VESSEL DETECTION ARTERIOLES AND VENULES WITH SEGMENTATION *) 
DisplayTogetherArray[ 
 Show[pic, ListPlot[xysart],  
  PlotLabel -> "Locations of arteriolar vessel tracking",  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 Show[pic, ListPlot[xysvein],  
  PlotLabel -> "Locations of venular vessel tracking",  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 ImageSize -> 1000] 
 
(* SHOW THE INTERSECTION BETEWEEN THE VESSEL POSITION AND \ 
SEGMENTATION *) 
xyvessels = FileNames["xy_P*vessel*.txt"]; 
(*Table of xy coordinates for all vessels*) 
xyvessels1 =  
  Table[Round[Get[xyvessels[[i]]]], {i, 1, Length[xyvessels]}]; 
 
(*How close in pixels should intersection be to count*) 
CloseEnough = r/50; 
 
(*Table for intersections*) 
VesselIntersections = Table[0, {Length[xyvessels]}]; 
 
(*Loop through vessels *) 
For[VesNo = 1, VesNo <= Length[xyvessels], VesNo++, 
   
  DimVes = Dimensions[xyvessels1[[VesNo]]]; 
  Dist = Flatten[ 
    Total[(xyvessels1[[ 
          VesNo]] - (Table[{x1,  
            y1}, {DimVes[[ 
             1]]}]))^2, {2}]^0.5];  (*Distance of each vessel point \ 
from centre of optic disk*) 
  Intersect = Table[0, {5}];  (*Table to hold intersections*) 
  q = 1; 
  (*Loop to find intersections for vessel from 1r to 5r*) 
  For[j = 1, j <= 5, j++, 
   IntDist = Abs[Dist - j r];  (*Distance from jth circle*) 
   If[Min[IntDist] <  
     CloseEnough,  (*Check if vessel is close enough to circle to \ 
count as intersection*) 
    Intersect[[q]] =  
     Ordering[IntDist, 1];  (*Find index of closest intersection*) 
    q = q + 1; 
    ]; 
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   ]; 
  VesselIntersections[[VesNo]] =  
   Intersect; (*Index number of coordinate pair *) 
  ]; 
 
TableForm[ 
 Transpose[{ 
   bb, 
   Table[i + 1, {i, 0, Length[bb] - 1, 1}], 
   Table[Length[Transpose[Get[bb[[i]]]][[All, 1]]], {i, 1,  
     Length[bb]}], 
   Table[Length[xyn[[i, 1]]], {i, 1, Length[bb]}], 
   VesselIntersections 
   }], 
 TableHeadings -> {Automatic, {"Filename", "FileNumber",  
    "Number of \nxyn profiles", "Check number \nin each pros",  
    "XY Intersection Position\n (Higher number closest to optic \ 
disc)"}}, 
 TableSpacing -> {1, 2}] 
 
 
 
METHODS: 
1. CUT, PASTE AND RUN THE MANIPULATION TO FIND THE 1ST DEGREE VESSEL FILE 
NUMBER - ENTER NUMBER IN "iv*" VARIABLES 
2.  CUT, PASTE THE TABLE WITH THE INTERSECTION VALUES ONTO SEPARATE 
NOTEBOOK AND USETO DEFINE THE POSITION OF THE XY COORDINATES THAT 
INTERSECT WITH THE SEGMENTATION 
 
SHOW LOCATION OF A SELECTED PROFILE AND THE CORRESPONDING TRACKED VESSEL 
 
Manipulate[ 
 profilelocation = 20; 
  
 Show[pic, 
   
  ListPlot[Join[xysart, xysvein][[profilevessel]],  
   PlotStyle -> {Yellow}], 
  ListPlot[ 
   xyn[[profilevessel,  
    1, {Round[Length[xyn[[profilevessel, 1]]]/2]}]],  
   PlotStyle -> {Red}], 
  PlotLabel ->  
   ToString[bb[[profilevessel]]] <> "\nPosition of intersections: " <> 
     ToString[VesselIntersections[[profilevessel]]] <>  
    "\nLength of profiles: " <>  
Locations of arteriolar vessel tracking
Disc
margin
0.5 dd 1dd 1.5 dd 2dd
Locations of venular vessel tracking
Disc
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    ToString[Length[xyn[[profilevessel, 1]]]], ImageSize -> 500,  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1], segtext1}}] 
 , {profilevessel, 1, Length[xyvessels], 1} 
 ] 
 
INSERT THE VESSEL FILE NUMBER "iv*" AND USE THE TABLE TO DEFINE THE POSITION 
OF THE XY COORDINATES THAT INTERSECT WITH THE SEGMENTATION 
 
(* vp DEFINES THE RANGE OF THE VESSEL POSITIONS FOR THE MEAN OD \ 
ANALYSIS *) 
vpr = 10; 
 
(* iv DEFINES THE VESSEL; 1 IS THE FIRST VESSEL  *) 
(* vp DEFINES THE VESSEL POSITION OF THE ANALYSIS  
REMEMBER THAT THE POSITION CLOSEST TO THE OPTIC DISC HAS A HIGHER \ 
VALUE (I.E REVERSE POSITION NUMBERING)*) 
 (* ST ARTERIOLES *) 
ivstadm = 10; 
ivstadd05 = 11; 
ivstadd1 = 12; 
ivstadd15 = 13; 
ivstadd2 = 14; 
 
vpstadm = 119; 
vpstadd05 = 47; 
vpstadd1 = 129; 
vpstadd15 = 76; 
vpstadd2 = 115; 
 
 (* IT ARTERIOLES *) 
ivitadm = 23; 
ivitadd05 = 26; 
ivitadd1 = 27; 
ivitadd15 = 27; 
ivitadd2 = 28; 
 
vpitadm = 12; 
vpitadd05 = 208; 
vpitadd1 = 292; 
vpitadd15 = 91; 
vpitadd2 = 190; 
 
 (* IN ARTERIOLES *) 
ivinadm = 32; 
ivinadd05 = 33; 
ivinadd1 = 33; 
ivinadd15 = 33; 
ivinadd2 = 33; 
 
vpinadm = 12; 
vpinadd05 = 273; 
vpinadd1 = 70; 
vpinadd15 = 22; 
vpinadd2 = 12; 
 
 (* SN ARTERIOLES *) 
ivsnadm = 35; 
ivsnadd05 = 35; 
ivsnadd1 = 35; 
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ivsnadd15 = 35; 
ivsnadd2 = 35; 
 
vpsnadm = 449; 
vpsnadd05 = 259; 
vpsnadd1 = 73; 
vpsnadd15 = 22; 
vpsnadd2 = 12; 
 
 (* ST VENULES *) 
ivstvdm = 39; 
ivstvdd05 = 39; 
ivstvdd1 = 39; 
ivstvdd15 = 39; 
ivstvdd2 = 39; 
 
vpstvdm = 1348; 
vpstvdd05 = 1159; 
vpstvdd1 = 963; 
vpstvdd15 = 731; 
vpstvdd2 = 479; 
 
 (* IT VENULES *) 
ivitvdm = 52; 
ivitvdd05 = 52; 
ivitvdd1 = 52; 
ivitvdd15 = 52; 
ivitvdd2 = 52; 
 
vpitvdm = 957; 
vpitvdd05 = 755; 
vpitvdd1 = 544; 
vpitvdd15 = 305; 
vpitvdd2 = 85; 
 
 (* IN VENULES *) 
ivinvdm = 61; 
ivinvdd05 = 61; 
ivinvdd1 = 61; 
ivinvdd15 = 61; 
ivinvdd2 = 61; 
 
vpinvdm = 309; 
vpinvdd05 = 115; 
vpinvdd1 = 32; 
vpinvdd15 = 22; 
vpinvdd2 = 12; 
 
 (* SN VENULES *) 
ivsnvdm = 63; 
ivsnvdd05 = 64; 
ivsnvdd1 = 65; 
ivsnvdd15 = 65; 
ivsnvdd2 = 65; 
 
vpsnvdm = 27; 
vpsnvdd05 = 30; 
vpsnvdd1 = 286; 
vpsnvdd15 = 98; 
vpsnvdd2 = 12; 
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(* vp DEFINES THE LOCATION OF THE PROFILES NOTE: SOMETIMES THE START  
OF THE VESSEL DETECTION IS AT THE POSITION OF THE PROFILE SO CLOSEST PROFILES 
INCORPORATING 20 PROFILES ARE TAKEN*) 
 (* ST ARTERIOLES *) 
staddm = xyn[[ivstadm, 1, {vpstadm, vpstadm - vpr, vpstadm + vpr}]]; 
stadd05 =  
  xyn[[ivstadd05, 1, {vpstadd05, vpstadd05 - vpr, vpstadd05 + vpr}]]; 
stadd1 = xyn[[ivstadd1,  
   1, {vpstadd1, vpstadd1 - vpr, vpstadd1 + vpr}]]; 
stadd15 =  
  xyn[[ivstadd15, 1, {vpstadd15, vpstadd15 - vpr, vpstadd15 + vpr}]]; 
stadd2 = xyn[[ivstadd2,  
   1, {vpstadd2, vpstadd2 - vpr, vpstadd2 + vpr}]]; 
 (* IT ARTERIOLES *) 
itaddm = xyn[[ivitadm, 1, {vpitadm, vpitadm - vpr, vpitadm + vpr}]]; 
itadd05 =  
  xyn[[ivitadd05, 1, {vpitadd05, vpitadd05 - vpr, vpitadd05 + vpr}]]; 
itadd1 = xyn[[ivitadd1,  
   1, {vpitadd1, vpitadd1 - vpr, vpitadd1 + vpr}]]; 
itadd15 =  
  xyn[[ivitadd15, 1, {vpitadd15, vpitadd15 - vpr, vpitadd15 + vpr}]]; 
itadd2 = xyn[[ivitadd2,  
   1, {vpitadd2, vpitadd2 - vpr, vpitadd2 + vpr}]]; 
 (* IN ARTERIOLES *) 
inaddm = xyn[[ivinadm, 1, {vpinadm, vpinadm - vpr, vpinadm + vpr}]]; 
inadd05 =  
  xyn[[ivinadd05, 1, {vpinadd05, vpinadd05 - vpr, vpinadd05 + vpr}]]; 
inadd1 = xyn[[ivinadd1,  
   1, {vpinadd1, vpinadd1 - vpr, vpinadd1 + vpr}]]; 
inadd15 =  
  xyn[[ivinadd15, 1, {vpinadd15, vpinadd15 - vpr, vpinadd15 + vpr}]]; 
inadd2 = xyn[[ivinadd2,  
   1, {vpinadd2, vpinadd2 - vpr, vpinadd2 + vpr}]]; 
 (* SN ARTERIOLES *) 
snaddm = xyn[[ivsnadm, 1, {vpsnadm, vpsnadm - vpr, vpsnadm + vpr}]]; 
snadd05 =  
  xyn[[ivsnadd05, 1, {vpsnadd05, vpsnadd05 - vpr, vpsnadd05 + vpr}]]; 
snadd1 = xyn[[ivsnadd1,  
   1, {vpsnadd1, vpsnadd1 - vpr, vpsnadd1 + vpr}]]; 
snadd15 =  
  xyn[[ivsnadd15, 1, {vpsnadd15, vpsnadd15 - vpr, vpsnadd15 + vpr}]]; 
snadd2 = xyn[[ivsnadd2,  
   1, {vpsnadd2, vpsnadd2 - vpr, vpsnadd2 + vpr}]]; 
 
 (* ST VENULES *) 
stvddm = xyn[[ivstvdm, 1, {vpstvdm, vpstvdm - vpr, vpstvdm + vpr}]]; 
stvdd05 =  
  xyn[[ivstvdd05, 1, {vpstvdd05, vpstvdd05 - vpr, vpstvdd05 + vpr}]]; 
stvdd1 = xyn[[ivstvdd1,  
   1, {vpstvdd1, vpstvdd1 - vpr, vpstvdd1 + vpr}]]; 
stvdd15 =  
  xyn[[ivstvdd15, 1, {vpstvdd15, vpstvdd15 - vpr, vpstvdd15 + vpr}]]; 
stvdd2 = xyn[[ivstvdd2,  
   1, {vpstvdd2, vpstvdd2 - vpr, vpstvdd2 + vpr}]]; 
 (* IT VENULES *) 
itvddm = xyn[[ivitvdm, 1, {vpitvdm, vpitvdm - vpr, vpitvdm + vpr}]]; 
itvdd05 =  
  xyn[[ivitvdd05, 1, {vpitvdd05, vpitvdd05 - vpr, vpitvdd05 + vpr}]]; 
itvdd1 = xyn[[ivitvdd1,  
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   1, {vpitvdd1, vpitvdd1 - vpr, vpitvdd1 + vpr}]]; 
itvdd15 =  
  xyn[[ivitvdd15, 1, {vpitvdd15, vpitvdd15 - vpr, vpitvdd15 + vpr}]]; 
itvdd2 = xyn[[ivitvdd2,  
   1, {vpitvdd2, vpitvdd2 - vpr, vpitvdd2 + vpr}]]; 
 (* IN VENULES *) 
invddm = xyn[[ivinvdm, 1, {vpinvdm, vpinvdm - vpr, vpinvdm + vpr}]]; 
invdd05 =  
  xyn[[ivinvdd05, 1, {vpinvdd05, vpinvdd05 - vpr, vpinvdd05 + vpr}]]; 
invdd1 = xyn[[ivinvdd1,  
   1, {vpinvdd1, vpinvdd1 - vpr, vpinvdd1 + vpr}]]; 
invdd15 =  
  xyn[[ivinvdd15, 1, {vpinvdd15, vpinvdd15 - vpr, vpinvdd15 + vpr}]]; 
invdd2 = xyn[[ivinvdd2,  
   1, {vpinvdd2, vpinvdd2 - vpr, vpinvdd2 + vpr}]]; 
 (* SN VENULES *) 
snvddm = xyn[[ivsnvdm, 1, {vpsnvdm, vpsnvdm - vpr, vpsnvdm + vpr}]]; 
snvdd05 =  
  xyn[[ivsnvdd05, 1, {vpsnvdd05, vpsnvdd05 - vpr, vpsnvdd05 + vpr}]]; 
snvdd1 = xyn[[ivsnvdd1,  
   1, {vpsnvdd1, vpsnvdd1 - vpr, vpsnvdd1 + vpr}]]; 
snvdd15 =  
  xyn[[ivsnvdd15, 1, {vpsnvdd15, vpsnvdd15 - vpr, vpsnvdd15 + vpr}]]; 
snvdd2 = xyn[[ivsnvdd2,  
   1, {vpsnvdd2, vpsnvdd2 - vpr, vpsnvdd2 + vpr}]]; 
 
 
(* -SHOWS THE SEGMENTATION OF THE RETINA AND LOCATION OF THE PROFILES AND THE 
VESSEL TRACKING *) 
DisplayTogetherArray[ 
 Show[pic,  
  ListPlot[#, PlotStyle -> {Red, Orange, Orange}] & /@ {staddm,  
    stadd05, stadd1, stadd15, stadd2, itaddm, itadd05, itadd1,  
    itadd15, itadd2, inaddm, inadd05, inadd1, inadd15, inadd2, snaddm, 
     snadd05, snadd1, snadd15, snadd2}, 
  PlotLabel ->  
   "Locations of arteriolar profile analysis\n and retinal image \ 
segmentation", ImageSize -> 500,  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 Show[pic,  
  ListPlot[xysart], 
  ListPlot[#, PlotStyle -> {Red, Orange, Orange}] & /@ {staddm,  
    stadd05, stadd1, stadd15, stadd2, itaddm, itadd05, itadd1,  
    itadd15, itadd2, inaddm, inadd05, inadd1, inadd15, inadd2, snaddm, 
     snadd05, snadd1, snadd15, snadd2}, 
  PlotLabel ->  
   "Locations of arteriolar profile analysis\n and arteriolar vessel \ 
tracking", ImageSize -> 500,  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 ImageSize -> 1000 
 ] 
 
DisplayTogetherArray[ 
 Show[pic,  
  ListPlot[#, PlotStyle -> {Red, Orange, Orange}] & /@ {stvddm,  
    stvdd05, stvdd1, stvdd15, stvdd2, itvddm, itvdd05, itvdd1,  
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    itvdd15, itvdd2, invddm, invdd05, invdd1, invdd15, invdd2, snvddm, 
     snvdd05, snvdd1, snvdd15, snvdd2}, 
  PlotLabel ->  
   "Locations of venular profile analysis\n and retinal image \ 
segmentation", ImageSize -> 500,  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 Show[pic,  
  ListPlot[xysvein], 
  ListPlot[#, PlotStyle -> {Red, Orange, Orange}] & /@ {stvddm,  
    stvdd05, stvdd1, stvdd15, stvdd2, itvddm, itvdd05, itvdd1,  
    itvdd15, itvdd2, invddm, invdd05, invdd1, invdd15, invdd2, snvddm, 
     snvdd05, snvdd1, snvdd15, snvdd2}, 
  PlotLabel ->  
   "Locations of venular profile analysis\n and arteriolar vessel \ 
tracking", ImageSize -> 500,  
  Epilog -> {Dotted, Yellow,  
    PointSize[0.015], {dm, dd05, dd1, dd15, dd2, Point[p1],  
     segtext1}}], 
 ImageSize -> 1000 
 ] 
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Appendix 5: Oximetry Results in Retinal Artery 
Occlusion 
 
Subject A3 is a 67 year old male with a 10 day history of a left superior branch retinal artery 
occlusion (Figure A3.1A). The BCVA of the left eye was 6/9 at the time of imaging. In 
contrast to subject A1, the dark calibrated spectral images of the left retina at the same 9 
selected wavelengths show a macular branch of the superotemporal arteriole appearing 
slightly more optically dense than in normal eyes at wavelengths greater than 590 nm 
indicating a lower OS (Figure A3.1B; yellow arrow head). The optical density profile and OS 
calculation of the selected macular branch of the superotemporal arteriole indicate a slightly 
lower OS of 86% compared to other selected arterioles. (Figure A3.1C, red bordered image). 
Observational abnormalities of the superotemporal and inferotemporal 1st degree venules are 
not apparent – the optical densities are similar to normal eyes at wavelengths above 600 nm. 
However, the OS calculation of the superotemporal venule is considerably higher than that of 
the inferotemporal venule, 32% vs. 5%. The pseudocolour oximetry maps of the retinal 
vessels show a slightly lower than normal OS in the superotemporal retinal arteriole 
traversing the macula (Figure A3.1D). 
 
 
 
 
 
 
 
 
 
 
 
 305 
 
Subject A3 
Figure A3.1: Subject A3: a 67 year old male with 
a 10 day history of a left superior branch retinal 
artery occlusion (BCVA: 6/9). A. A spectral 
image of the left fundus acquired at 580 nm 
(colour image was not obtained). B. Dark 
calibrated spectral images of the left retina at 9 
selected wavelengths (560, 570, 580, 590, 600, 
610, 620 and 630 nm). First degree retinal 
arterioles and venules are indicated by red and 
blue arrow heads respectively. An abnormal 
appearance of the retinal arteriole related to the 
OS is indicated by the yellow arrow head. C. The 
mean optical density profile (± SD; red filled 
circle and whiskers) of selected segments of the 
temporal arterioles and venules and the respective 
OS calculations (and 95% confidence interval). 
Locations of the analysis (red and orange lines) 
are shown in the grayscale image. Abnormal 
optical density profiles are indicated by red 
borders. D. Pseudocolour oximetry maps of the 
retinal arterioles (left images) and retinal venules 
(right images). A colour scale of the quantitative 
OS values is to the left of the images. 
B. Observational features of the spectral 
images 
 
 
 
 
 
A. Spectral image at 580 nm 
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C. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
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D. Oxygen saturation of the retinal vasculature 
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Appendix 6: Oximetry Results in Retinal Vein 
Occlusion 
 
 
Figure A4.1: Analyses of subject V1 with spectral images acquired of the superotemporal 
retina (superotemporal branch retinal vein occlusion). A.  Dark calibrated spectral images of 
the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First 
degree retinal arterioles and venules are indicated by red and blue arrow heads respectively. 
Abnormal appearances of the retinal venules relating to the OS are indicated by the green 
arrow heads. These venules appear to be less optically dense than in normal eyes at 
wavelengths greater than 600 nm indicating a higher OS. B. The mean optical density profile 
(± SD; red filled circle and whiskers) of selected segments of the temporal arterioles and 
venules and the respective OS calculations (and 95% confidence interval). Locations of the 
analysis (red and orange lines) are shown in the grayscale image. Abnormal optical density 
profiles are indicated by red borders. C. Pseudocolour oximetry maps of the retinal arterioles 
(left images) and retinal venules (right images). There is high venous oxygenation in the 
superotemporal venules. A colour scale of the quantitative OS values is to the left of the 
images. 
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Subject V1 – superotemporal field of view 
A. Observational features of the spectral images 
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B. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
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C. Oxygen saturation of the retinal vasculature 
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Figure A4.2: Analyses of subject V3 with spectral images acquired of the temporal retina 
(left ischaemic superotemporal branch retinal vein occlusion with neovascularization of the 
temporal retina). A. A colour image of the left fundus. B. Dark calibrated spectral images of 
the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First 
degree retinal arterioles and venules are indicated by red and blue arrow heads respectively. 
Abnormal appearances of the retinal venules relating to the OS are indicated by the green 
arrow head. Theses venules appear less optically dense than in normal eyes at wavelengths 
greater than 600 nm indicating a higher OS. C. The mean optical density profile (± SD; red 
filled circle and whiskers) of selected segments of the temporal arterioles and venules and the 
respective OS calculations (and 95% confidence interval). Locations of the analysis (red and 
orange lines) are shown in the grayscale image. Abnormal optical density profiles are 
indicated by red borders. D. Pseudocolour oximetry maps of the retinal arterioles (left 
images) and retinal venules (right images). There is high venous oxygenation in the 
superotemporal venules. A colour scale of the quantitative OS values is to the left of the 
images. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 313 
 
Subject V3 - temporal field of view 
A. Colour image B. Observational features of the spectral images 
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C. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Other vessel segments and macular branches  
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D. Oxygen saturation of the retinal vasculature 
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Figure A4.3: Subject V5: a 73 year old female with a 26 month history of a left ischaemic 
superotemporal branch retinal vein occlusion (BCVA: 6/36). A. A colour image of the left 
fundus. B. Fluorescein angiograms of the left fundus 2 years (left) and 1 week (right) prior to 
spectral imaging. There is a region of reduced background fluorescence (yellow arrow head; 
capillary “non-perfusion”) associated with hyperfluorescent segments of the superotemporal 
vessels (red arrow head; vessel wall staining) C. Dark calibrated spectral images of the left 
retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree 
retinal arterioles and venules are indicated by red and blue arrow heads respectively. 
Abnormal appearances of the retinal venules relating to the OS are indicated by the green 
arrow heads. These venules appear less optically dense than in normal eyes at wavelengths 
greater than 600 nm indicating a higher OS. D. The mean optical density profile (± SD; red 
filled circle and whiskers) of selected segments of the temporal arterioles and venules and the 
respective OS calculations (and 95% confidence interval). Locations of the analysis (red and 
orange lines) are shown in the grayscale image. Abnormal optical density profiles are 
indicated by red borders. E. Pseudocolour oximetry maps (top image: standard view of the 
posterior pole; bottom image: superotemporal field of view) of the retinal arterioles (left 
images) and retinal venules (right images). There is high venous oxygenation in the 
superotemporal venules. A colour scale of the quantitative OS values is to the left of the 
images 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 317 
 
Subject V5 
A. Colour image C. Observational features of the spectral images 
 
 
 
B. Fluorescein Angiogram 
 
2 years prior to spectral imaging 1 week prior to spectral imaging
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D. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Macular branches  
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E. Oxygen saturation of the retinal vasculature 
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Figure A4.4: Subject V6: a 53 year old female with a 4 month history of a right ischaemic 
superotemporal branch retinal vein occlusion (BCVA: 6/24). A. A colour image of the right 
fundus. B. Fluorescein angiograms of the right fundus. There is a region of reduced 
background fluorescence (yellow arrow head; capillary “non-perfusion”). C. Dark calibrated 
spectral images of the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 
and 630 nm). First degree retinal arterioles and venules are indicated by red and blue arrow 
heads respectively. Abnormal appearances of the retinal venules relating to the OS are 
indicated by the green arrow head. The venules appear less optically dense than in normal 
eyes at wavelengths greater than 600 nm indicating a higher OS. D. The mean optical density 
profile (± SD; red filled circle and whiskers) of selected segments of the temporal arterioles 
and venules and the respective OS calculations (and 95% confidence interval). Locations of 
the analysis (red and orange lines) are shown in the grayscale image. E. Pseudocolour 
oximetry maps of the retinal arterioles (left images) and retinal venules (right images). A 
colour scale of the quantitative OS values is to the left of the images. 
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Subject V6 
A. Colour image B. Observational features of the spectral images 
 
 
 
C. Fluorescein Angiogram 
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D. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Other vessel segments and macular branches  
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E. Oxygen saturation of the retinal vasculature 
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Figure A4.5: Subject V7: a 53 year old male with a 9 month history of a right ischaemic 
superior hemi-retinal vein occlusion (BCVA: 6/18). A. A colour image of the right fundus. B. 
Fluorescein angiograms of the right fundus. Hyperfluorescent segments of the 
superotemporal vessels are present (red arrow head; vessel wall staining). C. Dark calibrated 
spectral images of the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 
and 630 nm). First degree retinal arterioles and venules are indicated by red and blue arrow 
heads respectively. Abnormal appearances of the retinal venules relating to the OS are 
indicated by the green arrow head. The venule appears less optically dense than in normal 
eyes at wavelengths greater than 600 nm indicating a higher OS. D. The mean optical density 
profile (± SD; red filled circle and whiskers) of selected segments of the temporal arterioles 
and venules and the respective OS calculations (and 95% confidence interval). Locations of 
the analysis (red and orange lines) are shown in the grayscale image. E. Pseudocolour 
oximetry maps of the retinal arterioles (left images) and retinal venules (right images). A 
colour scale of the quantitative OS values is to the left of the images. 
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Subject V7 
A. Colour image C. Observational features of the spectral images 
 
 
 
B. Fluorescein Angiogram 
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D. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Macular branches  
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E. Oxygen saturation of the retinal vasculature 
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Figure A4.6: Subject V8: a 70 year old male with a 4 month history of a right non-ischaemic 
superior hemi-retinal vein occlusion (BCVA: 6/12). A. A colour image of the right fundus 
(fluorescein angiogram was not performed). B. Dark calibrated spectral images of the left 
retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First degree 
retinal arterioles and venules are indicated by red and blue arrow heads respectively. 
Abnormal appearances of the retinal venules relating to the OS are not present. C. The mean 
optical density profile (± SD; red filled circle and whiskers) of selected segments of the 
temporal arterioles and venules and the respective OS calculations (and 95% confidence 
interval). Locations of the analysis (red and orange lines) are shown in the grayscale image. 
D. Pseudocolour oximetry maps of the retinal arterioles (left images) and retinal venules 
(right images). A colour scale of the quantitative OS values is to the left of the images. 
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Subject V8 
A. Colour image B. Observational features of the spectral images 
 
 
 
Fluorescein angiogram not performed 
 
 
 330 
 
C. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Other vessel segments and macular branches  
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D. Oxygen saturation of the retinal vasculature 
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Figure A4.7: Subject V9: a 70 year old male with a 12 year history of a left non-ischaemic 
inferotemporal branch retinal vein occlusion (BCVA: 6/12). A. A colour image of the left 
fundus. B. Fluorescein angiograms of the left fundus. C. Dark calibrated spectral images of 
the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 and 630 nm). First 
degree retinal arterioles and venules are indicated by red and blue arrow heads respectively. 
Abnormal appearances of the retinal venules relating to the OS are indicated by the green 
arrow head. The venules appear less optically dense than in normal eyes at wavelengths 
greater than 600 nm indicating a higher OS. D. The mean optical density profile (± SD; red 
filled circle and whiskers) of selected segments of the temporal arterioles and venules and the 
respective OS calculations (and 95% confidence interval). Locations of the analysis (red and 
orange lines) are shown in the grayscale image. Negative OS values were calculated in the 
inferotemporal venules. E. Pseudocolour oximetry maps of the retinal arterioles (left images) 
and retinal venules (right images). There is low venous oxygenation (< 0%) in the 
superotemporal venules. A colour scale of the quantitative OS values is to the left of the 
images. 
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Subject V9 
A. Colour image F. Observational features of the spectral images 
 
 
 
B. Fluorescein Angiogram 
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D. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Other vessel segments and macular branches  
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E. Oxygen saturation of the retinal vasculature 
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Figure A4.7: Analyses of subject V9 with spectral images acquired of the inferotemporal 
retina (non-ischaemic inferotemporal branch retinal vein occlusion). A. Dark calibrated 
spectral images of the left retina at 9 selected wavelengths (560, 570, 580, 590, 600, 610, 620 
and 630 nm). First degree retinal arterioles and venules are indicated by red and blue arrow 
heads respectively. Abnormal appearances of the retinal venules related to the OS are 
indicated by the green arrow head. The venules appear less optically dense than in normal 
eyes at wavelengths greater than 600 nm indicating a higher OS. B. The mean optical density 
profile (± SD; red filled circle and whiskers) of selected segments of the temporal arterioles 
and venules and the respective OS calculations (and 95% confidence interval). Locations of 
the analysis (red and orange lines) are shown in the grayscale image. Negative OS values 
were calculated in the inferotemporal venules. C. Pseudocolour images of the oxygen 
saturation calculations overlayed onto the retinal arterioles (left images) and retinal venules 
(right images). 
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Subject V9 – inferotemporal field of view 
A. Observational features of the spectral images 
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B. Mean optical density profile and oxygen saturation of selected segments of the retinal blood vessels 
Location 1st degree vessels  Other vessel segments and macular branches  
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Appendix 7: Oximetry Results in Primary Open 
Angle Glaucoma. 
 
 
 
 
Figure A5.1: Colour images, Humphrey visual field analyses and pseudocolour quantitative 
oxygen saturation calculations of the retinal vasculature in patients with asymmetrical POAG. 
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